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Abstract 
 
This thesis describes a series of studies involving patients with neuropathies 
and healthy controls. In the studies of disease, two groups were recruited: 
patients with inflammatory neuropathies and those with hereditary 
neuropathies. Each group was separated into those with and those without 
tremor and compared with healthy controls. Clinical assessments and 
neurophysiological tests were employed to correlate cerebellar function with 
tremor. The final study of healthy participants investigated the effect of 
transcranial direct current stimulation (TDCS) on the cerebellum during finger 
tapping.  
 
1) Tremor was most common in IgM paraproteinaemic neuropathies, also 
occurring in 58% of those with chronic inflammatory demyelinating 
polyradiculoneuropathy and 56% of those with multifocal motor 
neuropathy with conduction block (MMNCB). Tremor was generally 
refractory to treatment and contributed to disability in some patients. 
Although tremor severity correlated with F wave latency, it was 
insufficient to distinguish those with, from those without tremor.  
 
2) Impaired eyeblink classical conditioning and paired associative 
stimulation in patients with inflammatory neuropathy and tremor 
differentiated them from neuropathy patients without tremor and healthy 
controls, strongly suggesting impairment of cerebellar function is linked to 
the production of tremor in these patients. 
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3) The prevalence study in CMT1A patients revealed tremor in 21% and in 
42% of those it caused impairment. Eyeblink conditioning, visuomotor 
adaptation and electro-oculography were no different between tremulous 
and non-tremulous patients and healthy controls. This argues against a 
prominent role for an abnormal cerebellum in tremor generation in the 
patients studied. Rather, they suggest an enhancement of the central 
neurogenic component of physiological tremor as a possible mechanism.  
 
4) TDCS of the lateral cerebellum and its effect on paced finger tapping was 
examined. There was no effect on accuracy or variability of the intertap 
interval, providing no support for a direct role of the cerebellum in event 
based timing. 
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Overall Summary 
 
The pathophysiological mechanisms underlying tremor may be investigated 
in a variety of ways. This thesis describes the use of a variety of 
electrophysiological techniques twinned with clinical assessment to 
determine features that may be pertinent to the occurrence of tremor in 
patients with neuropathies and in the final chapter aims to identify a rhythmic 
motor control task that can be modulated by cerebellar stimulation. 
 
The first chapter provides a clinical introduction to tremor and its various 
types, leading to contemporaneous hypotheses of pathophysiological 
mechanisms of some of these. This is a prelude to chapter 2 where the 
concept and clinical spectrum of neuropathic tremor is introduced and 
potential hypotheses of cerebellar dysfunction described. Chapter 3 outlines 
the aims of the thesis. Chapter 4 provides a background and detailed 
description of the methods used throughout the thesis. 
 
Chapter 5 describes the study conducted on patients with inflammatory 
neuropathies, comparing clinical and nerve conduction features of patients 
with and without tremor. 
 
Chapter 6 develops the findings from chapter 5 and is a description of a 
series of experiments on patients with inflammatory neuropathies aiming to 
distinguish those with and those without tremor based on response to paired 
associative stimulation and eyeblink classical conditioning. 
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Chapter 7 examines patients with CMT1A using an array of 
electrophysiological tests investigating function of the cerebellum and 
correlating these with clinical features of those with and without tremor as 
well as healthy controls. 
 
Chapter 8 moves beyond neuropathic tremor and aims to establish whether 
a paradigm of rhythmic finger tapping is amenable to modulation by non-
invasive stimulation of the cerebellum. 
 
Each of these experimental chapters includes more specific detail of 
methodology beyond that described in the general methods chapter 4. They 
outline results of experiments and lead to a discussion of methodological 
validity, relevance to previous work and insights into pathogenesis or motor 
control that they provide. 
 
The final chapter concludes by summarising the findings and putting them in 
context of current literature as well as generating ideas of further work, some 
of which has already commenced. 
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Chapter 1: Tremor: an introduction 
 
1.1 What is tremor 
 
Tremor is characterized by a rhythmic, involuntary, oscillatory movement of 
one or more body parts and is perceived to be involuntary by the patient 
(adapted from Movement Disorder Society (MDS) consensus statement3). 
Defining tremor is fraught with difficulty given the spectrum of differing types. 
The components of the consensus statement are prone to difficulties in 
capturing all that is considered tremor and excluding those hyperkinetic 
movements that are not. Nevertheless, a pragmatic clinical approach often 
needs to be taken, excluding all those movements which in aggregate have 
characteristics more akin to other hyperkinetic movements such as asterixis 
(negative myoclonus) or clonus and inclusion of those movements where a 
rhythmic or semi-rhythmic movement of a body part dominates with a pattern 
that equates roughly to an oscillation and is of an acceptably high frequency 
i.e. more than 2-3 Hz or so and perhaps describable by a layperson as 
‘shaking’ or ‘trembling’. 
 
1.2 Clinical spectrum of tremor 
 
The causes of tremor are many. It forms part of normal physiology at one 
end of the spectrum with so called physiological tremor, ubiquitously present 
when a limb is not at rest, and is of very low amplitude, relatively high 
frequency of oscillation and barely perceptible to the observer4. Tremor, 
when pathological can occur due to a number of hereditary or acquired 
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neurological and neurodegenerative conditions, systemic diseases as well as 
potentially arising as a side effect from a number of drugs such as sodium 
valproate, beta-agonists, neuroleptics, selective serotonin reuptake 
inhibitors, central nervous system stimulants and depressants and lithium. 
The diagnosis of tremor is most commonly clinical and less typically relies on 
imaging such as magnetic resonance imaging (MRI) or nuclear imaging of 
dopamine transport to positively identify an aetiology. Table 1.1 summarises 
a range of tremor types typically considered in a clinical setting when faced 
with a patient with tremor. 
Essential tremor Typically isolated action tremor of the 
upper limbs. Classically an 
autosomal dominant family history 
with alcohol responsiveness5 6 but 
likely represents a heterogeneous 
group of diseases. 
Parkinsonian tremor Archetypically tremor at rest in the 
upper limb with asymmetry between 
limbs in the idiopathic form of 
disease. Associated with other 
parkinsonian features. Other typical 
forms of tremor exist including re-
emergent postural tremor7. Other 
body parts may be affected such as 
the legs and jaw. 
Dystonic tremor Dystonic posturing in the tremulous 
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body part although ‘tremor 
associated with dystonia’ where 
tremor occurs in a different body part 
to the dystonia may well represent a 
spectrum of the same phenomenon. 
Often jerky due to varying amplitude 
and may be relatively task or 
position-specific.  
Drug-induced tremor Often upper limbs, low amplitude, 
high frequency, symmetrical action 
tremor. Other forms including 
parkinsonian tremor may occur. 
Enhanced physiological tremor Often upper limbs, low amplitude, 
high frequency, symmetrical action 
tremor. Often identifiable precipitants. 
Cerebellar tremor Head and upper limb action tremor of 
low frequency and large amplitude. 
Other cerebellar signs. Intention 
component. 
Oculopalatal tremor Low frequency and sometimes 
associated with tremor in related 
body parts. May in specific types be 
related to olivary hypertrophy that 
develops subsequent to a lesion 
typically within the Guillain-Mollaret 
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triangle, but this may be an 
oversimplification. 
Functional (psychogenic) tremor Behaves very similarly to volitional 
rhythmic oscillatory movements but 
perceived by patients as involuntary. 
Abrupt onset, distractibility, 
entrainment, high inter-limb 
coherence and response to placebo 
may be seen. 
Neuropathic tremor Predominantly action but can occur 
at rest. Infrequently in any other body 
part except arms. Typically found in 
demyelinating inflammatory 
neuropathies and some hereditary 
neuropathies. 
Fragile X tremor ataxia syndrome Associated with cognitive decline and 
ataxia with a family history. 
Other genetic causes (e.g. 
spinocerebellar ataxia) 
Additional features such as 
progressive ataxia. Often autosomal 
dominant family history with 
anticipation. 
Cortical tremor High frequency (20Hz) rhythmic 
cortical discharges. Family history 
and epilepsy may occur. 
Holmes tremor Low frequency, high amplitude 
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tremor in rest, postural and kinetic 
conditions usually due to a lesion in 
the brainstem or thalamus. 
Orthostatic tremor Very low amplitude, high frequency 
(usually 13-18Hz) tremor of the legs 
on standing with high inter-limb 
coherence, relieved by walking, 
causing a latent onset unsteady 
feeling when standing. Isolated or in 
the context of other diseases such as 
parkinsonism. 
Wilson’s disease tremor Wing-beating, rest or other action 
tremors seen. Usually young onset 
with copper metabolism abnormality 
due to an array of autosomal 
recessive mutations. 
Table 1.1 List of tremor-dominant or tremor-typical conditions and their 
associated features. 
 
1.3 Pathophysiological mechanisms of tremor generation 
 
Although tremor is one of the commonest movement disorders and amongst 
the commonest neurologic symptoms referred to neurologists, relatively little 
is understood about its pathogenesis. The clinical manifestation of tremor is 
wide and varies according to amplitude, frequency of oscillation, body part 
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affected, context in which tremor occurs (e.g. rest versus action) and 
associated features. Parallel to this, the pathophysiological mechanisms that 
underpin these different tremor types also likely varies although there may be 
some common mechanisms, supported in part, for example, by the near 
ubiquitous benefit of deep brain stimulation of nuclei such as within the 
ventral intermediate thalamus for a variety of tremor types, irrespective of 
their underlying aetiology or phenotype8. 
 
There are pure mechanical properties of limb oscillation that relate to a 
mechanical object’s propensity to oscillate when provided with mechanical 
energy. The weight, length and stiffness of the object then determine 
properties of the oscillation such as frequency and amplitude. Equation 1.1 
below summarises this relationship between the frequency of oscillation and 
the mentioned variables. 
 
f ∝ √(k/m)        Equation 1.1 
f = frequency; k = stiffness; m = limb inertia 
 
This equation demonstrates how increasing stiffness of a limb increases the 
natural frequency of oscillation of that limb. This natural frequency, or 
eigenfrequency, is the frequency at which the limb prefers to oscillate given 
an external mechanical perturbation such as that referred to as cardioballistic 
arising from cardiac contraction. The converse is true with limb weight; the 
greater the weight, the slower the natural oscillatory frequency. With 
enhanced physiological tremor, although these mechanics still hold, 
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excitation of short loop reflexes seem to enhance the oscillatory behaviour of 
the physiological tremor by providing EMG drive phase-locked to the tremor. 
Composition of the tremor may then be considered to be caused by a 
generator providing a perturbation, modulated by the oscillatory dynamics of 
the limb and the enhanced reflex circuits providing phase-locked EMG to 
augment the tremor. So-called central forms of tremor may have analogous 
reflex enhancement.  
 
Control of the hand demands accurate control and thus a high gain with 
responsive feedback. The motor command is continually updated according 
to feedback received from the periphery. This feedback occurs in various 
forms from short latency reflex arcs involving only the spinal cord to longer 
latency afferents including those involving the cerebellum or motor-sensory 
cortices. Any excess delay in feedback may be predicted by a model of 
optimal feedback control to lead to instability that would be prone to 
oscillating. Indeed, from an engineering point of view, a propensity to 
oscillate is an inevitable property of a system with a controller of high gain 
and negative feedback. It is possible that such instability with oscillatory 
circuits could lead to tremor in the periphery. There is an emerging view that 
suggests physiological or pathological networks may exist and oscillate with 
varying dynamics (for review, see 9). 
 
An alternative pathophysiological mechanism may be that cells, presumably 
in syncitia or with a common ion channel mutation or abnormality, have 
abnormal membrane conductance that promotes spontaneous or low-
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threshold recurrent depolarisation leading to a pacemaker drive modulating 
motor output and making it oscillatory at a tremor frequency. It is possible 
that abnormal local rhythmicity drives an otherwise normal circuit. The 
inferior olive has been proposed to be one such pacemaker locus with 
cerebellar modulation in oculopalatal tremor10, with intrinsic pacemaker 
properties of the inferior olive relating to its syncitia and drug treatments that 
are in development using this rationale. However, the evidence for the 
inferior olive as a central node in the network generating other tremor types 
is less cut-and-dry11 (see section 1.3.1 below on Essential tremor).  
 
Nevertheless, an account of tremor pathogenesis, by necessity, requires a 
specific approach to differing subtypes of tremor; despite potentially common 
final pathways, the upstream pathogenic mechanisms may well vary 
between tremor types. 
 
1.3.1 Essential tremor 
 
Essential tremor, primarily a monosymptomatic condition, is one of the 
commonest types of tremor. However, an array of other milder clinical 
neurocognitive features have been described in association but 
differentiating these from likely confounds is difficult. The estimated 
prevalence varies markedly between studies with a study from the USA12 
suggesting an overall prevalence of 2.2% whilst an influential study from 
Spain, entitled NEDICES13 suggested 8.9% although a third were not 
examined directly and this was a study of over 65 year-olds. Other reports 
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have estimated between 1% in the general population and about 5% in the 
population over 65 years of age14. ET has been reported to have a bimodal 
distribution of age of onset5, including adolescence/early adulthood and after 
the 5th decade of life (figure 1.1). Over half have affected family members. A 
substantial proportion of that described in the literature as essential tremor 
may well represent a heterogeneous group of diseases and some have used 
a distinction between senile, sporadic and hereditary forms15. Essential 
tremor primarily affects the upper limbs and is an action tremor. It can also 
affect other body parts such as the head, jaw, tongue, voice, trunk and legs 
but not in isolation3 6. A sub-group of ET where there is a clear autosomal 
dominant family history and often a responsiveness of the tremor to alcohol 
exists that may well represent a narrower aetiology. However, even here, 
difficulties may arise as both GWAS studies have identified specific risk 
factors such as LINGO1 that seem to be predictive only in specific 
populations16 and not others17. Other risk loci have been identified from 
similar GWAS studies including loci on chromosomes 2, 3 and 6 (for meta-
analysis and review, see18). Further, specific Mendelian genetic causes (e.g. 
ANO3) have been described in families where an autosomal dominant family 
history exists with cervical dystonia as the predominant feature and isolated 
tremor occurring in some of the family members19. Clearly, the report of 
dystonic posturing in the family history of those with pure isolated tremor may 
be unreliable meaning that a small proportion of those apparent autosomal 
dominant ET cases may represent genotype-phenotype correlations of 
genes predominantly responsible for familial dystonia. Another possibly rare 
cause of familial ET may be the gene, FUS, fused in sarcoma. There are 
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further potential candidate loci20 21 but these likely explain a very small 
minority of all familial ET. The surprisingly low prevalence of tremor in first-
degree relatives with ET in a community-based study perhaps speaks to the 
possibility of alternative inheritance modes rather than autosomal dominant 
or otherwise poor penetrance. These have been postulated to include 
polygenic, mitochondrial, recessive and X-linked modes of transmission22. 
Pairwise concordance in monozygotic twins was twice that in dizygotic twins 
(0.60 monozygotic; 0.27 dizygotic), indicating both environmental and 
genetic influences on pathogenesis23. 
 
Figure 1.1 Age of essential tremor onset. Adapted from Bain et al5 
 
 The question of whether or not ET is a neurodegenerative disorder has been 
the focus of some recent debate. Louis et al have published a series of 
autopsies in 11 patients with ET24, all of whom later developed dementia or 
progressive supranuclear palsy. Two clusters of pathology were identified, 
one of brainstem Lewy body disease and the other, cerebellar Purkinje cell 
loss. Concerns about the argument for a neurodegenerative process rest on 
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most of the evidence base of pathological changes in autopsy series being in 
patients over 70 years old where the co-existence of confounding 
pathologies is relatively high. Further, ET recruited in such studies does 
appear to be a heterogeneous group of conditions and as such, those 
included in autopsy series may well have heterogeneous aetiologies.  
 
1.3.1.1 The cerebellum in essential tremor 
 
Not entirely mutually exclusive to the neurodegenerative debate is the 
question of whether in ET there is evidence for a role of the cerebellum in 
generating the tremor. This is underpinned by functional imaging, 
electrophysiological and pathological studies. PET studies have 
demonstrated a bilateral increase in cerebellar and thalamic blood flow 25 and 
MR spectroscopy has suggested dysfunction in the cerebellar cortex 26.  Eye-
blink conditioning is also severely impaired in essential tremor 27 28 
implicating the cerebellum. A study with blood flow PET showed hyperactivity 
of the cerebellum at rest, and then further increase of activity in the 
cerebellum and red nucleus region as well29. The strong evidence for a role 
of the cerebellum in essential tremor has also been corroborated by 
structural imaging studies. Benito-Leon et al. 30 assessed whether white or 
grey matter changes occurred in 19 ET patients vs. 20 age and gender-
matched controls. The authors concluded that structural white and grey 
abnormalities may be detected in ET patients using VBM (voxel-based 
morphometry) and a 3-T (3-Tesla) MRI scanner, corroborated by other 
groups31. Using lower field scanners (1.5-T) delivered contradictory results32 
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33. Using Diffusion-weighted imaging (DWI) to search for evidence of tissue 
integrity abnormalities in these areas in ET patients failed to find any 
significant difference from controls 34, arguing against major structural 
damage in the ET brain, though more subtle neurodegenerative changes 
could not be ruled out. However, Shin et al. 35 investigated changes in 
anisotropy in patients with ET by comparing fractional anisotropy (FA) 
images generated from diffusion tensor imaging data acquired at 1.5-T in 10 
patients with ET compared with 8 control subjects using statistical parametric 
mapping to make voxel-by-voxel comparisons; compared with the control 
subjects, they found patients with ET exhibited significantly reduced FA in 
areas of the brainstem and bilateral cerebellum. As previously mentioned, 
the posterior part of the ventrolateral thalamus, a major recipient of 
cerebellar outflow, can be targeted with DBS for highly successful tremor 
suppression. Perhaps accordingly, there are also reports of damage to the 
cerebellum by a stroke that eradicated essential tremor on the same side36.  
 
With regards a neurochemical understanding of cerebellar involvement, 
magnetic resonance spectroscopy has shown diminished N-acetylaspartate 
(NAA). Moreover, decreased GABA-A and GABA-B receptors have been 
described in the dentate nucleus in ET37. However, results from other 
studies, although again implicating altered GABAergic transmission 
suggested by reduced parvalbumin staining, did so in the locus coeruleus 
and pons rather than the cerebellum38. Flumazenil PET studies have shown 
increased binding of radiolabelled flumazenil in the cerebellum and 
ventrolateral thalamus indicating increased affinity to the GABA-A receptor, 
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which is somewhat at odds with the pathological findings39 40. Increased 
affinity or avidity due to functional receptor changes in remaining but 
diminished GABA receptor numbers may resolve this apparent contradiction. 
CSF GABA is diminished41, and a tremor resembling essential tremor is seen 
in mice with a knock-out of the alpha-1 component of the GABA-A receptor. 
Despite this mounting evidence implicating GABA, no GABA receptor or 
transporter polymorphisms associated with ET have been found in humans42 
43 44. 
 
Pathological studies of degenerative changes in the cerebellum have been 
fraught with difficulty and diametrically opposed opinion. One group, as 
mentioned, led by Louis have provided much of the evidence purporting 
pathological changes consistent with neurodegeneration whilst Rajput et al45 
presented evidence in 12 ET patients and 6 controls that there was no such 
difference between groups. Louis et al46 demonstrated two pathological 
groups of ET, one with Lewy bodies in the locus coeruleus and the other with 
Purkinje cell loss in the cerebellum compared with normal controls. A further 
study47 reported similar findings with additional Purkinje cell axonal swelling 
(‘Torpedoes’) but this study investigated some of the same brains as the 
original report. A further study on 24 different ET brains compared with 21 
controls reported cerebellar disease in seven of the ET patients without 
evidence of Lewy bodies48. A more recent study (discussed below in section 
1.3.1.3 entitled Inferior olive as a pacemaker in essential tremor) found no 
pathological abnormalities in the inferior olive, another putative locus of 
tremor in ET. Overall, there are insufficient grounds for considering ET a 
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neurodegenerative disease on pathological evidence alone. However, in 
conjunction with structural imaging findings and neurochemical abnormalities 
described, this possibility needs further investigation, with larger 
corroborative autopsy studies from more than one centre. Further, distinction 
between aetiological pathological changes and those changes consequent of 
tremor or epiphenomenal must be made. 
 
1.3.1.2 An ‘oscillopathy’? 
 
ET is thought to be a centrally generated tremor that arises due to 
abnormally oscillating central nervous system loops that likely involve the 
cerebello-thalamo-cortical pathways49. This seems to be congruent with the 
effect of deep brain stimulation on the thalamus in patients with ET50 but 
appears somewhat surprisingly to be excitatory to this loop rather than 
inhibitory with cortical projections from the thalamus being facilitatory to 
cortical motor evoked potentials51. 
 
There may be different mechanisms underpinning the different types of 
tremor in ET. Pedrosa and colleagues52 demonstrated selective deterioration 
in intention tremor during low frequency (10Hz) stimulation particularly of the 
ventral aspect of the ventrolateral thalamus and an area a little inferior to 
this, potentially nodal to the cerebellothalamocortical network. This was 
found to be relatively selective for intention components of tremor when 
compared to the relatively little affected postural component of tremor. 
However, the authors did not clearly distinguish in their results between 
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kinetic and purely intention tremor. Nevertheless, this selective modulation of 
different tremor phenotypes within the same patient has been used by 
Brittain and Brown53, in their recent review, to outline the idea that tremor is 
not merely a fixed expression of a network or nodal pacemaker. Rather, they 
reinforce the idea of a dynamic network, subcircuits of which are prone to up- 
or down-regulation by the ambient motor state. Such dynamism is seen in 
coherence studies using EEG and EMG54. This responsiveness to the motor 
state could render the clinical manifestation of tremor labile and biased 
towards the current state of the motor system. They raise the possibility that 
multifocal nodes of synchronised neurones are, in fact, a physiological 
feature of the healthy motor network, but cause overflow to the periphery in 
the form of tremor when certain pathological triggers and task requirements 
drive supra-threshold oscillatory synchronisation53. This updates older views 
where a single focal oscillator was thought to be causal. It also fits with more 
contemporaneous data using coherence analysis where nodes of the 
network are able to become transiently phase coupled54 in a time-variant and 
dynamic fashion and the finding with DBS electrodes of multiple spatially 
distinct clusters of cells within the posterior ventrolateral thalamus driving 
tremor 55. Entrainment of typical networks such as the 
cerebellothalamocortical network may be better explained with such a model. 
For example, entrainment of the cerebellothalamocortical network can occur 
both in pathological tremor and voluntary rhythmic movements of the hand 
but only the former commands bidirectional coupling of the network56. 
Nevertheless, identifying critical nodes in such a network remains important, 
if only as a potential therapeutic target. 
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Figure 1.2 Central network in essential tremor. From Helmich et al 57. The 
basal ganglia and its connections are shown in red, and the cerebellar 
system and its connections are shown in blue. Modulatory neurotransmitter 
projections are shown as dotted black lines. Anatomical connections 
between basal ganglia and the cerebellum are shown as dashed yellow 
lines. DA dopamine, GPi internal part of the globus pallidus, GPe external 
part of the globus pallidus, ILN thalamic interlaminar nuclei, IO inferior olive, 
LC locus coeruleus, NE norepinephrine, RaN raphe nuclei, RN red nucleus, 
RRA retrorubral area, SE serotonin, SNc substantia nigra pars compacta, 
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STN subthalamic nucleus, VLa anterior part of the ventrolateral thalamus, 
VLp posterior part of the ventrolateral thalamus. 
 
1.3.1.3 Inferior olive as a pacemaker in essential tremor? (adapted from 
Saifee and Edwards, 201311) 
 
On the basis of three main lines of evidence, the inferior olivary nucleus 
(ION) has been suggested as a node in this pathological network and even 
as a main player. First, the harmaline animal model of ET unequivocally 
represents oscillatory output from the ION. Second, there is a physiological 
rationale that the ION could play a role in tremor generation given the 
calcium-dependent neuronal synchrony of the ION sufficient to drive the 
cerebellothalamocortical circuit to produce tremor58. Third, a functional 
imaging study59 has suggested abnormal activation of the ION in ET. The 
actual story, however, seems less clear-cut, with a lack of evidence of ION 
involvement in the majority of ET patients studied with functional imaging25 60 
61 and, less specifically, medullary activation in one study62 and brainstem in 
another63. 
 
Louis and others address the important issue of whether the ION is involved 
in ET from a neuropathological point of view24. They report a case–control 
series of 14 ET cases and 15 controls. Of note, none of their patients had 
Lewy bodies in regions normally examined in their assessment, despite 
previous reports from the same group of a Lewy body subtype of ET. By the 
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authors' rationale, all the ET cases in this study would thus be expected to 
fall within the “cerebellar” subtype coined by the group. The bottom line of 
the study is that there were no identifiable pathological changes in the IONs 
in these patients compared with controls. 
 
The lack of degenerative change does not exclude a role for functional 
disturbance within the ION in the generation of ET. However, in contrast to 
the key role of the ION in harmaline tremor and oculopalatal tremor, available 
evidence for functional disturbance is sparse. One study59 demonstrated 
alcohol-associated increases of regional blood flow in the IONs of patients 
with ET but not controls, perhaps via cerebellar projections to the ION. In a 
study by Bucher et al61 two of 12 patients with ET demonstrated ION 
activation. Notably, the excitatory cerebellar nuclei neurons that project to the 
thalamus and the inhibitory nuclei neurons that provide feedback to the olive 
are innervated by the same Purkinje cell axons64 although they take part in 
tonic and phasic control, respectively65. So, different cerebellar rhythms may 
coexist, and their underlying networks can still, at least partly, be shared. The 
variable involvement of the ION in functional imaging studies in ET59 60 61 62 
could relate to the nonlinear dynamics of the network54, the signal-to-noise 
ratio required for detection of activity, or the ever-present issue of case 
heterogeneity. We therefore still need categorical evidence for or against the 
functional involvement of ION in ET. If the ION is involved in the oscillatory 
network, this study is of importance because it would suggest that effects of 
abnormal synchrony are not necessarily toxic to cells leading to degenerative 
change as speculated15. Harmaline increases the oscillations in the inferior 
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olivary nucleus, and this might occur from one of two mechanisms (or both). 
The olivary neurons are spontaneously rhythmic, the rhythmicity supported 
by a low threshold calcium channel. The olivary neuron dendrites come 
together in clusters called glomeruli where they communicate with each other 
via gap junctions. In harmaline-induced tremor, the cells are more rhythmic 
and they communicate more strongly. Perhaps importantly, the gap junction 
communication is down-modulated by GABA, so a deficiency of GABA would 
increase synchronicity. The inferior olivary–cerebellar network has been long 
suspected as being the relevant generator, but the evidence is not strong. 
 
1.3.2 Parkinsonian tremor 
	
 
Multiple tremor types fit into this rubric. Tremor is part of the cardinal features 
classically used to describe the motor aspects of Parkinson’s disease. 
Tremor can occur in multiple body parts including the jaw, lips, arms and legs 
in PD. The phenotype of PD tremor is relatively distinctive with three main 
types often seen. The first, classical type of tremor is seen predominantly at 
rest. This may better be described as occurring during sates of stability as it 
can also occur once a posture of the arms is adopted but not usually until a 
brief latency after adopting such a position. The term re-emergent tremor is 
used to encapsulate this phenomenon. Other forms of tremor in PD might 
include an action tremor of the arms that has a higher frequency (>1.5Hz) 
than the rest tremor. Dystonic tremor, enhanced physiological tremor and 
even functional (psychogenic) overlay tremor may additionally occur in a 
small minority of patients that have recently been reported66-68. Finally, a 
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pure action tremor of the limbs seems to also occur in some patients with 
PD. This may manifest as an action tremor of the arms without rest tremor or 
even as orthostatic tremor in the legs, a form of isometric tremor. The 
orthostatic tremor here may occur secondarily to the PD, given the higher 
than expected prevalence of orthostatic tremor in patients who develop PD69. 
Further, there seems to be some dopaminergic responsiveness to this type 
of tremor in some and also those with orthostatic tremor who also develop 
PD seem to be older than controls with OT alone. Recently, ocular tremor 
has also been described in all patients with PD in a cohort of 118 patients70, 
however, there are reasonable grounds to believe that this is merely a 
manifestation of parkinsonian limb tremor mechanically conducted to the 
head tremor and resulting in a vestibulo-ocular reflex rather than primary 
ocular tremor, as we have recently argued71 72. 
 
Tremor in PD is an important part of the phenotype as some of those 
patients seem to have a tremor-dominant picture which when contrasted to 
posture and gait dominant (PIGD) subtypes, seems to predict a slower, more 
benign prognosis73 74. However, the story may not be quite as 
straightforward and more recently it has been suggested that this clinical 
distinction does not predict length of disease at death but rather the tremor-
dominant group lose their slowly progressing advantage later in the disease 
course75. The hallmark pathological finding in PD of loss of dopaminergic 
projection cells from the substantia nigra pars compacta to the striatum 
seems to co-vary with the severity of bradykinesia but not so clearly with 
tremor76. Degenerative changes in other brain areas such as the retrorubral 
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area (A8) have instead been indicated to correlate with the severity of rest 
tremor rather than the substantia nigra77. Abnormal oscillatory activity in the 
basal ganglia particularly the pallidum, though intermittent, seems to relate to 
tremor in PD. It has been proposed that a dimmer-switch model whereby 
abnormal oscillatory signals in the pallidum trigger activation of the 
cerebellar-thalamo-cortical loop which acts as the gain for peripheral tremor 
and the former as the switch7. 
 
The tremor of PD tends to transiently improve when changing motor state, 
for example moving from a rest state to one of action. Tremor in PD seems 
somewhat divorced from other motor features of PD such as bradykinesia 
and rigidity in the sense that it appears to be far less dopa-responsive 
(certainly at conventional doses) than the aforementioned symptoms, it does 
not seem well correlated with diminished dopamine uptake on nuclear 
imaging of presynaptic dopamine transport and even on post-mortem. There 
may well be a dopamine connection to tremor but if so, it is likely not the 
nigrostriatal pathway. Although serotonin has not proven an avenue to 
treatment of tremor, a nuclear imaging study utilising PET imaging of a ligand 
that binds to 5-HT1A receptors indicates that there is more tremor associated 
with less binding in the raphe78, but this may be particular to postural rather 
than rest tremor79. Differing network patterns have been revealed from an 
array of imaging and electrophysiological measures of tremor in PD. Using 
FDG-PET, the dentate nuclei of the cerebellum and rostral areas of the 
cerebellum, putamen and motor cortex all seem important80. M1 has been 
implicated using corticomuscular coherence in a MEG study81. Areas most 
45	
	
highly coherent with M1 on EEG seemed to be secondary somatosensory 
cortex, posterior parietal cortex, cingulate and supplementary motor areas, 
diencephalon and the cerebellum. Functional MRI on the other hand has 
demonstrated increased BOLD signal in the putamen and both internal and 
external global pallidi at the onset of tremor whilst the cerebellum, thalamus 
and pre-motor areas seemed to correlate with amplitude82. This latter finding 
nicely tying the cerebellothalamocortical circuit, thought to be the gain control 
in the dimmer switch model of PD, to amplitude modulation. This plays 
conveniently into the observations that targeting a node in this network, the 
VIM, with high frequency stimulation or destruction is a highly efficient way of 
ameliorating tremor. The proposed model is that of a simultaneously 
oscillating network in the basal ganglia and also cerebellothalamocortical 
loops, both coupled to produce tremor83. Although this hypothesis is 
attractive in that it integrates evidence linking both basal ganglia and 
thalamic networks to Parkinson’s disease tremor and might explain why high 
frequency stimulation of both the subthalamic nucleus and of the 
ventrolateral thalamus can be effective in controlling Parkinson’s disease 
tremor, Cagnan et al84 demonstrate a role for both the subthalamic nucleus 
and thalamus in tremor pace-making that would question this hypothesis. 
Moreover, despite tremor entrainment, they did not observe significant 
related modulation of the amplitude of tremor from either site, arguing that 
any such tremor amplitude modulation might occur at remote sites. In line 
with this, motor cortex stimulation is known to both entrain and modulate 
Parkinson’s disease rest tremor amplitude in a phase-dependent manner85. 
This study raised the possibility that the motor cortex is not only involved as 
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part of a tremor pacemaker network, but that the motor cortex and its outflow 
may be targets for amplitude modulation86. This would also be consistent 
with previous reports of cortico-muscular coherence at tremor frequency and 
its first harmonic87. In fact, transcranial alternating current stimulation over 
the motor cortex when specifically phase aligned can provide nearly 50% 
reduction in tremor amplitude85. 
 
1.3.3 Physiological tremor  
	
 
Physiological tremor of the outstretched arms with a peak frequency of 7–12 
Hz has been widely described88 89 90. A kinetic tremor of similar frequency 
has also been identified during slow upper limb movements91 92. The relative 
contribution of central and peripheral networks to this form of tremor remains 
debatable53 93. Considerable evidence points towards a central network 
underlying this type of tremor92 94-105. Despite this, mechanical resonance of 
the limb has been shown to generate a tremor with a similar spectrum106, 
and some argue that the apparent motor unit synchronization and coherence 
between cortex and tremor EMG are an epiphenomena, reflecting peripheral 
resonance or reafference107. 
 
Lakie and colleagues107 argue that changing mechanical properties of 
muscle in static versus dynamic conditions, affects how frequency and gain 
of tremor changes. Large amplitude movements (greater than observed in 
physiological tremor) of the wrist have an effect of relaxing the muscles, i.e. 
altering its thixotropic properties, thus modulating the resonance properties 
47	
	
of the hand. Lakie and colleagues showed this using a computer model of a 
hand with a single muscle behaving as a damped linear spring in series with 
a linear elastic tendon, with the exception that the muscle generated an 
active force. They modelled active force by passing the measured rectified 
EMG through a low-pass filter. They compared this scenario with the use of 
white noise though the low-pass filter instead of rectified EMG. Interestingly, 
either input (i.e. including the random perturbations from white noise) 
seemed to equally generate tremor-like acceleration profiles. Realistic 
reductions in stiffness closely reproduced the decrease in frequency and 
increase in amplitude observed in experiments. They argued that their 
simulations show that physiological tremor can be explained in entirely 
mechanical terms, without the need to invoke mechanisms that cause 
muscle force to fluctuate at tremor frequencies. 
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Chapter 2: Tremor in neuropathies – the clinical spectrum 
 
Tremor seems to occur as a symptom of peripheral neuropathies including 
inflammatory neuropathies and hereditary neuropathies. It appears to be 
more prevalent in demyelinating neuropathies as opposed to pure axonal 
neuropathies, yet this may be specific to the type of neuropathy1. 
 
2.1 Tremor in inflammatory neuropathies 
 
Immune-mediated neuropathies such as chronic inflammatory demyelinating 
polyradiculoneuropathy (CIDP) are relatively common and disabling108 109. It 
has been recognised for many years that tremor can be an accompanying 
feature of peripheral neuropathy110 111. In immune neuropathies, tremor is 
found more often than not in patients with IgM paraproteinaemic neuropathy 
(IgMPN)111-113, in patients with CIDP114 and in the recovery phase of Guillain-
Barré syndrome115 although there is lack of a larger scale prospective 
assessment of this.  
 
2.1.1 Tremor in IgMPN 
 
IgMPN associated neuropathy is a primarily demyelinating neuropathy. Anti-
MAG antibodies are the most common type of IgM antibody found in these 
acquired demyelinating peripheral neuropathies. The targets for human anti-
MAG IgM in the peripheral nervous system (PNS) include MAG, a PNS 
glycolipid, and a PNS low-molecular-weight myelin protein, any of which (if 
any) may conceivably be involved in the pathogenesis of the tremor 116. 
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Clinically, anti-MAG neuropathy is similar to other inflammatory neuropathies 
such as CIDP but nerve conduction studies reveal prolonged distal motor 
latencies. There is a large variance in the prevalence of tremor reported in 
this condition. Some series do not report any tremor whilst others report up 
to 90% prevalence of tremor. However, more reliable reports aiming to 
identify this symptom report arm tremor in 40-90% of anti-MAG neuropathy 
patients 117-119. Tremor was thought to be a later symptom of this condition 
and this was felt to explain the apparent difference in prevalence of tremor 
between different published cohorts 117 120-125. Specifically, Smith 126 
suggested that this variation may relate to the length of follow-up in these 
studies. Although anti-MAG neuropathy rarely presents with tremor, the 
range of time of onset between neuropathic symptoms and tremor in these 
studies was 1.5 to 12 years (mean 4.7 years). Another suggested reason for 
not reporting tremor was that it tends to be mild and thus overlooked 126, 
although it can be disabling at one extreme. When tremor occurs, it tends to 
be late-onset, male dominant, slowly progressive, symmetrical, and the 
neuropathy is dominated by sensory loss and is often rather refractory to 
treatment. Tremor has also been reported to occur in IgG and IgA 
paraproteinaemic neuropathies without anti-MAG activity 117 127. The 
frequency of oscillation is predominantly 3-6 Hz 117 128. There have been no 
previous associations with weakness, proprioceptive loss or other 
neurological findings predicting 111 117 128 the presence or absence of tremor 
in this condition. Recordings revealed a tremor frequency that seemed to co-
vary between 3.3 and 10Hz with ulnar conduction velocities; higher velocities 
associated with higher tremor frequencies. Amplitude did not seem to share 
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a similar association. The pathophysiology is as yet undetermined but has 
been suggested to depend on central nervous system changes 128 129. Bain 
et al128 considered the alternative explanation in the neuropathy where 
tremor is most prevalent. They posited that in patients with IgM 
paraproteinaemic neuropathy, the development of a coincidental tremulous 
condition is unlikely on epidemiological, clinical and neurophysiological 
grounds. The percentage of patients with IgM paraproteinaemic neuropathy 
that have tremor, as mentioned up to 90% in some reports, is 45 times 
greater than the prevalence of essential tremor in the whole population12. 
Furthermore, the clinical features of the tremor associated with IgM 
paraproteinaemic neuropathy are not those of hereditary essential tremor. 
The male preponderance, the typically negative family history and the mean 
age at onset of 59 years in patients with tremor and IgM paraproteinaemic 
neuropathy contrast with the equal sex incidence, positive family history and 
a median age of onset in the second decade in patients with hereditary 
essential tremor, although in the latter condition the age of onset has a 
bimodal distribution with a second lesser peak in the fifth decade5. Lastly, the 
polymyographic findings in patients with IgM paraproteinaemic neuropathy 
differ from those obtained in patients with essential or parkinsonian tremor. 
 
The largest study to address this issue to date has been a retrospective 
series1. In this cohort of patients with IgM monoclonal gammopathy of 
undetermined significance (IgM-MGUS), tremor occurred in 29% (60) of 207 
patients compared to 9% (38) of 414 matched other-cause neuropathy 
controls. Of the 207 IgM patients, 70% (145) had a demyelinating neuropathy 
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while 30% (62) had an axonal neuropathy. Amongst the tremulous IgM 
patients, there was an over-representation of demyelinating neuropathies 
(82%; 49) compared with axonal neuropathies (18%; 11), although clearly 
tremor was also common in axonal neuropathies (see table 2.1). Of 414 
controls, only 9.2% (38) were found to have tremor. The ratio of axonal to 
demyelinating neuropathies in the group was 75%:25% respectively. This 
would implicate the presence of an IgM paraprotein as the single strongest 
determinant in developing tremor in neuropathies rather than purely the 
presence of demyelination. Markedly absent from the report of this series, 
however, was the MAG antibody status in serum as this in other series has 
been the strongest determinant for the presence of tremor. Nevertheless, the 
results seem to also suggest that in the IgM group, tremor is more common 
and particularly in the demyelinating sub-group, whilst for non-IgM controls, 
tremor is less common and when it does occur, it is particularly in the axonal 
sub-group. This might implicate axonal neuropathies as causal or perhaps 
more likely, unexplored by the authors, that the axonal neuropathy group is a 
more heterogeneous group with a variety of confounds for tremor. Indeed, 
axonal neuropathies in the wider literature make up the bulk of type of 
neuropathies and the causes are typically more heterogeneous than 
demyelinating neuropathies which nearly always tend to be hereditary or 
inflammatory.  In the demyelinating neuropathy group, all those with tremor 
had an inherited or inflammatory neuropathy. Interestingly, in the control 
group patients, age significantly correlated with tremor occurrence. Of 
patients with IgM neuropathies and tremor, a rest hand tremor has been 
reported130 131 and comprised 13.6% of the cohort in Ahlskog et al’s1 case 
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series of IgM associated tremor. Other body parts may similarly but rarely be 
affected including chin, head or voice tremor; in aggregate comprising 5% of 
the Ahlskog et al1 series, but not reported by other authors. Moreover, in the 
published cohort of Ahlskog et al, there was no individual case description so 
it is difficult to know whether this could have represented a confound such as 
essential or other primary tremor. These are usually patients without 
neuropathic symptoms in these body parts so it raises the possibility of either 
a confounding cause for tremor or if IgM is mechanistically related, perhaps 
not directly through the neuropathy, i.e. via direct central mechanisms. Also, 
strengthening this argument was the symmetry of tremor in the limbs, 
contrary to possible asymmetry of some of the neuropathies although this 
data was not explicitly available in the published paper and further, 
judgement of symmetry of tremor clinically often contrasts with potentially 
rather marked asymmetry on tremor quantification using accelerometry. One 
patient with disabling familial tremor responded well to DBS of the left VIM. 
The authors stated the case that this patient’s tremor may have related to the 
neuropathy rather than being solely a familial tremor. This was argued on the 
grounds that his tremor was markedly worse than other family members and 
worsened with the course of the neuropathy. Ahlskog et al also 
demonstrated in their cohort, a higher prevalence of tremor in those with 
more severe neuropathies. However, this result needs to be taken with 
caution in a retrospective case series as it may well instead implicate the 
association of greater severity of tremor with more severe neuropathies, 
given the likely lack of documentation of mild tremor in a retrospective case 
series from a neuromuscular centre. On the other hand, some cases may 
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represent the concurrent diagnosis of a common condition such as essential 
tremor (ET). The pathophysiology of inflammatory neuropathy related tremor 
remains uncertain. There have not been any definitive central sensory or 
motor pathway abnormalities demonstrated, however, a role for the 
cerebellum has been postulated 128. To add to the weight of this evidence is 
enhanced activation of the cerebellum in patients with neuropathy and tremor 
in functional imaging studies 132. Further, there is indirect evidence of IgM 
binding in the cerebellum in patients with IgM paraproteinaemic neuropathies 
with features such as tremor 118 133. 
 
Control group Axonal Demyelinating  IgM group Axonal Demyelinating 
Tremulous 34 4 Tremulous 11 49 
Non-tremulous 277 99 Non-tremulous 51 96 
Table 2.1 Primary results from Ahlskog et al1 shown as a cross-table 
distribution for each group. 
2.1.2 Tremor in chronic inflammatory demyelinating 
polyradiculoneuropathy 
 
CIDP, a chronic relapsing-remitting or progressive inflammatory neuropathy 
is autoimmune in nature and associated with demyelination of nerves and 
their roots. The proportion of patients with CIDP in whom tremor is reported 
varies widely from 3%134  to 84% 135 and may well be under-recognised. In a 
recently discussed study reporting the prevalence of tremor in a cohort of 
patients with neuropathies, although the exact number of CIDP patients in 
the control group with tremor is not explicitly stated by the authors, by 
inference the figure stands at no more than 10.5%1. However, as mentioned, 
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such a retrospective series, spanning 34 years suffers from a likely under-
estimation of tremor, given that this was not an intended focus when data 
was being documented for each patient. Dalakas et al 117 reported seven 
patients with CIDP and four with polyneuropathy associated with a 
monoclonal gammopathy who had tremor during the course of their illness. 
The recorded tremor frequency varied between 3.3 Hz and 6.4 Hz. Some 
series have shown co-variation of the presence of tremor with the severity of 
the neuropathy symptoms. However, there was no good correlation between 
the presence of tremor and the severity of muscle weakness, proprioceptive 
loss or motor conduction velocity. Further, motor conduction velocities 
seemed not to vary in those with or without a tremor136. Most series describe 
a postural and kinetic tremor of the hands, although uncommonly variants 
are also reported such as the existence of hand tremor at rest130 although 
such individual variants are subject to potential coexistent pathology such as 
parkinsonism or primary tremor syndrome such as essential tremor.  
 
2.1.3 Treatment response of tremor in neuropathies 
 
Although tremor improves with treatment of the underlying disease in some 
patients117, a significant burden of the disease may be refractory to treatment 
or require considerable immunosuppression114. The response of the 
neuropathy or the tremor to immunomodulatory treatment with steroids or 
steroid-sparing agents, intravenous immunoglobulin and plasmapharesis has 
been varied, improving neuropathic and tremulous symptoms in some 
patients but not others117 123 but has been reported to improve in the context 
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of patients with ataxia122. The tremor is often not particularly disabling to the 
patient but where it is disabling, generic anti-tremor approaches to 
medication may be employed. Propranolol, for example, has been shown to 
have mixed effect117 137 138. Three patients with tremor were treated with 
steroids, one (anti-MAG positive) had no response but in two, the tremor 
improved as the neuropathy improved. One patient with anti-MAG 
neuropathy and tremor was described to have improved from the neuropathy 
and tremor point of view following rituximab, a monoclonal anti-CD20 
treatment. This is not typical for anti-MAG neuropathy, as it can often prove 
fairly resistant to treatment. Deriving any certainty from current data is futile 
given the low numbers and heterogeneous sample reported in an array of 
small case series. In hereditary neuropathies, the response of treatment to 
propranolol is not clear but it has been suggested that some patients do 
respond137. There is accumulating evidence that VIM stimulation with DBS is 
an effective treatment of neuropathic tremor, as with many tremor types. A 
patient with a demyelinating tremor coined as hereditary Roussy-Levy 
syndrome but without definitive genetic confirmation139, a patient with IgM 
paraproteinaemic tremor140, another with IgM kappa associated 
demyelinating neuropathy but insufficient clinical detail to determine if a 
typical phenotype for anti-MAG (demyelinating distal sensorimotor 
neuropathy with widely spaced myelin and prolonged distal motor 
latencies)141 and other similar cases142 143 have all benefited from VIM 
stimulation.  
 
56	
	
2.2 Hereditary neuropathies 
 
Genetically inherited neuropathies (e.g. Charcot-Marie Tooth (CMT), distal 
hereditary motor neuropathy (dHMN)) are an important cause of 
neuropathies. These disorders are estimated to affect over 24,000 people in 
the UK. Neuropathic tremor was described in hereditary neuropathies as part 
of Roussy-Levy syndrome144, which has since been shown to be a 
genetically heterogeneous entity145 146. In some patients with CMT, tremor is 
a prominent symptom, and prior to advances in genetic understanding of 
CMT such patients were sometimes classified as Roussy-Levy syndrome. 
CMT can be divided into type 1 and type 2, amongst others. Type 1 has 
predominantly demyelinating damage to nerves and type 2, predominantly 
axonal. Tremor has been asserted to be commoner in type 1 in a comparison 
with type CMT2147 but the evidence for this rests on little systematic data. 
Recent genetic advances have demonstrated that patients with Roussy-Levy 
syndrome do not have a single genetic abnormality, with the original Roussy-
Levy family having been shown to have a point mutation in the myelin protein 
zero gene (MPZ)146 with other families with the Roussy-Levy phenotype 
reported to have the chromosome 17  duplication and connexin 32 
mutations148 149. Roussy-Levy syndrome (RLS) was originally described as a 
dominantly inherited early-onset syndrome with features of gait ataxia, pes 
cavus, areflexia, with evolution of muscle atrophy, postural limb tremor, limb 
ataxia, kyphoscoliosis and sensory loss. Zubair et al150 amongst others have 
collectively described an array of genes associated with this phenotype. 
Thus, the syndrome of RLS does not provide a highly specific phenotype-
genotype correlation. In their case series, one man and his daughter were 
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found to have a point mutation in the peripheral myelin protein (PMP)22 
allele 1 with T-to-C translocation at codon position 108 (amino acid change 
leucine to proline). RLS has been described to be somewhat distinct from 
other hereditary neuropathies predominantly due to its prominent ataxia. 
Salisachs and colleagues151 described seven patients with hereditary 
sensorimotor neuropathy and tremor, four of whom were significantly 
disabled by the tremor. The dominant pattern of neuropathy was distal motor 
weakness in the limbs with little sensory loss and markedly reduced motor 
conduction velocities. The tremor has been reported to be suppressible with 
propranolol. 
 
2.3 Putative mechanisms of neuropathic tremor 
 
To begin this section, it is useful to look at other types of tremor, where 
considerably more evidence has been published. The accumulating evidence 
delineating the pathological network of essential tremor comes from 
structural, functional and molecular imaging as well as eye movement 
analysis, gait analysis, electrophysiological techniques including MEG and 
intracranial recordings from DBS electrodes. Far fewer data exist for the 
rarer neuropathic tremor. Currently there are functional imaging data, 
electrophysiological results and immunological studies that might help shape 
our understanding of this symptom. These shall be appraised in relation to 
each other. On the basis of current evidence, neuropathic tremor appears to 
occur particularly in patients with demyelinating neuropathies with reduced 
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conduction velocities, although from the evidence presented, this appears 
not to be exclusive and not predictive of severity when present.  
 
Thus, conceivably, tremor might relate to the altered timing and dispersion of 
combined action potentials of peripheral afferents and efferents152, although 
challenging this is lack of a straightforward relationship between the 
development of tremor and conduction velocity. Although, Smith 153 recorded 
tremor frequency in patients with IgMPN and in all patients there was a direct 
correlation between tremor frequency and ulnar nerve motor conduction 
velocity (higher velocities associated with higher frequency tremor).  
However, no relationship seems to exist between tremor and the severity of 
neuropathy as assessed by proprioceptive loss, weakness or fatigue117 136 
although tremor may be commoner during a relapse 117. There is also a lack 
of difference between motor nerve conduction velocities in those with versus 
those without tremor 136. Nevertheless, slowing of nerve conduction may 
improve with improvement of the neuropathy and this has been shown in a 
small number of patients to be associated with an increase in the tremor 
frequency. Such a relationship might indicate tremor frequency is determined 
by conduction velocity, which if true, would likely invoke the stretch reflex 
mechanism as part responsible for the generation of tremor given theories of 
the role of the stretch reflex in so called peripheral reflex enhanced tremor. 
This appears not to be the only factor, given that many patients with slowed 
nerve conduction do not develop tremor and those with tremor may well have 
near-normal conduction velocities. Further, the critical finding of an 
association between conduction velocity and tremor frequency has not been 
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re-capitulated in other studies128. Indeed, in their study, Bain et al considered 
the possibility of a central nervous system integrator that may behave 
differently between patients and thus provide a variable determining the 
occurrence of tremor in this context, not provided for by parameters defining 
severity of the neuropathy. One would have to assume that such variance in 
such a putative CNS integrator would have to be particular to neuropathic 
tremor given the relative lack of tremor in the context of other types of 
neuropathy such as diabetic neuropathies which may well cause 
demyelination, i.e. demyelination of peripheral nerves and roots alone seems 
insufficient to generate tremor. This may raise the possibility of a mechanism 
intrinsic to the neuropathy disease that also affects the central nervous 
system. In inflammatory neuropathies, a direct immunogenic target, similar to 
the antibodies targeting peripheral nerves, to central nervous system 
structures, would most parsimoniously explain this. For hereditary 
neuropathies, the process would likely be a central degenerative process 
akin to occurring in the periphery. In their study, Bain et al128 compared six 
patients with IgM paraproteinaemic neuropathy and tremor with healthy 
controls, but not with non-tremulous neuropathy patients. The tremor was of 
variable amplitude and frequency (not correlated with nerve conduction 
velocity). There was no evidence of a central delay in conduction (the central 
portion of somatosensory evoked potentials was of normal latency), wrist 
tremor could be phase reset by median nerve stimuli to an extent that would 
make the peripheral nervous system important in the network of tremor 
rather than acting as a simple final common pathway for expression of 
tremor.  Ballistic wrist movements demonstrated a delayed second agonist 
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burst of the triphasic EMG and underdamped oscillations after wrist 
movement, seen in essential tremor154 and cerebellar disease155 156. The 
authors suggested that temporally dispersed peripheral inputs from 
demyelinated nerves reach a central processor, such as the cerebellum, 
which is misled into producing a delayed second agonist burst and tremor.  A 
number of aspects of motor system physiology depend on precisely timed 
interactions between sensory afferents from the limbs and motor output. 
Given the clinical finding that demyelinating neuropathies rather than axonal 
neuropathies most commonly give rise to tremor, again, it might suggest that 
afferent and or efferent delay are important pathophysiological factors in the 
development of neuropathic tremor. However, as discussed, delay in 
conduction alone cannot be the cause of neuropathic tremor given that 
tremor does not occur in all patients with demyelinating neuropathy and that 
there is no relationship between conduction velocity and presence of tremor. 
As such, rather than it simply being delay in conduction, it may be the degree 
of temporal dispersion of input and output that gives rise to tremor.  
Experimental paradigms that are thought to correspond to motor sensory 
integration are dependent on precise central nervous system conduction 
times. It is possible that if input and output are highly dispersed and 
adaptation is not possible or effective, continuous iterative errors that are not 
corrected may conceivably produce an oscillatory output such as tremor. 
Alternatively, it may be that individual differences in cerebellar function impair 
the ability to adapt to dispersed sensori-motor signals in the periphery. 
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This ties in with the proposed role of the cerebellum as an adaptive filter157. 
Damage to the cerebellum due to mechanisms innate to the neuropathic 
disease process such as direct cerebellar inflammation in inflammatory 
neuropathies or cerebellar damage in hereditary neuropathies could 
conceivably interfere with such sensory-motor integration. Alternatively, it 
may be that certain individuals do not have the capacity to adapt to 
mismatched motor commands and motor efference copies or mismatched 
sensory information with planned motor commands. This could cause 
problems with such integration in the cerebellum or may exist more widely 
affecting disparate parts of the central nervous system. In order to test such 
hypotheses, one could look to clinical and electrophysiological processes 
indicating integrity of motor control and learning in the cerebellum.  
 
A unique insight has been gleaned from a single patient study in this regard. 
Weiss et al129 reported a patient with tremor associated with IgM 
paraproteinaemic neuropathy after deep brain stimulation of the VIM. 
Coherence analysis between local field potentials (LFP) from DBS electrode 
leads implanted in the thalamus, M1 EEG and contralateral flexor and 
extensor digitorum EMG. They found significant coherence between all 
combinations: M1 and contralateral EMG, VIM and ipsilateral M1, VIM and 
contralateral EMG but not VIM and contralateral M1. Directed transfer 
function and phase analyses were used to demonstrate information flow 
unidirectionally from M1 to VIM and bi-directionally between M1 and muscle, 
VIM and muscle respectively. VIM stimulation caused suppression of the 
cortico-muscular coherence. Re-afference lagged the feedforward drive. 
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However, this is a single case report and as such its generalizability is 
limited. Activation of the VIM likely indicates cerebellar involvement in the 
same network but this was not explicitly measured in this study. The 
presence of functional involvement of the cerebellum in neuropathic tremor is 
also supported by positron-emission tomography (PET) findings 
demonstrating cerebellar  hyperactivity in this condition  132. Brooks et al2 had 
presented results summarising a PET study of regional blood flow in 8 ET 
and 6 neuropathic tremor patients and 6 age-matched controls2. The results, 
reported in abstract form, are summarised in table 2.2. It is, however, not 
clear whether this finding reflects primary changes in the cerebellum or 
whether this is secondary to the effect of the tremor, except for the finding of 
bilateral cerebellar activation in limb tremor on posture in contrast to purely 
ipsilateral cerebellar activation on a similar task in healthy controls mimicking 
tremor. Also, bilateral cerebellar activation is seen at rest as well as during 
involuntary tremor, suggesting the possibility of a static abnormality of the 
cerebellum perhaps similarly reflected by the abnormal classical eyeblink 
conditioning. However, there remains a possibility that his could represent a 
function of oscillatory frequency or other confound. There have been no 
studies to date assessing the structural integrity of the cerebellum in patients 
with neuropathic tremor compared to those with neuropathy but without 
tremor.  
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 Essential tremor Neuropathic 
tremor 
Healthy 
controls 
Rest state ↑cerebellar 
bilaterally 
↑cerebellar 
bilaterally 
Normal 
Passive 
movement 
↑some cerebellar 
bilaterally 
↑some cerebellar 
bilaterally 
- 
Posture 
(extended) 
- - ↑cerebellar 
ipsilaterally 
Involuntary 
tremor 
↑cerebellar 
bilaterally 
↑cingulate 
↑contralateral 
sensorimotor 
cortex 
↑contralateral 
thalamus 
↑cerebellar 
bilaterally 
↑cingulate 
↑contralateral 
sensorimotor 
cortex 
- 
Mimicked 
tremor 
- - ↑ cerebellar 
ipsilaterally 
Table 2.2 Summary results of PET imaging in neuropathic and essential 
tremor versus controls (Summarised from Brooks et al2) (↑ indicates 
increased PET activity). 
 
A central nervous system component to these diseases is recognised to 
exist, but only in the small minority of cases. Leger et al119, for example, 
investigated 13 patients with IgMPN of demyelinating type and antibodies to 
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glycolipids present in CNS white matter in five patients, two of whom had 
abnormal MRI. Three had measurably prolonged central motor conduction 
times, of whom two patients had anti-CNS glycoplipid antibodies. Three of 
those with measurable CNS anti-glycolipid antibodies also had tremor. 
Tremor seemed to occur only in those with anti-MAG antibodies but did not 
seem to correlate with paraprotein level or light chain subtype. However, the 
MRI changes may well be confounded by age as suggested in another study 
of patients selected only by the need for nerve biopsy and diagnosis of 
CIDP158. 
 
Tremor in a patient with a neuropathy could conceivably have its origin from 
a number of different mechanisms (which may not be mutually exclusive): 
 
1) Concurrent central nervous system disease driven by the same process 
causing the neuropathy, i.e. antibody-mediated or genetic mechanism 
and a purely centrally driven tremor potentially akin to those seen, for 
example, in cerebellar, Holmes or essential tremor. 
2) Coincident tremor syndrome (e.g. ET). Although this may conceivably 
account for a small number of cases proportional to the prevalence of ET 
(0.5 – 5%), the temporal onset of neuropathy and tremor and the high 
prevalence of tremor in patients with specific neuropathies make this 
unlikely an explanation for the majority of cases.  
3) In the context of a hereditary neuropathy, coexistent primary tremor 
syndrome such as essential tremor associated by genetic linkage. Little 
has been established here and even where it is reported, there seems 
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doubt about the likelihood of this being the case. For example, Louis et 
al159 presented a case series of a family with TRPV4 mutation CMT 2C 
presenting with typical leg and voice abnormalities. In addition, there was 
a possible autosomal dominant history of isolated tremor in the family but 
this did not seem to segregate with CMT and so it was concluded that this 
tremor likely represented coexistent essential tremor. However, analysis 
of the pedigree reveals seven patients affected with either tremor or CMT, 
three with both; two with tremor alone and two with CMT alone. However, 
there are four siblings with tremor as well as their maternal uncle. Their 
mother is not stated to be affected by tremor in the pedigree. If one 
assumes that this is autosomal dominant ET, as the authors do, then by 
definition, the deceased mother must have carried the gene, but not 
manifested either due to incomplete penetrance or being undiagnosed. 
The pedigree also suggests that tremor is much more likely in those with 
the TRPV4 gene mutation. This could lend itself to a ‘two hit’ hypothesis 
for tremor generation with a susceptibility to tremor being important and 
the CMT making it more likely to manifest. This is more likely than mere 
co-existence or co-segregation of genes as this was not the case with this 
case series where the tremor and TRPV4 mutation did not co-segregate. 
Other such susceptibility genes in GWAS studies have been reported 
such as LINGO1 but on repeated studies, it seems these are likely 
susceptibility factors in limited populations. 
4) Peripheral demyelination with maladaptive central sensorimotor 
integration as a trigger to cerebellothalamo-cortical network driven 
tremor. 
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5) Reflex mechanical tremor (enhanced physiological). 
6) An alternative hyperkinetic movement or tremor ‘mimic’ such as 
‘fasciculatory tremor’, pseudoathetosis and polyminimyoclonus, all 
distinguishable from tremor (as defined by the MDS task force3) on 
clinical grounds. 
7) Peripheral myoclonic tremor. There are case reports of tremor arising 
after peripheral nerve injury160 but these likely represent myoclonus given 
the irregularity of tremor shown in the needle EMG and the persistence 
during sleep. This also raises the discussion regarding peripherally-
induced movement disorders for which there is considerable controversy. 
Many feel that this represents a group of disorders with 
psychogenic/functional aetiology whilst others argue that this represents 
an organic group of conditions161 162. The conditions that are represented 
under this rubric are heterogeneous. Neuropathic tremor occurs in the 
context of damage to peripheral nerves and so is relevant in this 
discussion.  
 
2.3.1 A role for the cerebellum in neuropathic tremor 
 
Voluntary movements are based on interacting but spatially distributed 
neural networks. Connectivity between such disparate regions may depend 
upon synchronised oscillatory behaviour (for a review, see McAuley and 
Marsden101; and Schnitzler and Gross 163). Using electroencephalography 
(EEG), coherent activity between the prefrontal cortex, lateral, and mesial 
premotor areas, the primary sensorimotor, and posterior parietal cortex 
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during the execution of rhythmic finger-tapping tasks164 165 166 has been 
demonstrated. EEG and magnetoencephalography (MEG) have been used 
to demonstrate that pathological81 as well as physiological but involuntary 
movements167 are associated with oscillatory coupling in a cerebello-
thalamocortical network. Pollock et al168 (figures 2.1 and 2.2) aimed to 
determine in healthy controls, the oscillatory network associated with a 
unimanual auditorily paced finger-tapping task and the dynamic relationship 
between these structures. Subjects performed a finger tapping task with 
interstimulus interval (ISI) of 800 ms. Their results demonstrated that an 
auditory paced finger-tapping task is associated with a cerebello-
thalamocortical network comprised of primary auditory cortex and cerebellum 
ipsilateral to the tapping hand; thalamus, SMA, PPC, and S1/M1 
contralateral to the tapping hand, providing comparable agreement with 
previous fMRI-studies169-173. Within this network, the pivotal role of the 
cerebellum in the execution of movements has been substantiated in 
imaging studies174 175. Specifically, it has been put forth that the cerebellum 
is involved in monitoring and optimizing movements by processing sensory 
information. Indeed, data from a PET study demonstrated that the cerebellar 
signal is, at least partially, a result of the processing of proprioceptive 
information. Furthermore, the cerebellum shows increased activation during 
visual guidance of a movement when compared to the execution of the same 
movement without visual information (for a review, see Jueptner and Weiller 
176). However, it should be stressed that cerebellar activity has been 
observed in the absence of somatosensory or visual feedback indicating the 
pivotal role of the cerebellum in motor processing177. The cerebellum 
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influences the motor cortex via the cerebello-thalamocortical pathway (for a 
review, see Horne and Butler178; Middleton and Strick 179). Evidence has 
been found for further connections between cerebellum and premotor and 
primary motor areas179. Although the precise functional meaning of these 
connections is still uncertain, it has been suggested that via connections to 
the primary motor cortex the cerebellum receives an efference copy, which is 
compared to sensory information about the outcome of the movement 178. 
Connectivity between premotor areas and cerebellum may be concerned 
with higher order aspects of motor behaviour like the execution of movement 
sequences179.  
 
Papka et al180 demonstrated likely overlapping cerebellar circuitry between 
eyeblink classical conditioning (EBCC) and tapping tasks. This was shown 
by providing data illustrating the effect of tapping in interfering with EBCC. 
Controls for hippocampal-dependent declarative memory system along with 
recognition and other non-cerebellar-dependent tasks were effectively used 
to rule out confounds. 
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Figure 2.1 Analysis of cerebromuscular coherence of the right-hand 
condition in one representative subject. From Pollok et al168. (A) Left panel: 
traces of surface EMG activity of right first dorsal interosseus (FDI). EMG 
was high-pass filtered at 60 Hz and rectified. Regular EMG bursts occur at 
the frequency of the paced movement of 1.2 Hz. Right panel: FDI power 
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spectral activity. Distinct peaks at 1.2, 2.5, and to a lesser degree at 3.7 Hz, 
representing the movement frequency and its first and second harmonic. (B) 
Coherence between right FDI and MEG sensors. Coherent activity was 
restricted to the sensors covering the left parietal area. Coupling occurred at 
1.2, 2.5, and 3.7 Hz representing the movement frequency and its first and 
second harmonic. The dashed line indicates the 95% confidence level of 
coherence. (C) Localization of cerebromuscular coherence at 1.2 Hz as 
revealed with DICS in the individual MRI scan. In all subjects, the source with 
the strongest coherence to right FDI was localized in the contralateral 
sensorimotor hand area. Coherence between EMG and the S1/M1 source 
was observed at 1.4 and at 2.5 Hz. The dashed line indicates the 95% 
confidence level of coherence. 
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Figure 2.2 Mean localization of cerebral sources across all subjects for the 
right-hand condition. From Pollok et al168. Mean localization of cerebral 
sources across all subjects for the right-hand condition. Sources were 
localized with respect to the S1/M1 source (A). Coherent activity was found 
in the premotor cortex (B), SMA (C), posterior parietal cortex (D), ipsilateral 
S1/M1 (E), and superior temporal sulcus corresponding to the primary 
auditory cortex (F). Additionally, coherent activity was detected in the 
thalamus (G) and in the ipsilateral cerebellum (H). Crossing lines indicate the 
local activity maximum of each source. 
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Chapter 3: Aims and hypotheses 
 
We hypothesise that tremor is an occasional feature of Charcot-Marie-Tooth, 
common feature of inflammatory neuropathy and is a contributor to disability; 
that certain clinical features (e.g. more rapid progression, large fluctuations in 
symptom severity (immune neuropathy)) will be associated with a greater 
likelihood of developing tremor. There is a considerably lower prevalence of 
severe, disabling tremor associated with hereditary as opposed to 
inflammatory neuropathies. There are also fewer reports in the literature of 
deep brain stimulation being required to treat CMT associated tremor whilst 
there are emerging reports of this last resort treatment being used in tremor 
in inflammatory neuropathies. These features suggest that there may be 
different mechanisms causing tremor in hereditary versus inflammatory 
neuropathies. We further explore the pathophysiological features of tremor 
associated with both inflammatory neuropathies and CMT in this study. 
 
We set out to explore aspects of central nervous system physiology in a 
group of tremulous and non-tremulous patients with inflammatory 
neuropathies and compared these to healthy controls. We perform a similar 
comparison for patients with CMT. We propose that measures of dispersion 
of sensory input and motor output will be different in patients with peripheral 
neuropathy and tremor compared to those without tremor. We hypothesise 
that the central compensation needed to account for (afferent and efferent) 
delays caused by the peripheral neuropathy would most likely depend on 
plastic changes within the cerebellum and connections that mediate 
interaction between sensory and motor systems. We hypothesise that 
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patients with tremor would have evidence of dysfunction in the cerebellum 
and interactions in sensorimotor cortex compared to non-tremulous patients 
and healthy controls.   We tested paired associative stimulation (PAS)181, a 
paradigm akin to long-term potentiation-like plasticity in the sensorimotor 
cortex, short-afferent inhibition (SAI), a measure of sensorimotor integration 
in the sensorimotor cortex and eye-blink classical conditioning (EBCC), an 
associative conditioning paradigm, dependent on the cerebellum for 
acquisition182 183 (see Bracha184 for review).  
 
Our hypothesis is that normal cerebellar function is necessary to adapt to 
mistimed and unpredictable peripheral nerve conduction, and where this 
fails, it is associated with the production of tremor, perhaps due to mismatch 
between the efference copy and sensory feedback from the periphery. 
Defining the effects of cerebellar stimulation on timing modulation of rhythmic 
movements and the potential effect on tremor could prove a primer for further 
work aimed towards understanding pathogenesis but also at investigating 
potentially new treatment approaches. In ET, there is multimodal evidence 
for dysfunction in the cerebellum that includes eye movement analysis, 
classical associative eyeblink conditioning, structural and functional imaging 
and pathology. There is also evidence that rhythmic finger tapping is also 
abnormal and consistent with damage to the cerebellum. In fact non-invasive 
brain stimulation methods including rTMS to the cerebellum have probed 
tapping in patients with ET. Others have demonstrated that rTMS may be 
able to affect motor tasks attributable to the cerebellum. It has also been 
shown that polarity-specific stimulation can modulate motor tasks dependent 
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on the cerebellum185. In aggregate, these have demonstrated that there is an 
abnormality in tapping that can be temporarily ameliorated with rTMS that 
then reverts to the pre-stimulation state. Tapping seems to potentially use 
similar oscillatory networks to tremor2 168, posing the question of whether 
modulating timing properties of the cerebellum may effectively alter both 
tapping and tremor through similar mechanisms. We aim to explore whether 
modulation of these putative timing properties are achievable using TDCS 
over the cerebellum. If timing could be enhanced (polarity specific), then a 
similar paradigm could be assessed (polarity specific) with NT to see if 
tremor modulation is achievable in correspondence with the effects on the 
timing properties of the cerebellum.  
 
3.1 Aims: Chapter 5: Tremor in inflammatory neuropathies 
 
1) Determine the prevalence of tremor in a single centre inflammatory 
neuropathy service. 
2) Determine the clinical features and electrophysiological characteristics 
of those patients with tremor to determine if any variables predict 
occurrence or severity of tremor. 
3) Determine differences in the subtypes of inflammatory neuropathies 
and whether these predict prevalence or characteristics of tremor. 
 
3.2 Aims: Chapter 6: Cerebellar function in inflammatory 
neuropathy tremor 
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1) Measure and compare a group of patients with inflammatory 
neuropathies and tremor, those without tremor and healthy controls on 
the following paradigms: 
a. Tremor accelerometry and surface EMG 
b. Classical eyeblink conditioning 
c. Paired associative stimulation 
d. Short-afferent inhibition 
e. Somatosensory evoked potentials 
 
3.3 Aims: Chapter 7: Tremor in Charcot-Marie-Tooth disease 
 
1) Determine the prevalence of tremor in a single centre hereditary 
neuropathy service. 
2) Determine the clinical features and electrophysiological characteristics 
of those patients with tremor to determine if any variables predict 
occurrence or severity of tremor. 
3) Determine differences in the subtypes of hereditary neuropathies and 
whether these predict prevalence or characteristics of tremor. 
4) Measure and compare a group of patients with CMT1A neuropathies 
and tremor, those without tremor and healthy controls on the following 
paradigms: 
a. Tremor accelerometry and surface EMG 
b. Classical eyeblink conditioning 
c. Eye movement analysis using electro-oculography 
d. Visuomotor adaptation 
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3.4 Aims: Chapter 8: Effect of TDCS of cerebellum on rhythmic 
finger tapping 
 
1) Determine polarity-dependent effects of cerebellar transcranial direct 
current stimulation on variability and timing of rhythmic finger tapping 
task during synchronisation and continuation phases. 
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Chapter 4: Methods 
 
Where applicable, patients were divided into tremulous and non-tremulous 
groups depending on whether arm tremor was clinically detectable. Healthy 
controls, where applicable were also considered in a separate group. This 
was the basis for group-wise analysis where applicable. Each group was 
matched for age, gender, diagnosis and severity of neuropathy. Detailed 
clinical assessment was performed (see section 4.2 below). Patients taking 
medications potentially causing tremor were excluded from 
electrophysiological studies. Clinical assessments included summed scores 
for limb strength (MRC score)186, sensation (subset of CMT neuropathy 
score187) and deep tendon reflexes (NINDS myotactic reflex scale188). 
Tremor was assessed using the Fahn-Tolosa-Marin score189 and the Bain 
and Findley spiral score depending on the study. The CMT study included 
saccadic and pursuit eye movements recordings as well as a positional 
manoeuvre for signs of cerebellar dysfunction190. Neuropathy severity was 
assessed with the CMT neuropathy score187 (where applicable) and disability 
measured by the overall neuropathy limitation scale191. Patients were divided 
into two groups for subsequent analysis depending on the clinical presence 
of tremor (tremulous and non-tremulous groups). Patients’ nerve conduction 
studies were reviewed. 
 
4.1 An electrophysiological approach to studying tremor 
 
A myriad of methodological approaches have been used to study tremor. 
These include direct measures of the tremor, for example, with 
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accelerometry, surface EMG or goniometry, measuring respectively, the 
acceleration of a body part, summative muscular electrical activity and 
angular deviation of body parts due to tremor. Other methods such as 
classical eyeblink conditioning and eye movement analysis or gait analysis 
are used to make inferences regards the pathophysiology of the tremor 
based on known anatomy and networks underlying such physiological tasks. 
 
4.1.1 Non-invasive brain stimulation 
 
Non-invasive brain stimulation includes both transcranial magnetic 
stimulation (TMS) and TDCS. TMS is a non-invasive focal method for 
modulating cortical activity. It utilizes the principle of electromagnetic 
induction and involves discharging a large current from a set of capacitors 
that flows through a circuit and copper-wire coil. This current induces a rapid 
time-varying magnetic field in the coil and when held over the head of a 
subject, the magnetic field penetrates the scalp and skull inducing a very 
small current parallel to the plane of the coil in the brain. With sufficient 
current, neuronal membranes depolarize and action potentials are 
generated. This ability of TMS to alter cortical activity has allowed for a wide 
array of uses. Multiple studies have since demonstrated that TMS can alter 
functional organization of the human cortex, leading to changes in both the 
neurophysiological properties of those brain areas and in the performance of 
tasks reliant on those regions. TDCS will be considered below. 
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4.1.1.1 Paired pulse techniques 
 
With paired pulse techniques, two stimuli are delivered. The first is 
considered the conditioning stimulus followed by a test stimulus. The latter, if 
over motor cortex, may generate a motor evoked potential, an electrical 
potential measurable by EMG. The MEP amplitude generated from TMS 
stimulation of the contralateral motor cortex is a function of the interstimulus 
interval and the intensity of the stimulus. The conditioning stimulus can be 
TMS or electrical stimulation over brain, spinal cord or lower motor neurons. 
Examples of paired pulse stimulation include short latency intracortical 
inhibition and long latency intracortical inhibition where each stimulus is 
given over motor cortex with short and long interstimulus intervals 
respectively. 
 
4.1.1.1.1 Short afferent inhibition 
 
Ascending sensory information from the periphery reaches the sensory 
cortex and has a direct and indirect modulatory effect on motor output and 
motor learning. In demyelinating peripheral neuropathies, the ascending 
sensory input, at least at the peripheral level, is dispersed and delayed and 
may conceivably impact upon subsequent motor sensory integration in the 
cortex. It is seen to be abnormal in a number of neurological diseases 
including Parkinson’s disease192 and Alzheimer’s disease193. 
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Short afferent inhibition is a paradigm that uses peripheral nerve stimulation 
as the conditioning stimulus followed by a contralateral motor cortical test 
stimulus timed to collide with the ascending afferent volley. This 
phenomenon is recordable when the interstimulus interval between median 
nerve stimulation and motor cortex stimulation is between 2 and 8 ms longer 
than latency of the afferent volley from median nerve stimulation to arrive at 
the cortex. A ratio of the effect size is determined by measuring the MEP 
amplitude arising from the test stimulation as a proportion to MEP amplitudes 
arising from a series of test stimuli that are not preceded by conditioning 
stimuli. Typically, the resulting MEP amplitude from paired pulse stimulation 
is smaller than arising from the test stimulus alone. This is termed short-
afferent inhibition and is thought to reflect sensory-motor integration in the 
cortex, perhaps primarily through cholinergic transmission. It is dependent on 
precise timing and appropriate cortical mechanisms enabling such 
integration. It has been demonstrated that stimulation of the median nerve at 
the wrist can inhibit EMG responses evoked in the FDI and APB muscles by 
TMS of the motor cortex194 195. They provided evidence to support the view 
that this represents a reduction of cortical excitability. Firstly, they were able 
to modulate the number and amplitude of descending corticospinal volleys 
elicited by cortical magnetic stimulation by preceding these stimuli with 
median nerve electrical stimuli at specific inter-stimulus intervals modified to 
accommodate varying muscle-cortex conduction times between patients. 
Secondly, comparison of TMS with Transcranial Electrical Stimulation (TES) 
in other studies showed that peripheral electrical pulses reduced the size of 
MEPs elicited with TMS but not, or much less, those following TES at 
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intervals between 20 and 30 ms indicating that the suppression at these 
intervals is intracortical in nature195 196. Evidence for a transcortical route of 
SAI comes from Tokimura et al195 who recorded corticospinal volleys in 
patients with implanted electrodes in the cervical epidural space and showed 
that indirect waves (I2 and I3), that are of cortical origin, were smaller when 
the magnetic stimulus was given at appropriate ISI after the conditioning 
peripheral electrical pulse.  
 
4.1.1.1.1.1 Short afferent inhibition: Methods 
	
4.1.1.1.1.1.1 Conditioning stimuli 
 
Conditioning stimuli were single pulses (200 µs) of electrical stimuli applied 
through bipolar electrodes to the median nerve at the wrist. The intensity was 
set at just over motor threshold for evoking a visible twitch of the thenar 
muscles. Somatosensory potentials were evoked on the scalp by 
conditioning stimuli to the left median nerve. The active electrode was 
attached 3 cm posterior to C3 (10–20 system) and the reference electrode 
was 3 cm posterior to C4. Five hundred responses were averaged to identify 
the latency of the N20 peak.  
 
4.1.1.1.1.1.2 Experimental design and data analysis 
 
Each block typically consisted of 110 trials. The motor cortex was stimulated 
on every trial. Ten trials included motor cortex stimulation alone and the rest 
of the trials were preceded by conditioning peripheral nerve stimuli at ten 
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different intervals in reference to subjects’ N20: -18ms, -4ms, -2ms, 0ms, 
+2ms, +4ms, +6ms, +8ms, +10ms, +18ms. All trials were performed in 
randomised order. Ten trials for each state were derived. Measurements 
were made of MEP area, and the size of conditioned responses was 
expressed as a percentage of the unconditioned response. Repeated-
measures ANOVA with STATE (11) as within-subjects factor and GROUP (3) 
as between-subjects factor. Post-hoc analysis was performed. 
 
4.1.1.1.2 Paired associative stimulation 
 
In the originally described form of PAS181, a transcranial magnetic stimulus to 
the primary motor cortex (M1) is preceded by a single pulsed electrical 
stimulus applied to a peripheral nerve, such as median nerve.   The inter-
stimulus interval of this pairing is adjusted to ensure that the afferent volley 
generated by peripheral nerve stimulation arrives at the cortex at the same 
time as the cortex is stimulated by a TMS pulse. Repeated associative 
pairing of the two sources of stimuli over an extended time period increases 
the excitability of corticospinal neurons. Such excitability after associative 
pairing could be considered a neuroplastic effect. This putative effect of PAS 
mirrors those attributable to long-term potentiation (LTP), a long-lasting 
enhancement in signal transmission between two neurons that results from 
stimulating them synchronously and reflects changes in synaptic plasticity. 
PAS shares similar properties, with short-latency effects that last beyond the 
period of stimulation but seems reversible and modifiable with the use of 
modulators at the NMDA receptor197 198 and behaves in accordance with 
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Hebbian principles181 199. More specifically, since the polarity of the induced 
effects appears contingent upon the order of the stimulus-generated cortical 
events, and that effective inter-stimulus intervals are within the millisecond 
range, a similarity to spike-timing dependent plasticity (STDP) has been 
suggested200. 
 
An   individualized   approach   has   been employed, whereby   the   latency   
of   the   N20   component   of   an SEP, elicited in each participant   by   
stimulating   the   peripheral   nerve, is   used   as   a   reference. In some 
instances the magnetic pulse has been timed to coincide with the N20 
component201. On the basis of the most common PAS variants alone, it is 
tempting to conclude not only that the order of the stimulus-generated 
cortical events is critical, but also that the effective inter-stimulus intervals lie 
within a very restricted range. 
 
4.1.1.1.2.1 Paired associative stimulation: Methods 
 
For the PAS protocol, subjects were seated in a comfortable reclining chair. 
Electromyographic (EMG) recordings were made from the abductor pollicis 
brevis (APB) and first dorsal interosseous (FDI) muscles with Ag-AgCl 
surface electrodes using a bipolar belly-tendon montage. Recordings were 
made from the less tremulous hand in patients. Subjects received auditory 
(speakers) and visual (oscilloscope) feedback of EMG activity. Traces with 
excessive activity were deleted online. EMG signals were amplified and 
filtered using a time constant of 3 ms and a lowpass filter set at 2.5 kHz 
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(Neurolog System, Digitimer Ltd., Welwyn Garden City, Herts, UK). EMG 
signals were digitized at 5 kHz using an analog to digital interface and stored 
on a personal computer for offline analysis (CED 1401 interface and Signal 
software, Cambridge Electronic Design, Cambridge, UK). 
 
TMS was given via a figure-of-eight coil (mean loop diameter 9cm) 
connected to a Magstim 200 stimulator (Magstim, Whitland, Dyfed, UK). The 
coil was held tangentially to the skull with the handle pointing backwards and 
laterally at an angle of 45° to the sagittal plane and was optimally positioned 
to obtain motor-evoked potentials (MEPs) in the APB. TMS was used to 
probe corticospinal excitability before and after PAS. The coil position and 
orientation and the intensity of the stimulator were kept constant throughout 
all the experimental sessions. In each testing block, we assessed the mean 
MEP amplitude for the APB and FDI muscles. Thirty consecutive MEPs were 
recorded using an interstimulus interval of 5 s. Stimulus intensity was defined 
at the beginning of the experiment at a stimulator output that induced MEPs 
of approximately 1mV in the APB muscle. These recordings were performed 
before PAS (baseline) and immediately (T0), 15 min (T15) and 30 min (T30) 
after the end of PAS. PAS consisted of 200 electrical stimuli of median nerve 
at the wrist paired with TMS over the hot spot of the APB muscle area. The 
rate of paired stimulation was 0.25 Hz. Electrical stimulation was applied 
through a bipolar electrode (cathode proximal). The stimulus duration was 
0.2 ms, the intensity was 300% of perceptual threshold. The intensity of the 
TMS pulse was adjusted to produce a MEP of ~1 mV in peak to peak 
amplitude in the resting APB when given without the preceding median nerve 
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stimulus. The conditioning median nerve electrical stimulus, given first, was 
given 5ms plus individual N20 (i.e. 25 ms if N20 latency was 20 ms) before 
the TMS pulse. Subjects were instructed to look at their stimulated hand and 
count the peripheral electrical stimuli they perceived in order to ensure 
comparable levels of attention.  
 
Repeated measures analyses of variance (ANOVA) were performed for MEP 
amplitudes. For group comparisons we computed repeated measures 
ANOVA with TIME (baseline, T0, T15, T30) and MUSCLE (APB, FDI) as 
within-subjects factors and GROUP (tremulous, non-tremulous, healthy 
controls) as between-subjects factors). The results were corrected for 
multiple comparisons (Bonferroni). If the main factors showed significant 
main effects or interaction, the effect of time and muscle in each group was 
explored with separate one-way repeated measures ANOVA. The 
Greenhouse-Geisser method was used to correct for nonsphericity. For the 
ANOVA, a non-corrected p-value of < 0.05 was considered significant. 
Conditional on a significant F-value, post hoc t-tests were used.  
 
4.1.1.1.3 Classical eyeblink conditioning 
 
Eyeblink classical conditioning (EBCC) is a paradigm of associative motor 
learning tested in humans since the 1920s (see Freeman and Steimetz for 
review202). It involves paired presentation of a conditioned stimulus (CS), 
typically a tone or light, paired with an unconditioned stimulus (US). The US, 
often an air puff or brief electrical stimulus over the supraorbital nerve, is 
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chosen as a reliable method for producing eyelid closure. In humans, an 
unconditioned short-latency low-amplitude response is usually seen in 
response to an auditory stimulus, known as the auditory blink. However, the 
repeated pairing of the CS-US leads to the production of a conditioned 
eyeblink response (CR). The maximum CR occurs very close in time to the 
onset of the US. Animal studies reveal cerebellar circuitry underlying EBCC 
in which the cerebellar cortical Purkinje cell (PC) receives convergent 
afferent information about the CS and US via two separate pathways203 with 
an additional  potential convergence upon the underlying interpositus 
nucleus (IN)204-206. Initial studies demonstrated an essential role for the 
cerebellum in EBCC using ipsilateral lesions of the cerebellar hemisphere 
that abolished CRs whilst leaving the contralateral conditioning intact207-209. 
Selected lesions of lateral cell clusters of the anterior interpositus nuclei 
reveal that this group of cells is essential for retention of EBCC210 and their 
damage could not only permanently block acquisition211, but also abolish 
retention after memory consolidation205. Although the cerebellar cortex 
clearly plays an important role in EBCC, it appears that learning can still 
occur without its function, although progresses at a considerably slower rate 
in such a context212. EBCC, with its considerable dependence on cerebellar 
function, is an ideal paradigm with which to assess and potentially quantify 
possible abnormalities of the cerebellum and its efferent and afferent 
connections which by inference may be relevant in generation of tremor. 
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4.1.1.1.3.1 Eyeblink conditioning: Methods 
 
The conditioning stimulus (CS) was a loud (∼70 dB) pure auditory tone (2000 
Hz) of 400 ms duration delivered by binaural headphones. The CS 
inconsistently produced an acoustic startle response (known as an alpha 
blink) occurring within 200 ms of the CS onset. An electrical stimulus (200 µs 
pulse-width at 5× sensory threshold) was given over the supraorbital nerve 
400 ms after the CS, to elicit a blink reflex (US). Repeated pairs of CS and 
US at 400 ms intervals (i.e. delay eyeblink conditioning) yield conditioned 
blink responses (CRs) occurring within 200 ms before the US on subsequent 
trials. EMG activity was recorded from both orbicularis oculi muscles (see 
figure 7.1G). 
 
Conditioning consisted of six learning blocks of 11 trials. Trials 1–9 were CS-
US pairs, trial 10 was US only and trial 11 was CS only. The US only trial 
was to detect spontaneous blinks and the CS only trial was to confirm that 
CRs were being acquired independently to the US. In the inflammatory 
neuropathy tremor study, an eighth and ninth block were used to measure 
extinction. For the CMT1A tremor study, a seventh block consisted of 11 CS 
only trials to measure extinction. This study was designed later and fewer 
blocks were used to minimise the long experimentation time for each patient. 
To reduce habituation, the inter-trial interval was randomised between 10 
and 30 s. To detect spontaneous blinks recording began 400 ms prior to the 
CS (800 ms before the US).   
 
88	
	
4.1.1.1.3.1.1 Data and statistical analysis 
 
For measurement of R2, EMG data were rectified and averaged. R2 latency 
was measured from the first EMG deflection 30 ms after the stimulus. For 
measurement of eyeblink conditioning, CRs were counted manually. EMG 
bursts were regarded as alpha blinks if their amplitude exceeded 50 µV and 
if latency was <200 ms after the CS. EMG bursts were regarded as CRs if 
latency was >200 ms after the CS but before the US. CR onset was defined 
by an increase in EMG activity greater than 1 SD above baseline noise 
occurring within 200 ms before the onset of supraorbital nerve stimulation. In 
cases where the CR had multiple peaks, the amplitude and latency of peak 
amplitude were identified for the largest amplitude peak. For the CS only 
trials, EMG bursts occurring 200–600 ms after the CS were considered CRs.  
 
Statistical analysis was performed using SPSS 19.0. To analyse CRs, two 
factorial repeated measures ANOVA was used with the ‘within subject factor’ 
block (block1, block2, block3, block4, block5, block6) and the ‘between 
subject factor group’ (tremulous, non-tremulous, healthy controls). For the 
extinction block, only subjects who were successfully conditioned (>40% 
CRs in any block) were analysed. Statistical significance was defined as 
p<0.05. 
 
4.1.2 Eye movement analysis 
 
A variety of different types of eye movement exist, including saccades, 
pursuit, vergence and reflexic movements relating to oculocephalic reflexes. 
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These can be measured and inferences made on integrity or disruption of 
well-established specific networks when these movements are abnormal. 
Eye movements can be measured in a number of ways. Electro-oculography 
exploits the permanent potential difference between the cornea and the 
fundus which varies with eye movements and can be recorded from the 
region around the eyes using skin surface electrodes (akin to EMG). Other 
methods including scleral search coils, video-based eye trackers and infra-
red trackers are also available. 
 
Eye movement analysis and inferences on pathophysiology in tremor has 
been most examined in parkinsonian tremor and ET. Gitchel and 
colleagues213 used a video-based eye tracker to compare 60 ET patients 
with 60 age-matched controls on binocular eye position during reflexive 
saccades to horizontally and vertically step-displaced targets. They 
demonstrated the saccadic latencies in ET to be abnormally prolonged with 
slowed velocity profiles. Further, although ET subjects were ostensibly able 
to maintain stable fixation, their saccades were interrupted by increased 
numbers of square wave jerks, a sign suggestive of fixation instability but 
with little value in anatomical localisation214 unless of large amplitude, though 
there was no difference in amplitude between patients and controls in their 
study. 
 
Helmchen and colleagues215 used a magnetic scleral search-coil system and 
direct current electro-oculography to study 17 patients with ET and compared 
them to 11 healthy aged-matched controls. Intention tremor was 
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distinguished from postural tremor. They demonstrated eye movement 
abnormalities that are not typically detected clinically. These included a 
decreased initial pursuit acceleration and also a deficient capacity to 
discharge the velocity storage mechanism, i.e. the impaired vestibule-
cerebellar function to reduce the time constant of post-rotatory vestibular 
nystagmus by head tilts, both potentially implicating networks involving the 
cerebellum. 
 
4.1.2.1 Eye movement study methods 
 
5 patients and 8 age-matched healthy controls underwent electro-
oculography to record horizontal saccadic and smooth pursuit eye 
movements. Subjects were seated with a chin support at a distance of 84cm 
from a target light source. For saccades, LEDs were presented at 10, 20, or 
30 degrees in rightward and leftward directions in random order, with an 
inter-stimulus interval of 4 seconds. Smooth pursuit eye movements were 
assessed using 8 cycles of a sinusoidally-moving target at 4 different 
frequencies (0.1, 0.2, 0.3 and 0.4Hz; target displacement +/- 20º, peak 
velocities from 12.5, 25, 37.5, and 50º/s respectively). Subjects were 
instructed to keep their eyes on the laser target “as closely as possible”. Eye 
movements were calibrated for 30 degrees and recorded using DC electro-
oculography (EOG, bandwidth 0-30Hz), and stored on a computer at a 
sampling rate of 250Hz for later offline analysis. Bitemporal electrodes 
(Viasys Healthcare GmbH, Germany) were used for conjugate horizontal eye 
movement recording. For saccades, we assessed the latency (time to initial 
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horizontal eye velocity offset from target presentation), maximum peak 
velocity and metrics. Velocity measures were calculated as the differential of 
the EOG (eye position) trace and are expressed in angular velocity units 
(º/s). We calculated the gain (slow phase eye velocity/stimulus velocity) for 
saccades and pursuit, for both right and left eye movements.  
  
4.1.3 Transcranial direct current stimulation (tDCS)  
 
TDCS delivered through the scalp modulates motor cortex excitability216-218. 
TDCS applied over the cerebellum has been utilised as a research tool to 
affect motor learning and adaptation presumably though its effects at least in 
part by polarising the neuronal membrane and inducing neuroplastic 
changes similar to those seen in LTP or long-term depression (LTD). TDCS 
utilises an anode and cathode connected to a direct current source. A weak 
direct current (0.5-2.0 mA) passes through two of these electrodes, at least 
one of which is attached to the scalp, with the majority passing through the 
brain. Anodal TDCS induces depolarization of the neural tissue immediately 
below the electrode, inducing a subthreshold change in membrane potential, 
thus increasing the tendency for neuronal firing, and therefore enhancing the 
overall neural activity and excitability of the stimulated cortical areas.   
Cathodal stimulation has the reverse effect, by hyperpolarising neuronal 
membranes. Beyond the acute effects, GABAergic and NMDA-glutamatergic 
systems may induce longer-term effects. Although the effect of TDCS is 
relatively non-focal compared to other brain stimulation methods, such as 
TMS or DBS, the accurate positioning of electrodes is still crucial. Differing 
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factors such as electrode positioning, size, current intensity and duration of 
stimulation can all affect the outcome of target stimulation.  
 
4.1.3.1 Tapping task 
 
Motor control and sensory perception are both dependent on precise timing 
mechanisms. Despite the emerging concept of a distributed network 
underpinning timing, the cerebellum appears to play a key role219. The 
cerebellum seems to be integral in synchronisation between a predictable 
timed external stimulus and a motor response, dubbed sensorimotor 
synchronisation (SMS)220. The paced finger tapping task (PFT) has been 
described widely in the literature as a measure of timing. Patients with 
unilateral cerebellar lesions performing repetitive finger tapping tasks 
demonstrated ipsilesional increase in the variability of the inter-tap interval221. 
 
The synchronisation-continuation task (SCT) utilises the PFT, requiring 
participants to tap with their index finger in time to a train of auditory stimuli 
separated by a fixed time period, or inter-stimulus interval (ISI). In the second 
part of the SCT, the continuation phase, the auditory stimulus is omitted and 
the participant is required to continue tapping at the previous learned rate. 
The PFT task enables measurement of two fundamental variables, accuracy 
and variability of the tap interval. The accuracy of the timed response, 
through the framework of the tapping paradigm, demonstrates how ‘well 
timed’ the taps are, measurable by the mean inter-tap-interval (ITI), or 
alternatively the mean absolute error. Variability is a measure of the spread 
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of taps around the temporal target and patients with lateral cerebellar lesions 
demonstrate greater variability in their performance of the PFT task 
compared with healthy controls222. 
 
4.1.3.1.1 TDCS and tapping task: Methods 
 
The main intention in the series of experiments was to examine performance 
of a tapping task at different frequencies with the right (dominant in all cases) 
index finger following application of anodal, cathodal and sham TDCS over 
the lateral cerebellum. In all experiments, performance was recorded before 
TDCS and during TDCS. 
 
 
  
 
 
 
 
A. Trial Composition 
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Figure 4.1 Trial design for the paced finger tapping task study. A) A trial is 
composed of 30s of tapping in time to a tone (synchronisation phase), and 
then 30s continuing tapping without the tone. B) A sample participant 
timetable, exhibiting the pre-stimulation, rest and stimulation stages. Note 
that stimulation days and order of frequency trials are randomised across 
participants. 
 
4.1.3.1.1.1 Design 
	
Experiments for all participants took place over three days with at least a 
week between days. On each experimental day, participants were randomly 
allocated to receive anodal, cathodal or sham stimulation. On each of these 
days, the participant would complete a pre-stimulation trial where they were 
required to tap in time with a fixed frequency repetitive auditory tone for a 
period of 30 seconds (synchronisation phase), followed by a period of 
tapping for 30 seconds at the same learned frequency but without the 
B. Sample Participant Timetable 
95	
	
queued tone (continuation phase). This pre-stimulation trial was repeated 
three times to include in randomised order, three frequencies (0.5Hz, 1Hz, 
3Hz) of tapping. Participants then had a two-minute rest period during which 
they had stimulation with TDCS (randomised to anodal, cathodal and sham). 
For sham stimulation, ‘real’ stimulation (randomised to either cathodal or 
anodal) was provided for a 30 second period to improve sham credibility. For 
anodal and cathodal stimulation, TDCS was continued until the end of the 
experiment. The rest period, utilised after the pre-stimulation trials, was 
similarly included for the sham stimulation session. Three blocks of 
synchronisation-continuation trials were performed for each frequency in a 
randomised order for each participant. After each 3Hz trial, a small break of 
90 seconds was given to allow the subject to rest their finger before the next 
trial, to avoid excessive fatigue from affecting performance. Participants were 
then required to undertake nine consecutive trials of tapping, similar to pre-
stimulation trials but in blocks of three of the same tapping frequency. Order 
of blocks was randomised (see figure 4.1). The experiment was repeated on 
three days to include all three forms of stimulation (anodal, cathodal and 
sham) in randomised order to minimise the effect of practice. 
 
4.1.3.1.1.1.1 Task 
	
Participants were sat comfortably in a chair with their right arm supported by 
a foam pad resting on a table surface. Subjects used their right index finger 
to tap in the centre of a round plate. A calibrated goniometer (Biometrics) 
was attached at end to the proximal phalanx of the index finger and at the 
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other, over the dorsum of the hand to measure the angle between the two 
and allow measurement of tap amplitudes and timing. Participants were 
instructed to tap using movements at their metacarpophalangeal joints rather 
than using movements at the wrist or elbow. Taps were performed at a 
comfortable force for the participant. Participants were asked to tap up to the 
height of a visual target. The purpose of the target was to maintain a 
constant tapping height throughout trials. Prior to the beginning of the 
experiment, TDCS electrodes were attached to intended stimulation loci (see 
below). The goniometer and force plate were connected to an amplifier and 
data acquisition system, which relayed the information to a desktop PC. 
Subjects were not provided with any additional feedback regards their 
tapping. Information from the tapping apparatus and auditory tone was 
entered in to the computer and visible to the experimenter using the Spike2 
program (CED, Cambridge, UK).  
 
4.1.3.1.1.1.2 TDCS 
	
TDCS was delivered to the right cerebellar cortex using a commercially 
available DC stimulator (Magstim neuroConn) as previously described185. 
The TDCS electrodes were 25cm2 (5cm by 5cm) in surface area, encased in 
sponge pockets, soaked in saline solution and secured to the scalp surface 
with crepe bandage. To stimulate the right cerebellar cortex, one electrode 
was secured 3cm laterally to the inion, and the other electrode was secured 
over the right buccinator muscle. In the anodal condition the electrode from 
the negative terminal electrode was placed over the right buccinator. In the 
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cathodal condition the electrode positions were switched. An intensity of 2mA 
was used for 18 minutes for both anodal and cathodal conditions. The sham 
current consisted of 2mA anodal or cathodal stimulation for 30s, over the 
right cerebellum, enough to briefly mimic the signs of stimulation (itching, 
burning, metallic taste, and rarely, visual phosphenes) without allowing any 
known alteration in cortical activity. During the onset of stimulation the 
current in all conditions was increased in a ramp like fashion over a period of 
15s and ramped down for the termination of stimulation over the same 
duration, a method shown to achieve good blinding223. Anodal, cathodal and 
sham conditions were performed on different days with at least a week’s rest 
interval owing to the long lasting effects of TDCS. The participant but not 
experimenter was blinded to randomisation of stimuli settings. 
 
4.1.3.1.1.2 Data Analysis 
	
In the data analysis, the ITIs were determined as measurements in time 
between peaks of finger displacement measured by goniometry. For each 
frequency (0.5Hz, 1Hz, 3Hz), mean ITIs and coefficients of variation were 
computed for the synchronisation and continuation phase for each of the 
three trials, which were then averaged to gain a mean ITI for that condition. 
CV was used as an indicator of temporal variability where CV (%) = 
(SD/mean)/100. To determine effects of stimulation on variability and 
accuracy, a 3-way repeated measures ANOVA was planned for ITIs 
(accuracy) and CV ITIs (variability) with main factors of stimulation (anodal, 
cathodal, sham), frequency (0.5, 1, 3Hz) and block (synchronisation, 
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continuation). Similar 3-way repeated measures ANOVAs were planned for 
pre-stimulation information but with factor stimulation replaced with day (day 
1, day 2, day 3 and sham). Sham was to be included in the pre-stimulation 
analyses to evaluate its validity as a control for the stimulation conditions. 
Tap amplitude data was derived from the amplitude of the movement from 
the goniometric data. This was to be done in the final trials of each condition, 
as those were most likely to show fatiguing effects. The first 3 taps and last 3 
taps of each trial were removed as subjects often performed poor quality 
taps during these periods. After this truncation, the 4 taps at the beginning of 
the trial were compared to the 4 taps at the end of the trial, as these often lay 
outside of the 1min trial window. A three-way ANOVA was planned for tap 
amplitude measured by goniometry with factors of trial point (beginning, 
end), stimulation (anodal, cathodal, sham) and frequency (0.5, 1 and 3Hz). 
Post hoc t-test were computed using a Bonferroni correction. None of the 
data violated the normality assumption necessary to conduct parametric 
statistical tests. 
 
4.1.4 Visuomotor adaptation 
 
In tasks requiring a subject to reach a target, external perturbations (such as 
distortion of visual feedback) introduces a movement error. The difference 
between the sensory feedback generated after the movement from the 
predicted sensory movement outcome can be considered the sensory 
prediction error. The cerebellum seems to play a key role as an adaptive 
filter, updating subsequent motor performance with the sensory prediction 
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error. The adaptation of dynamic and kinematic errors is impaired by 
cerebellar lesioning224-228.  
 
4.1.4.1 Visuomotor adaptation: experimental method (adapted from 
Parees et al229) 
 
Participants were sat opposite a 17-inch computer screen (refresh rate: 50 
Hz; distance from subject to screen: 45 cm) with a joystick secured to the 
table in front of them. The monitor displayed eight targets (1.5cm x 1.5cm 
squares) arranged in a circular array (radius 13 cm), each target equally 
separated from other targets by 45°. A similar square marked the centre of 
the circle, and a small yellow circular cursor indicated the joystick position 
(figure 4.2). The experiment was programmed in Matlab (version 7.0.1; 
MathWorks, Natick, MA) using the Cogent Toolbox 
(http://www.vislab.ucl.ac.uk/cogent.php). 
 
The targets were constantly visible to participants. In the baseline condition, 
four blocks of 40 trials were presented. At the start of each trial, the target to 
be aimed for turned red, and participants were instructed to move the joystick 
to manipulate the yellow cursor inside the target square. Once the cursor 
was kept within the target square for 1 second, the target changed colour 
from red to green, and participants were instructed to move the joystick back 
to the centre square to commence the next trial (figure 4.2A and B). Targets 
were presented in a random sequence during each block. Participants were 
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instructed to react and to move to the target squares as quickly and 
accurately as possible upon target appearance. 
 
Temporal and spatial variables used to characterize task performance were 
reaction time (RT; time in milliseconds from target presentation to movement 
onset), movement time (MT; time in milliseconds from movement onset to 
stabilisation of the cursor in the target), and displacement ratio (DR; ratio 
between the length—measured in pixels—of a straight line “perfect path” 
between the starting point and the target, and the length of the actual path 
taken by the participant, with higher values of DR indicating increasing 
deviation from the perfect path). Participants then performed a rotation 
learning task (ROT). With this task, implicit motor control was tested230 by 
measuring the ability of participants to adapt to a visuomotor perturbation. A 
constant 30° anticlockwise rotation was introduced into the path of the cursor 
displayed on the screen but participants were not made explicitly aware. 
Targets were displayed in a randomized order, and participants had to move 
the cursor to the highlighted target as quickly as possible (figure 4.2C). 
Participants were not instructed how to compensate for the rotation. 
Improvement would be indicated by a ratio in the first 10 trials and the last 10 
trials of <1 for RT, MT, and DR. The total time of the experiment was 30 
minutes with opportunities for patients to rest between blocks. No patient 
reported problems with fatigue or concentration. 
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Figure 4.2 Screenshots of visuomotor adaptation experiments. Adapted from 
Parees et al229. (A) Baseline condition. Yellow cursor in centre square. (B) 
The target square turns red and the participant is instructed to manipulate 
the joystick to maneuver the yellow cursor into the target square until the 
target square returned to a green colour (occurred after 1 s), upon which the 
participant was instructed to return the cursor to the centre square. (C) 30-
degree anticlockwise rotation is superimposed to the path of the cursor.  
 
4.1.5 EMG and accelerometry 
 
A variety of techniques may be used to quantify tremor. Tremor can be 
analysed in real time using digitisation of analogue signals at high sampling 
rates. The data can then be processed further off-line. Tremor is classically 
described electrophysiologically after tremor analysis by amplitude and 
frequency. The frequency, or oscillations per second, is measured in Hz. The 
period (or 1/frequency) and number of points sampled per second (N) then 
dictate the maximum recordable frequency, known as the Nyquist frequency 
(Nyquist frequency = N/2T Hz). Signal processing theory dictates that in 
order to avoid artefactual frequencies in tremor analysis due to insufficient 
A B C 
102	
	
sampling rates (known as aliasing), the sampling rate must be kept above 
the Nyquist frequency. 
  
Surface EMG is usually sufficient for tremor measurement, rather than 
necessitating needle EMG. It can provide useful information about the 
activity of muscles involved in the generation of tremor. EMG can provide 
useful information about motor unit synchronisation and motor unit 
recruitment and help clarify the relationship between muscles and the 
resulting limb movement, revealing information about the synchronicity or 
otherwise of antagonist pairs of muscles. The EMG signal is processed by 
rectification and smoothing to produce a tremor envelope from which tremor 
frequency in the tremor range can be derived. 
 
4.1.5.1 Methods 
	
Surface electromyographic (EMG) recordings were made with Ag-AgCl 
surface electrodes using a belly-tendon montage. Data were stored in a 
computer for display and off-line analyzed using Signal version 4.00 (and 
Spike version 2 for tremor analyses).  
 
4.1.5.1.1 Accelerometry 
 
Accelerometers measure proper acceleration ("g-force") rather than 
coordinate acceleration (rate of change of velocity). Acceleration is quantified 
in the SI unit metres per second per second (m/s2), or popularly in terms of 
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g-force (g). Accelerometers can be considered to behave as a damped mass 
on a spring, such that when exposed to acceleration, the mass is displaced 
to the point that the spring is able to accelerate the mass at the same rate as 
the casing. The displacement is then measured to give the acceleration. 
Piezoelectric, piezoresistive and capacitive components are commonly used 
to convert the mechanical displacement into an electrical signal. Most 
micromechanical accelerometers operate in-plane, that is, they are designed 
to be sensitive only to a specific plane. By integrating two devices 
perpendicularly, a two-axis accelerometer can be made and similarly for 
three axes.  
 
4.1.5.1.1.1 Accelerometry and EMG for tremor 
 
A triaxial accelerometer transducer (sensitivity ± 100 mV/g) was attached to 
the dorsal surface of the middle phalanx of the index fingers. EMG 
recordings were made of wrist extensor muscles (WE), wrist flexors (WF), 
abductor pollicis brevis (APB) and biceps brachii (BB) bilaterally. Recordings 
were performed with arms relaxed (rest), with arms/wrists outstretched at 
shoulder level (posture), and a 500-g mass attached to the wrists (loading), 
and while performing a goal-directed task (action). Accelerometry and EMG 
were recorded and analyzed for 30 seconds in each condition. 
 
EMG signals were amplified using a Digitimer D360 amplifier (Digitimer Ltd, 
Welwyn Garden City, Herts, UK), analogue filtered (low pass at 1000 Hz and 
high pass with 3ms time constant and sampled at 2000 Hz, off-line digitally 
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full-wave rectified, smoothed (CED 1401 laboratory interface; Cambridge 
Electronic Design, UK) and stored on a laboratory computer for on line visual 
display using dedicated software (SPIKE software; Cambridge Electronic 
Design).  
 
Variables measured were peak tremor frequency (PF), the total power of the 
spectra between 1 and 30 Hz as a measure of tremor amplitude (TP), the 
half-width power (HWP) given by the area under the curve between two 
vertical straight lines intersecting the rising and falling edge of the peak at 
half of the peak power (full-width at half maximum (FWHM)), the latter being 
a measure of frequency stability/variability231. 
 
4.2 Clinical assessment 
	
4.2.1 The Fahn-Tolosa-Marin Tremor Rating Scale 
	
The Fahn-Tolosa-Marin scale, revised in 1993232 assesses tremor amplitude 
at rest, on posture and kinetic/intention components in specific body parts. 
Tasks such as tremor during writing, drawing, and pouring are assessed; 
activities of daily living; and global assessments by the patient and examiner, 
with each item rated on an integer scale from 0 to 4. It has been widely used 
in clinical trials and has favourable clinimetric properties reviewed by Elble et 
al233. The scale has a high correlation between examiners (ρ = 0.93 – 
0.99)232 and high test-retest reliability (intraclass correlation) of 0.859 for the 
total score234 The scale has good face validity and correlates strongly with 
transducer measures of tremor235 236. It includes both clinician-based and 
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patient-based ratings as well as aspects of functional impairment. Its 
limitations include a potential ceiling effect for large amplitude tremor. 
 
4.2.2 Bain and Findley spirography scale 
	
Bain and Findley defined a scale of tremor severity using integer ratings from 
0 to 10 to grade the tremor evident on drawing an Archimedes spiral237 238. 
Assessment of clinimetric properties of the scale reveal an inter-rater ICC 
was 0.93 for patients with ET236, though somewhat lower in a cohort of 
patients with multiple sclerosis239. Bain and Findley reported 95% of normal 
controls had a score of 1 or lower238. Despite the potential ceiling effect 
associated with this scale238, it correlated well with ET that was quantified 
with a digitizing tablet and the Fahn-Tolosa-Marin scale236, accelerometry, an 
ADL questionnaire, postural tremor rating, and a handwriting scale237. There 
were also strong correlations with an ADL questionnaire, a finger-tapping 
task, and a pegboard task  in patients with multiple sclerosis239.  
 
4.2.3 MRC power score 
	
The MRC sum score is calculated by summating the total MRC score186 for a 
number of muscle pairs (i.e. left and right side): upper-arm abductors, elbow 
flexors, elbow extensors, wrist extensors, hip flexors, knee extensors, and 
foot dorsiflexors. Each muscle scores from 0 (“no movement”) to 5 (“full 
strength”), thus generating a potential sum score ranging between 0-70.  
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4.2.4 Sensory score 
	
The sensory system was graded as follows: touch and pin prick sense 
normal 4; distal to wrist/ankle abnormal 3; distal half forearm/leg abnormal 2; 
distal to elbow/knee abnormal 1; distal to axilla/groin abnormal 0. Vibration 
sense: tuning fork perception (128 Hz) on middle finger for 15 seconds, or on 
the hallux (big toe) for 10 seconds 4, decreased on middle finger/hallux 3, 
ulnar styloid/medial malleolus 2, elbow/knee 1, clavicula/crista or higher 0. 
Joint position sense of middle finger/hallux normal 2, diminished 1, absent 0. 
The score ranged from 0-56 (56 representing greatest sensory abnormality). 
This score creates a summative score for sensory abnormalities in 
inflammatory neuropathies240. A moderate to good validity was obtained for 
the INCAT sensory sum score, with acceptable internal consistency, inter- 
and intraobserver reliability as well as evidence for good responsiveness of 
the scale. 
 
4.2.5 NINDS myotactic reflex score 
	
The National Institute of Neurological Diseases and Stroke (NINDS) 
myotactic reflex scale provides a summation of reflex scores (0 = reflex 
absent, 1 = reflex less than normal; includes a trace response or a response 
brought out only with reinforcement, 2 = reflex in the lower half of normal 
range, 3 = reflex in the upper half of normal range, 4 = reflex enhanced, 
more than normal)241. A summation of scores for biceps, supinator, triceps, 
knee and ankle) were calculated188. 
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4.2.6 Overall Neuropathy Limitations Scale 
	
For an overall measure of disability in inflammatory neuropathies, we use the 
Overall Neuropathy Limitations Scale (ONLS), a modification of the pre-
existing Overall Disability Sum Score (ODSS). It has been found to correlate 
well with its predecessor, the ODSS, as well as with the 36-item Short Form 
Questionnaire Physical Component Summary Score. It has a high inter-rater 
reliability and the responsiveness of the ONLS was considered acceptable. 
The ONLS has better content validity and less ceiling effect than its 
predecessor, the ODSS191. The range of possible scores is 0-12 (12 
representing greatest impairment). 
 
4.2.7 CMT sum score 
	
The Charcot-Marie-Tooth neuropathy score (CMTNS) has been shown to be 
a reliable and valid composite score combining data from symptoms, signs, 
and neurophysiological investigations. It has been used in epidemiological 
studies of CMT1A and as an outcome measure in treatment trials. The 
CMTNS has been modified to reduce floor and ceiling effects and to 
standardize patient assessment with the updated scale known as CMTNS, 
with an aim to improve the sensitivity for detecting change over time and the 
effect of an intervention. It performs well clinimetrically on inter- and intra-
rater reliability242. 
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Chapter 5: Clinical study of inflammatory neuropathic tremor 
 
5.1 Introduction 
	
It has been recognised for many years that tremor can be an accompanying 
feature of peripheral neuropathy110 111. This neuropathic tremor was first 
described in hereditary neuropathies as part of Roussy-Lévy syndrome144 
which has since been shown to be a genetically heterogeneous entity145 146. 
In inflammatory neuropathies, tremor is found in up to 80% of patients with 
IgM paraproteinaemic neuropathy111 120 128, in the recovery phase of Guillain-
Barré syndrome126 and is occasionally reported in patients with chronic 
inflammatory demyelinating polyradiculoneuropathy (CIDP)114. No 
relationship seems to exist between the development of tremor and the 
severity of the neuropathy, proprioceptive loss, weakness or fatigue117 136 but 
it may relate to disease activity117. Thus, it is not clear why only a subset of 
patients develop tremor.  
 
Tremor in neuropathies has been described as disabling but no formal study 
of this has been undertaken128 except in paediatric Charcot-Marie-Tooth 
disease where it has been shown to be one of the strongest independent 
determinants of reduced quality of life (QOL)243; successful treatment in this 
context would likely have a substantial effect on QOL. Tremor in this 
population also predicts other disabling symptoms244. Currently, there is no 
consensus on the best way to treat neuropathic tremor, or why only some 
patients seem to be at risk of developing it. Certainly some cases of tremor in 
109	
	
inflammatory neuropathies are very disabling necessitating both medical and 
invasive surgical approaches to treatment129 139 141-143. 
 
In this case-control study we gathered consecutive and clinically well-
characterised patients with inflammatory neuropathy with the main aims of 1) 
documenting the incidence and nature of tremor, 2) assessing the additional 
disability that might be present in patients with tremor and 3) determining the 
predictors of tremor onset and its subsequent severity. 
 
5.2 Methods 
	
5.2.1 Patients 
	
All patients with a diagnosis of an inflammatory neuropathy made by a 
neuromuscular expert and who were receiving regular intravenous 
immunoglobulin treatment at the National Hospital for Neurology and 
Neurosurgery were approached to take part in the study. Those taking drugs 
known to commonly cause tremor were excluded. Written informed consent 
was obtained from all patients and the study was approved by the local 
ethics committee and conducted in accordance with the Declaration of 
Helsinki. 
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Variable Tremulous 
patients 
Non-tremulous 
patients 
Number 27 (63%) 15 (37%) 
Disease CIDP 15 (58%)  11 (42%)  
MMNCB 5 (56%)  4 (44%)  
IgMPN 7 (88%)  1 (12%)  
Sex 6 female, 21 male 7 female, 9 male 
Age of patients (yrs) Mean † 63.3 (11.0)  60.5 (12.0) 
Median 63.0 (34.0-83.0) 59.0 (44.0-85.0) 
Disease duration 
(yrs) 
Mean † 12.8 (8.9)  14.3 (9.2) 
Median 10.0 (2.0-30.0) 12.5 (2.0-33.0) 
Table 5.1 Demographics of patients. Expressed as mean (SD) and median 
(range). †Denotes use of either mean or median for pairwise comparison. 
Bonferroni corrected significance value of 0.025 used and p-values where 
relevant are reported in the manuscript. 
 
5.2.2 Clinical evaluation 
	
Details regarding demographic and medical history were obtained from 
patients directly and corroborated with their medical notes. A standardised 
clinical examination was performed. In particular, careful examination for 
parkinsonian signs and signs of functional tremor245 were sought. Tremor, 
where present, was distinguished from other spontaneous movements 
including fasciculations and myokymia. A modified summed Medical 
Research Council score (MRC score)186 was calculated (maximum score 70) 
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as well as a sensory sum score246. Tremor was assessed using the Fahn-
Tolosa-Marin scale189 232 with higher scores attributed to worse tremor. 
Tremor severity in the limbs was specifically assessed with Archimedes 
spirals and using the Bain and Findley spiral score (rated 0-10 with 10 
representing most severe tremor)238 to rate these. Patients were divided into 
two groups for subsequent analysis depending on the presence, clinically, of 
pathological tremor (tremulous group) or absence (non-tremulous group). 
Disability was assessed with the Overall Neuropathy Limitation Scale 
(ONLS)191. It has separate subscales for arms and legs with higher scores 
indicating more functional impairment. Results of patients’ most recent nerve 
conduction studies were obtained and correlations of clinical features of 
tremor to median nerve conduction alone was made to limit the number of 
potential comparisons. Brain imaging results, where performed, were 
collated. 
 
5.2.3 Accelerometry 
	
Nine patients with tremor (four CIDP, two MMNCB, two IgMPN) took part in 
this evaluation. Subjects were seated in a comfortable chair.  A triaxial 
accelerometer transducer (sensitivity ± 100 mV/G, Biometrics ACL300; 
Biometrics Ltd., Cwmfelinfach, Wales, UK) was attached to the dorsal 
surface of the middle phalanx of the index finger bilaterally. Recordings were 
performed (a) with arms/wrists outstretched at shoulder level (posture), and 
(b) with similar posture but a 500g mass also attached to the wrists. 
Accelerometry was recorded and analyzed for 30 seconds. The 
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accelerometry traces were stored in a laboratory computer for display and 
off-line analysis using customized Spike version 2. 
 
5.2.4 Statistical analysis 
	
For accelerometry data, a Fourier analysis of the signals derived from 
accelerometry was performed to define peak tremor frequency (PF).  
Statistical analysis was performed using PASW Statistics 19 (SPSS, Inc., 
Chicago, IL). All results are expressed as mean (standard deviation) or 
median (range) where assumptions of parametric data were not met. 
Baseline tremor characteristics were compared between tremulous and non-
tremulous controls by independent-samples t-test or Mann-Whitney test 
where data could not be transformed to fulfil assumptions for parametric 
distributions. For categorical data, group analysis was performed with 2 × 2 
cross-tabs. We compared the frequency of abnormal test results by chi-
square tests and Fisher's exact test (two-sided). Correlations were derived 
using Pearson’s coefficient or Kendall’s tau where data could not be 
transformed to fulfil assumptions for parametric distributions. P values below 
0.05 were considered to indicate statistical significance except where 
indicated, in which case Bonferroni correction for multiple comparisons was 
employed. 
 
5.3 Results 
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From a total group of 44 patients, 43 patients agreed to take part. Clinical 
and demographic details are summarised in Table 5.1.  
 
5.3.1 Clinical evaluation 
	
Twenty seven (63%) of patients had tremor. The mean age of tremor onset 
was 57.6 (11.6) years. The mean duration of disease before tremor onset 
was 5.8 (7.2) years. There were more men in the tremulous group (Table 
5.1) but this did not reach statistical significance (p = 0.14). One patient had 
onset of tremor during a relapse of his MMNCB, 6 years after the clinical 
onset of his neuropathy. One non-tremulous patient had a previous episode 
of tremor during her first GBS-like presentation. A precipitating event prior to 
tremor onset was recalled in 10 of the 27 patients: six were at the onset of 
the neuropathy, two were with relapses and two were at the time of general 
medical complications (1 with a pulmonary embolus and ITU admission and 
the other with a pulmonary embolus, but neither had abnormal structural MRI 
brain scans to account for the onset). Of the tremulous patients, four 
reported tremor in one first degree relative (one of these reported it in two 
first degree relatives). Of those, two were in the context of a diagnosis of 
Parkinson’s disease in old age, one in the context of substantial alcohol 
misuse and the other reported hand tremor in his father with no known 
secondary cause. Of those with tremor, seven had trialled medical 
treatments specifically for tremor (number of patients in brackets) 
(propranolol (3), atenolol (1), levodopa (1), clonazepam (2), trihexyphenidyl 
(benzhexol) (1), topiramate (1), gabapentin (1), pregabalin (2), primidone (1)) 
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all without benefit. Only one reported possible benefit with alcohol. Five 
patients reported benefit from treatment given for their neuropathy (three with 
intravenous immunoglobulin, one with CHOP-R chemotherapy and one with 
rituximab) while the remaining 22 patients reported no benefit from treatment 
for their neuropathy (all these patients had only received intravenous 
immunoglobulin treatment apart from one who was also treated with 
rituximab).  
 
Of the non-tremulous group, we could obtain neuroradiology reports of four 
that had previous brain imaging (sometimes for incidental purposes) with 
MRI and one with CT. Three of four with MRI had changes consistent with 
mild or moderate small vessel disease. The patient with CT had evidence 
suggesting small vessel disease. Of the tremulous group of patients, we 
were able to obtain imaging reports of eight with MRI and two with only CT. 
Five of those with MRI had mild or moderate changes consistent with small 
vessel disease, one with frontoparietal atrophy bilaterally and two reported 
as normal. Of those who had CT, one was reported as normal and one 
reported as suggesting small vessel disease. The overall proportion of those 
with abnormal imaging versus those with normal imaging (in any modality) 
was not statistically different between the two groups (p > 0.99). 
Tremor, when present, was always seen on posture or action apart from one 
patient with anti-MAG associated neuropathy who had tremor solely at rest. 
Rest tremor in addition to postural tremor occurred in 8/15 tremulous CIDP 
patients, 1/5 MMNCB and 2/7 IgMPN (1 with and 1 without anti-MAG). One 
patient (CIDP) had mild voice tremor.  
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Clinical score Tremulous patients Non-tremulous 
patients 
P value 
MRC 
score 
Mean † 65.7 (3.9) 56.6 (13.4),  0.017* 
Median 66.0 (58.0-70.0) 58.0 (29.0-70.0)  
Sensory 
score 
Mean † 39.9 (14.2)  42.3 (16.2) 0.63 
Median 41.0 (8.0-56.0) 48.0 (3.0-56.0)  
ONLS 
score  
Mean 3.7 (1.5) 4.5 (2.3)  
Median † 4.0 (0.0-6.0)  4.5 (1.0-10.0) 0.32 
Table 5.2 Clinical scores for patients comparing tremulous and non-
tremulous groups. Expressed as mean (SD) and median (range). †Denotes 
use of either mean or median for pairwise comparison. n/a – not compared. 
Bonferroni corrected significance value of 0.017 used. *Denotes significance. 
 
Nerve conduction result Tremulous 
patients 
Non-tremulous 
patients 
P 
value 
Median nerve 
MCV (m/s) 
Mean 40.5 (19.7) 37.6 (10.1)  
Median † 46.0 (10.0-97.0)  41.5 (21.0-56.0) 0.42 
Median nerve 
CMAP (mV) 
Mean † 5.8 (3.1) 4.0 (3.2) 0.07 
Median 5.5 (0.8-11.5) 3.3 (0.2-9.7)  
Median nerve 
DML (ms) 
Mean 7.0 (5.0) 5.8 (2.7)  
Median † 4.5 (3.0-18.4)  5.3 (3.3-12.4) 0.98 
Median nerve 
SCV (m/s) 
Mean 24.4 (24.8) 42.7 (19.7)  
Median † 28.5 (0.0-59.0)  50.0 (0.0-60.0) 0.03 
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Median nerve F-
wave latency 
(ms) 
Mean 43.9 (24.7) 40.1 (7.8)  
Median † 31.3 (26.3-98.0)  36.9 (31.9-51.5) 0.22 
Ulnar nerve F-
wave latency 
(ms) 
Mean 43.4 (20.5) 36.3 (6.2)  
Median † 34.4 (27.7-96.5)  35.7 (29.7-46.6) 0.82 
Table 5.3 Nerve conduction study results for inflammatory neuropathy 
patients with tremor compared to those without tremor. Expressed as mean 
(SD) and median (range). MCV – motor conduction velocity; CMAP – 
compound motor action potential; DML – distal motor latency; SCV – sensory 
conduction velocity. †Denotes use of either mean or median for pairwise 
comparison. n/a – not compared. Bonferroni corrected significance level of 
0.0083 used.  
 
5.3.1.2 Measures of tremor severity  
	
The median FTM score in tremulous patients was 14.0 (9.8-18.3). The FTM 
score includes components assessing disability and tremor in body parts 
other than the arms. Using spiral scores is a purer measure of tremor 
amplitude in the upper limb and thus of value in correlating with upper limb 
clinical and electrophysiological measures. Nevertheless, there was a strong 
correlation between both measures of tremor (Kendall’s τ = 0.59; p < 0.001). 
There was also a difference between the median score for spirals in those 
with tremor (3.0) compared to those without tremor (1.0) U = 16, Z = -4.5, 
p<0.001, r = -0.73. Spirals in non-tremulous patients were often abnormal but 
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typically lacked periodic oscillatory patterns. To investigate whether other 
symptoms of neuropathy were confounding the spiral score, we correlated 
spiral scores to strength and sensory deficit (using a Bonferroni corrected 
significance level of 0.0167 to adjust for 3 comparisons). In those with 
tremor, higher spiral scores did not correlate with worse MRC scores (see 
table 2) (p = 0.45) or worse sensory scores (p = 0.98). In those with tremor, 
there was a correlation between higher (more severe) ONLS arm scores and 
higher spiral scores (Kendall’s τ = 0.44; p = 0.01).  
 
5.3.1.3 Correlation of tremor with electrophysiological markers 
	
A number of variables measured are dependent on conduction velocity but 
principal component analysis was not used given the inadequately low 
Keiser-Meyer-Olkin measure of sampling adequacy (0.43). There was no 
difference in F-wave latencies between tremulous and non-tremulous groups 
(see table 5.3). However, with individual correlation of variables (using a 
Bonferroni corrected significance level of 0.025 for 2 comparisons), using 
spiral scores, there was a correlation between spiral scores and median 
nerve F-wave latency (p = 0.02) (see Figure 5.1). Given this, ulnar nerve F-
wave latency was examined post hoc and a similar but stronger correlation 
was found with spiral scores (p = 0.003) (see figure 5.1). F-wave latency was 
only calculated for those in whom it could be measured. Where F-waves 
were not seen, the mean spiral score was 3.5 (3.0). There was no correlation 
between spiral scores and median nerve motor conduction velocity (p = 0.49) 
or median nerve sensory conduction velocity (p = 0.36).  
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Figure 5.1 Correlations between measured F-wave latency (ms) and tremor 
severity as measured by spiral scores (higher scores more severe) in 
tremulous patients for (A) the ulnar nerve and (B) the median nerve. The 
correlation coefficient (Kendall's tau) and corresponding p-value for each 
correlation in text box. 
 
5.3.1.4 Correlation of tremor with clinical features of neuropathy 
	
Those with tremor had better MRC scores than those without tremor 
(t(16.8)= -2.6; p = 0.017), yet had similar disability scores measured by 
ONLS (see table 5.2). Using spiral scores as a measure of tremor severity, 
there was a correlation with ONLS arm sub-scores in tremulous patients 
(Kendall’s τ = 0.44; p = 0.01 using a Bonferroni corrected significance level of 
0.01 to adjust for 5 comparisons), demonstrating an association between 
increasing tremor severity and increasing disability. There was no correlation 
of tremor severity measured by spiral scores with disease (neuropathy) 
duration (p = 0.67), MRC score (p = 0.45), overall sensory score in the arms 
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(p > 0.99) or arm proprioception score (p = 0.68). In regard to hypotheses of 
tremor pathophysiology in these disorders, there was no difference in the 
proportion of tremulous patients who had a serum paraprotein (44%) from 
the proportion of non-tremulous subjects (31%) with a paraprotein (p = 0.52). 
There was also no difference in the proportion of tremulous patients who 
demonstrated pseudoathetosis (22%) compared with the proportion of non-
tremulous patients with pseudoathetosis (13%) (p = 0.69). 
 
5.3.2 Accelerometric measure of tremor 
	
In all nine patients recorded with accelerometry, a bilateral rhythmic tremor 
was noted during posture. There was no significant difference in tremor 
frequency between left and right hands (p = 0.53). The mean frequency of 
tremor in both hands in all nine patients was 6.1 (1.6) Hz with the highest 
recorded frequency at 10.0 Hz and the lowest frequency, 3.3 Hz. There was 
no significant difference in tremor frequency between the three groups of 
patients (CIDP, MMNCB, IgMPN) (p = 0.33). Weight loading did not alter the 
mean tremor frequency (p = 0.23). A sample of tremor recording is 
demonstrated in Figure 5.2. 
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Figure 5.2 Sample of tremor recording from a patient with chronic 
inflammatory demyelinating polyradiculoneuropathy (CIDP) showing tremor 
measured by triaxial accelerometry of each hand with arms outstretched (A) 
and with 500g weight loading of limbs (B). Recording of patient with IgMPN 
showing triaxial accelerometry in each hand with arms outstretched (C) and 
with weight loading of limbs causing tremor amplitude suppression but no 
modulation of frequency (D). 
 
5.4 Discussion 
	
We describe the clinical and electrophysiological characteristics of 43 
patients with inflammatory neuropathies. This is the largest prospective 
cohort of patients with inflammatory neuropathy reported with the primary 
purpose of investigating tremor. We highlight that a majority of patients with 
inflammatory neuropathy in our cohort had tremor (63%), particularly those 
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with IgMPN, but also the majority of patients with CIDP. We also describe, 
for the first time, tremor in the majority of patients with MMNCB.  Tremor in 
all these patients seems not to improve with treatment of the underlying 
neuropathy except in a small number of cases. Specific treatments for 
tremor, where used in a few cases also proved to be, in the majority of 
cases, unsuccessful. We provide evidence that tremor may add to disability 
in patients with inflammatory neuropathy as has similarly been described in 
children with CMT243. We also demonstrate for the first time a correlation of 
tremor severity with ulnar F-wave latencies.   
 
5.4.1 Impact of tremor on disability 
	
Patients with tremor scored similarly to patients without tremor on the ONLS, 
a validated disability score. Despite this, non-tremulous patients were weaker 
than tremulous patients. This suggests that the presence of tremor accounts 
for part of the disability measured by the ONLS, similarly suggested by 
Ahlskog et al1. Interestingly, in multiple sclerosis tremor, as limb weakness 
progresses, tremor may improve suggesting a necessary role for limb 
strength in generating tremor247. This may similarly be true for patients with 
inflammatory neuropathy and tremor, however, we observe that none of our 
patients reported worsening of tremor associated with improvement in their 
neuropathy (and strength) after treatment with IVIg or other 
immunomodulators. All the patients examined had been given IVIg and other 
immunomodulatory treatments without benefit on the tremor in most of these 
cases. Although a few appeared to improve with treatment, this was 
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sometimes with substantially immunosuppressive drugs such as rituximab. 
Where tremor was specifically treated, in most cases, there was a poor 
response to usual anti-tremor drugs. The high prevalence of tremor in our 
cohort, the component of disability potentially attributable to tremor and the 
refractoriness to treatment where tried frames tremor as a potentially 
important symptom contributing to untreated disability in patients with 
inflammatory neuropathies. 
 
5.4.2 Pathogenesis of tremor 
	
On most demographic and clinical features, except gender, there was no 
difference between the tremulous and non-tremulous patient groups or any 
correlation within the tremulous group. There were no differences in F-wave 
latency between tremulous and non-tremulous patients, but there was a 
strong correlation between tremor severity (assessed by spiral scores) and 
F-wave latencies (see figure 5.1). However, this should be tempered with the 
fact that we, a priori, planned analysis of only median nerve data and added 
the ulnar F-wave correlation post-hoc. Nevertheless, the finding of similar F-
wave latencies between tremulous and non-tremulous patients, yet a strong 
correlation between delayed F-wave latencies and tremor severity points 
towards F-wave delay being an important modulator of tremor in those prone 
to it, but in itself seems insufficient to explain the presence or absence of 
tremor. This might indicate the importance of an additional variable, such as 
the ability of a central processor (most likely the cerebellum) to adapt to such 
dispersion and delay, in preventing tremor from arising128. Recent data 
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demonstrating defective cerebellar associative learning in patients with 
inflammatory neuropathy and tremor, but not those without tremor, supports 
the hypothesis of cerebellar dysfunction in patients with inflammatory 
neuropathy and tremor248.  Activation studies in PET demonstrating 
cerebellar overactivity in patients with IgM paraproteinaemic neuropathy and 
tremor seems concurrent with this possibility2. Alternative hypotheses such 
as that proposed by Smith et al126 in which tremor was felt to be in part 
dependent on the stretch reflex given the finding of a correlation between 
ulnar motor conduction velocities and thumb tremor, does not seem 
consistent with our findings. Bain et al128 similarly were unable to find such a 
correlation. Our finding of a tremor frequency that does not vary with weight 
loading also promotes the hypothesis of an important central mechanism in 
generating the tremor.  
 
Busby and Donaghy, in their study of 102 patients with chronic dysimmune 
neuropathy114 remarked upon slowed motor nerve conduction velocities and 
prolonged distal motor latencies in all patients with tremor, but F-waves were 
not commented upon. However, this was based upon conduction velocities in 
only four patients of their series of 102 patients all of whom had very severe 
tremor. This indicates a selection bias for severe tremor in their calculation 
and there was no comparison reported between conduction velocities in 
these patients compared with non-tremulous patients. Thus, there is 
insufficient evidence to conclude that our results differ from theirs. Indeed, 
other series136 do not demonstrate a difference in motor conduction velocities 
in tremulous versus non-tremulous patients. A caveat is that patients here 
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were recruited from those attending hospital regularly for treatment with 
intravenous immunoglobulin which thus may have biased the sample 
towards one with greater severity of neuropathy. As such, conclusions drawn 
here can only be applied to this subgroup of patients. 
 
Limb tremor has rarely been described in patients with MMNCB; three 
patients of a case series of 39 cases of MMNCB had tremor, all at rest249. 
We describe 5/9 MMNCB patients in our study to have tremor. In two of 
these, the tremor was jerky. In only one of these was tremor present at rest 
in addition to action tremor. Treatment of inflammatory tremor has previously 
been reported to be variable (summarised by Smith126) with many treatment 
failures but some treatment successes using immunomodulators for treating 
the underlying neuropathy and rare success using other medications such as 
pregabalin250 251. Here, patients with tremor were refractory to normal oral 
medications used for treating tremor252 including pregabalin. There were a 
small number of cases that responded to treatment of the underlying 
inflammatory process with immunomodulators, however, the numbers were 
too small to draw clear conclusions. 
 
The presence of tremor in inflammatory neuropathies seems unlikely to 
represent the coexistence of essential tremor (ET) on epidemiological, 
clinical and neurophysiological grounds128. In our series, the prevalence of 
tremor is some magnitudes higher than that reported for essential tremor in 
the general population14, even for a population over the age of 40 years253. 
Further, the male predominance in tremulous patients (though not 
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statistically significant), similarly described previously128 would be atypical for 
ET, as would the very low rate of a family history of tremor (15% in our 
cohort, a proportion of which may be attributable to parkinsonism rather than 
ET) and lack of response to alcohol as may be expected in ET. There was no 
evidence on careful clinical examination that these patients had an 
alternative tremor diagnosis such as parkinsonism or functional tremor. 
 
5.4.3 Use of spirals for rating neuropathic tremor 
	
The use of spirals for rating tremor and their automated analysis has 
attracted considerable attention in the literature236 237 254, particularly for use 
in clinical trials. Our results suggesting that tremor provides a component of 
the disability experienced by some patients with inflammatory neuropathy, 
indicates that a simple measure of tremor severity would be of interest for 
future clinical trials in inflammatory neuropathy. However, the potential for 
confounding of spiral scores from factors due to the neuropathy itself 
(weakness, sensory impairment) has not previously been addressed. In our 
series, although patients without tremor made some errors in spiral drawings, 
these were not typical for those produced by patients with tremor, lacking 
periodic oscillation. We therefore suggest that this simple measure could be 
utilised in future clinical trials.  
 
Tremor in inflammatory neuropathies is common, not just in IgMPN, but also 
in CIDP and MMNCB.  Tremor appears to cause disability independent of 
other factors relating to the neuropathy and is therefore an important 
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outcome measure in future clinical trials of treatment, with simple spiral 
assessments offering an easy tool to do so. Outcomes for treatment of 
tremor are disappointing except in a small number of cases where tremor 
improves with immunomodulatory treatment of the neuropathy. F-wave 
latencies correlate strongly with the severity of tremor, but this is insufficient 
to fully explain the presence of tremor in only a proportion of patients with 
inflammatory neuropathy. Perhaps, as suggested by Bain et al128, the 
presence of an additional factor such as the inability of a central processor 
such as the cerebellum to adapt to these mistimed signals is additionally 
required for patients to develop tremor.  
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Chapter 6: Cerebellar learning distinguishes inflammatory 
neuropathy with and without tremor 
 
6.1 Abstract 
	
6.1.1 Objectives 
 
This study aims to investigate if patients with inflammatory neuropathies and 
tremor have evidence of dysfunction in the cerebellum and interactions in 
sensorimotor cortex compared to non-tremulous patients and healthy 
controls.   
 
6.1.2 Methods 
 
A prospective data collection study investigating patients with inflammatory 
neuropathy and tremor, patients with inflammatory neuropathy without tremor 
and healthy controls on a test of cerebellar associative learning (eyeblink 
classical conditioning), a test of sensorimotor integration (short afferent 
inhibition), and a test of associative plasticity (paired associative stimulation). 
We also recorded tremor in the arms using accelerometry and surface EMG. 
 
6.1.3 Results 
 
We found impaired responses to eyeblink classical conditioning and paired 
associative stimulation in patients with neuropathy and tremor compared with 
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both neuropathy patients without tremor and healthy controls. Short afferent 
inhibition was normal in all groups.  
 
6.1.4 Conclusions 
 
Our data strongly suggest impairment of cerebellar function is linked to the 
production of tremor in patients with inflammatory neuropathy.  
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6.2 Introduction 
	
Inflammatory mediated neuropathies are common and potentially 
treatable255. Tremor occurs with IgM paraproteinaemic neuropathy (IgMPN)1 
111 120 and less commonly in other inflammatory neuropathies256. It has been 
suggested that temporally distorted peripheral inputs reach a normally 
functioning central processor, such as the cerebellum, which is misled into 
producing a delayed second agonist burst and tremor128 257 258. The 
involvement of the cerebellum in neuropathic tremor is supported by 
functional imaging abnormalities2.  There does not seem to be a 
straightforward relationship between the development of tremor and 
conduction velocity126. Further, no relationship seems to exist between 
tremor and the severity of neuropathy as assessed by proprioceptive loss, 
weakness or fatigue117 136. However, we have shown that although 
conduction velocity does not predict the presence of tremor, it is correlated 
with its severity for those in whom tremor is present256. This indicates a 
second mechanism may be necessary to produce tremor. 
  
Here we set out to explore aspects of central nervous system physiology in 
tremulous and non-tremulous patients with inflammatory neuropathies 
compared to healthy controls. We hypothesised that the central 
compensation needed to account for delays caused by the peripheral 
neuropathy would most likely depend on plastic changes within the 
cerebellum and connections that mediate interaction between sensory and 
motor systems and therefore that patients with tremor would have evidence 
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of dysfunction in the cerebellum and interactions in sensorimotor cortex 
compared to non-tremulous patients and controls.  
 
6.3 Methods 
	
6.3.1 Subjects 
	
Eighteen out of 43 consecutive patients with a diagnosis of inflammatory 
neuropathy (either CIDP (chronic inflammatory demyelinating 
polyradiculoneuropathy), MMNCB (multifocal motor neuropathy with 
conduction block) or IgMPN) agreed to take part in all or just parts of the 
study. The latter depended on contraindications to electrical/magnetic 
stimulation and on the cumulative length of study sessions.  
 
Patients were divided into tremulous and non-tremulous depending on 
whether arm tremor was clinically detectable. The Fahn-Tolosa-Marin 
score232, a modified summed Medical Research Council score186 (MRC 
score; maximum 70), a sensory score246 (maximum 56), and the Overall 
Neuropathy Limitation Scale191 (ONLS; maximum 12) were performed. 
 
Ten tremulous patients (mean age: 60.0 (9.7) years; mean disease duration: 
12.5 (8.2) years; total sensory score 41.7 (13.8); total MRC score: 65.3 (4.2); 
ONLS score: 3.6 (1.3)) were studied. They were compared with eight non-
tremulous patients who did not differ in these characteristics (mean age: 63.3 
(8.3) years (p = 0.46); mean disease duration: 14.1 (10.6) years (p = 0.72); 
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total sensory score: 42.0 (16.1) (p = 0.97); total MRC score: 63.2 (9.0) (p = 
0.59); ONLS score: 4.2 (1.2) (p = 0.38)) (Table 1). We also recruited nine 
healthy age-matched controls (mean age: 59.0 (7.7) years (p = 0.54)). 
Age Sex Disease Duration FTM  Group Study 
51 M CIDP 3 9 T T,E,S,P 
66 M CIDP 11 20 T E,S,P 
51 M CIDP  9 13 T T,E,S,P 
63 M CIDP 30 17 T T,E,S,P 
74 M CIDP 7 13 T T,E,P 
70 M CIDP 14 17 T T,E,P 
64 M MMNCB 12 2 T T,E 
56 M MMNCB 22 29 T T,E 
76 M IgM (anti MAG positive) 13 37 T T,S,P 
62 M IgM (anti MAG negative) 4 43 T T,E,S,P 
62 M CIDP 7 - NT E,S,P 
51 M CIDP 28 - NT E,S,P 
77 F CIDP 15 - NT E,S,P 
48 M CIDP (IgG paraprotein) 7 - NT S,P 
67 F CIDP 9 - NT E,P 
51 F MMNCB 33 - NT E 
61 M IgM (anti MAG negative) 6 - NT E 
63 F IgM kappa (anti MAG 
positive) lymphoblastic 
lymphoma 
8 - NT E,S 
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Table 6.1 Demographics, clinical characteristics and studies undertaken for 
patients with inflammatory neuropathies. Disease – disease duration (years), 
M – male, f – female. R – right, L – left. FTM – Fahn-Tolosa-Marin total score 
(0 (minimum) to 4 points (maximum severity) are assigned for tremor 
amplitude under a variety of conditions and 0 – 4 points for severity in daily 
activities). Group T – tremulous, NT – non-tremulous. Study T – tremor 
analysis, E – eyeblink classical conditioning, S – short afferent inhibition, P – 
paired associative stimulation.  
	
Before inclusion in the study, written informed consent was obtained from all 
participants. This study was approved by the local Research Ethics 
Committee. 
 
6.3.2 Electrophysiological evaluation 
	
Surface electromyographic (EMG) recordings were made with Ag-AgCl 
surface electrodes using a belly-tendon montage. Data were stored in a 
computer for display and off-line analyzed using Signal version 4.00 (and 
Spike version 2 for tremor analyses). 
 
6.3.2.1 Accelerometry and EMG for tremor 
 
Nine patients with tremor (five CIDP, two MMNCB, two IgMPN) took part in 
this evaluation. A triaxial accelerometer transducer (sensitivity ± 100 mV/g) 
was attached to the dorsal surface of the middle phalanx of the index fingers. 
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EMG recordings were made of wrist extensor muscles (WE), wrist flexors 
(WF), abductor pollicis brevis (APB) and biceps brachii (BB) bilaterally. 
Recordings were performed (1) with arms relaxed (rest), (2) with arms/wrists 
outstretched at shoulder level (posture), and (3) a 500-g mass attached to 
the wrists (loading), (4) while performing a goal-directed task (action). 
Accelerometry and EMG were recorded and analyzed for 30 seconds in each 
condition. 
 
6.3.2.2 Blink reflex and eyeblink classical conditioning (EBCC) 
 
Three age matched groups were examined, nine healthy controls, seven 
non-tremulous patients (four CIDP, one MMNCB, two IgMPN), nine 
tremulous patients (six CIDP, two MMNCB, one IgMPN). Tremulous and 
non-tremulous patients did not differ regarding age (p = 0.97), disease 
duration (p = 0.59), total sensory score (p = 0.72), MRC score (p = 0.63) or 
ONLS score (p = 0.26).  
 
Blink reflex and R2 blink reflex recovery cycle were assessed in all subjects 
according to a protocol previously described259. EBCC is an associative 
learning paradigm, dependent on the cerebellum for acquisition205. The 
conditioning stimulus (CS) was a loud (50 dB above auditory threshold) 2000 
Hz tone lasting 400 ms played via binaural headphones. The CS 
inconsistently produced an acoustic startle response (‘‘alpha blink’’) 
occurring within 200 ms after the CS. An electrical stimulus (unconditioned 
stimulus (US); 200 µs pulse width at 5x sensory threshold) was given to the 
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left supraorbital nerve 400 ms after the CS, eliciting a blink reflex 
(unconditioned response (UR)).  
 
Repeated pairs of CS and US at 400 ms intervals yield conditioned blink 
responses (CR) occurring within 200 ms before the US (see figure 6.1). EMG 
was recorded bilaterally from orbicularis oculi. Conditioning consisted of 
seven acquisition blocks (each consisting of nine CS-US pairs, one US only, 
one CS only trial). An eighth and ninth block consisted of eleven CS only 
trials to measure extinction. 
 
 
Figure 6.1 Example EMG recording of orbicularis oculi muscle during 
eyeblink conditioning. CS (dotted line) – onset of conditioned stimulus 
(auditory tone); CR – conditioned response; US – unconditioned stimulus; 
UR – unconditioned response. A) Recording demonstrating presence of an 
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alpha blink and absence of a CR prior to the US. B) Recording 
demonstrating presence of a CR prior to the US. 
 
6.3.2.3 Short Afferent Inhibition (SAI) and Paired Associative 
stimulation (PAS) 
 
Both SAI and PAS rely on precisely timed interactions between sensory 
afferents and motor cortical stimulation. In healthy subjects, these 
interactions occur at specific times related to the N20 response. We 
expected N20 responses to be delayed in our patients and therefore we 
evaluated N20 latency in each subject. One patient had to be excluded 
because N20 could not be identified. N20 could be measured in all other 
subjects studied (expressed as mean (SD): healthy controls 20.3(1.5); 
neuropathic tremor 33.8(11.5); no tremor 32.6(6.6)).  
 
EMG recordings were made from the abductor pollicis brevis (APB), first 
dorsal interossei (FDI) and abductor digiti minimi (ADM) muscles of the right 
side. Test responses in the target muscles were evoked by transcranial 
magnetic stimulation (TMS) of the left primary motor cortex applied through 
Magstim 200 magnetic stimulators (Magstim, Whitland, Dyfed, UK) with a 
monophasic current waveform, connected to a figure of eight coil (mean loop 
diameter 9cm). The coil was held tangentially to the skull with the handle 
pointing backwards and laterally at an angle of 45∘ to the sagittal plane and 
was optimally positioned to obtain motor-evoked potentials (MEP) in the 
APB. TMS was used to probe corticospinal excitability before and after PAS. 
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The coil position and intensity were kept constant throughout the 
experimental sessions. Electrical stimulation was applied to the median 
nerve at the wrist at 300% of perceptual threshold using a constant current 
generator. The stimulus duration was 0.2 ms. 
 
6.3.2.3.1 Short afferent inhibition 
	
Three age matched groups were examined, six healthy controls, five non-
tremulous patients (four CIDP, one IgMPN) and six tremulous patients (four 
CIDP, two IgMPN). Tremulous and non-tremulous patients did not differ 
regarding age (p = 0.84), disease duration (p = 0.82), total sensory score (p 
= 0.63), MRC score (p = 0.90) or ONLS score (p = 0.44).  
 
SAI was assessed as previously described195 (see section 4.1.1.1.1). We 
assessed the response to a cortical stimulus alone and when preceded by 
conditioning stimuli at ten interstimulus intervals in reference to subjects’ 
N20: -18ms, -4ms, -2ms, 0ms, +2ms, +4ms, +6ms, +8ms, +10ms, +18ms. 
Comparison of responses between groups was based on motor evoked 
potential (MEP) area.  
 
6.3.2.3.2 Paired associative stimulation 
	
Three age-matched groups were studied, including six healthy controls, five 
non-tremulous patients (five CIDP) and eight tremulous patients (six CIDP, 
two IgMPN). Tremulous and non-tremulous patients did not differ regarding 
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age (p = 0.61), disease duration (p = 0.72), total sensory score (p = 0.62), 
MRC score (p = 0.96) or ONLS score (p = 0.83).  
 
A conditioning median nerve electrical stimulus was given 5ms plus 
individual N20 (i.e. 25 ms if N20 latency was 20 ms) before a TMS pulse 
over the APB muscle ‘hot spot’ at an intensity predetermined to yield a ∼1 
mV resting MEP. Two hundred paired stimuli were delivered at a rate of 0.25 
Hz (see section 4.1.1.1.2.1 and Stefan et al181). Thirty MEPs were recorded 
before, immediately after, 15 min and 30 min after PAS. Comparison of PAS 
response was based on MEP area. 
 
6.3.3 Data Analysis and Statistics 
	
A Fourier analysis of signals derived from accelerometry was performed to 
define peak tremor frequency (PF). Total power of the spectra between one 
and 30 Hz was used as surrogate measure of tremor amplitude (TP). All 
parameters were calculated for each accelerometer axis, and then averaged. 
For EMG, the signal was full-wave rectified and smoothed and Fourier 
analysis was performed to derive PF. 
 
For measurement of eyeblink conditioning, CRs were counted manually. 
EMG bursts were regarded as “alpha blinks” if their amplitude exceeded 50 
µV and if latency was <200 ms after the CS. EMG bursts were regarded as 
CRs if latency was >200 ms after the CS but before the US. For the CS only 
trials, EMG bursts occurring 200–600 ms after the CS were considered CRs. 
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Statistical analysis was performed using PASW Statistics 18. All post-hoc 
comparisons were corrected by the Bonferroni method. The level of 
statistical significance was pre-set at P< 0.05.      
 
6.4 Results 
	
6.4.1 Tremor recordings 
	
In all nine patients a bilateral tremor was recorded during posture and action. 
Five patients had additional bilateral rest tremor. The power spectra of 
accelerometry and WE EMG showed corresponding peaks. Since there was 
no side-to-side difference in PF or TP in any position (p>0.3), we used the 
mean of both sides for PF and TP for further analyses. Mean PF and TP in 
the four recorded conditions are shown in Table 6.2.  
 
 Accelerometry 
PF (Hz) TP (milli-g) 
Rest 7.1 (1.6) 0.55 (1.65) 
Posture 6.1 (1.6) 0.85 (2.41) 
Weight  6.4 (1.4) 1.21 (2.48) 
Action 5.5 (1.4) 7.48 (9.69) 
 
Table 6.2 Mean peak frequency (PF) and total power (TP) (derived from 
accelerometry) in the four recorded conditions. Results expressed as mean 
(SD). Rest – rest position; posture – arms outstretched; weight – arms 
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outstretched with weight loading; action – repetitive finger-to-nose 
movements.  
 
To compare PF and TP measured by accelerometry at rest, posture, and 
action we computed two repeated-measures ANOVAs. For PF, there was no 
effect of CONDITION [F(2,16)=3.47; p=0.06). For TP, there was an effect for 
CONDITION [F(1,8)=6.76; p=0.03), however post-hoc comparisons showed 
no differences (p>0.09). 
 
A t-test for pairwise comparisons showed no difference in PF (accelerometry, 
WE EMG) before and after loading (p>0.2) indicating that loading did not 
decrease tremor frequency. Five out of nine patients had an increase of 
tremor amplitude after loading by at least 100%. However, there was no 
difference regarding TP before and after loading (p=0.33) on group level. 
In three out of nine patients (two with IgMPN, one with MMNCB), PF in the 
APB was more than 1Hz lower compared to the biceps. However, a paired t-
test comparing PF during posture in biceps and APB in the whole group of 
patients showed no difference (p=0.17).  
 
6.4.2 Blink reflex and eyeblink classical conditioning 
	
R2 blink reflex recovery curves, R1 and R2 latencies and latency variability 
did not differ between the three groups.  
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Repeated-measures ANOVA with BLOCK (7) as within-subject factor and 
GROUP (3) as between-subject factor revealed an interaction of BLOCK x 
GROUP (F(12,132) = 3.34, p<0.001). There were also effects of BLOCK 
(F(6,132) = 12.2, p<0.001) and GROUP (F(2,22) = 16.6, p<0.001) (figure 
6.2). Post-hoc tests showed that tremulous patients had a lower rate of CRs 
as the blocks progressed compared to healthy controls and non-tremulous 
patients (p<0.001). This difference was significant in conditioning blocks 
three to seven (figure 6.2). Latencies of CRs, spontaneous blink rates and 
"alpha blinks" were not different between the groups.  
 
 
Figure 6.2 Eyeblink classical conditioning in the three groups. Mean 
percentage of conditioned responses of each group of subjects over the 
seven conditioning blocks (C1-C7). E1 and E2 represent extinction blocks. 
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Error bars represent standard error. * Significant lower rate of CRs in 
tremulous patients compared to healthy controls and to non-tremulous 
patients. 
 
6.4.3 Short afferent inhibition 
	
Repeated-measures ANOVA with STATE (11) as within-subjects factor and 
GROUP (3) as between-subjects factor showed an effect of STATE 
(F(3,48)=6.64; p<0.001). There was no effect of GROUP or the GROUP x 
STATE interaction. Post-hoc tests showed a reduction in MEP size occurring 
at ISI of N20 (p<0.001) and N20 minus 2 (p=0.007) (figure 6.3). 
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Figure 6.3 Short afferent inhibition in the three groups. Effect of short 
afferent inhibition on mean conditioned/unconditioned MEP area. *Significant 
inhibition at N20 and N20-2ms among all groups. Relative values are used 
for figure. Error bars represent standard error. 
 
6.4.4 PAS 
	
Mean intensity to produce 1mV MEPs was not different between patients 
(56%) and controls (61%). Mixed-factorial design ANOVA with TIME (4) and 
MUSCLE (3) as within-subject factors and GROUP (3) as between-subject 
factors revealed that PAS produced a lasting increase in mean MEP area 
demonstrated by an effect of TIME (F(2,33) = 4.762, p = 0.014). The size of 
MEP facilitation differed among groups and muscles, indicated by an effect 
of GROUP (F(2,16) = 9.890, p = 0.002) and an interaction of TIME x GROUP 
(F(4,33) = 5.166, p = 0.002). The interaction between TIME x MUSCLE x 
GROUP (F(8,62) = 3.436, p = 0.003) demonstrates that the effect of PAS on 
the homotopically (APB) and heterotopically (FDI, ADM) conditioned muscles 
differed time-dependently between groups (Figure 6.4). 
 
To further explore the conditioning effects of PAS on MEP areas in each 
group, we computed separate repeated-measures ANOVAs with TIME and 
MUSCLE as within-subject factors. In controls, an effect of TIME 
(F(3,15)=3.212; p=0.047) was found. The facilitatory effect was stronger in 
the APB compared to the FDI/ADM, reflected by a strong TIME x MUSCLE 
interaction (F(6,30)=7.257; p<0.001). In patients without tremor, a different 
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pattern of PAS induced changes occurred. MEP facilitation was higher and 
spatial specificity was compromised as indicated by a main effect of TIME 
(F(3,12)= 6.570; P=0.007) without TIME x MUSCLE interaction. Patients with 
tremor had an effect of TIME (F(3,21)=3.479; p=0.034) due to overall MEP 
depression without TIME x MUSCLE interaction. 
 
Post-hoc comparisons revealed that PAS induced an increase in MEP areas 
compared to baseline in the APB in controls (T15: p=0.023), but not in 
neuropathy with and without tremor. A facilitation of the MEP area in the 
ADM and FDI was only observed in patients without tremor (T15(FDI): 
p=0.003; T15 (ADM): p=0.036). 
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Figure 6.4 Paired associative stimulation (PAS) in the three groups. Effect of 
PAS on mean MEP areas in healthy controls (blue), patients with 
inflammatory neuropathies without tremor (yellow), and patients with 
inflammatory neuropathies with tremor (green). The data are plotted as a 
ratio to the baseline MEP area. Error bars represent standard deviation. 
Ratios higher than 1 indicates facilitation and ratios below 1 indicate 
inhibition of MEP area. The effect of PAS on MEP area for the APB (target) 
muscle (A), on the FDI (B), and on the ADM (C). *P < 0.05 paired t-test 
comparing MEP area with baseline (corrected for multiple comparisons by 
Bonferroni method). 
 
6.5 Discussion 
 
We demonstrate that patients with inflammatory neuropathy and tremor differ 
from patients without tremor with regard to cerebellar function and 
sensorimotor plasticity. We found very low rates of EBCC in patients with 
inflammatory neuropathy and tremor compared to non-tremulous patients 
and healthy controls suggesting abnormal associative learning in the 
cerebellum that segregates with tremor. We also describe an absence of 
normal facilitation in TMS-evoked EMG potentials after PAS in patients with 
tremor, suggesting abnormal sensorimotor cortex plasticity. In non-tremulous 
patients, sensorimotor plasticity, demonstrated by facilitation of TMS-evoked 
EMG potentials after PAS, occurred in neighbouring muscles but without a 
normal facilitatory response in the target muscle, suggesting a lack of 
topographical specificity of sensorimotor plasticity. 
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Tremor in our patients with inflammatory neuropathies was invariably present 
during posture and action. Five patients had additional rest tremor. When 
present in all three conditions, tremor was worst during posture or action 
which is in concordance with previous reports128 260. Previously, a lower 
tremor frequency in distal compared to proximal hand muscles in two out of 
six patients with paraproteinaemic neuropathy was described128. This was 
also observed in three of our patients. However, on a group level the peak 
tremor frequency did not differ between proximal and distal muscles.  
 
EBCC is a form of simple associative learning that is well studied and for 
which the cerebellum is both necessary and sufficient. Structural or 
functional impairments of the cerebellum lead to abnormalities in acquisition 
of this conditioned response182 205 259. We demonstrate abnormal EBCC in 
tremulous neuropathy patients that clearly differentiates them from the 
normal rates of conditioning in non-tremulous neuropathy patients and 
controls. Mean R1 and R2 latencies and latency variability did not differ 
between groups making it unlikely that desynchronization of the afferent 
volley alone may be a factor in the lack of conditioned responses in the 
tremulous patients. The degree of impairment of acquisition of conditioned 
responses reported here is in line with the degree of impairment reported in 
patients with cerebellar degeneration or cerebellar lesions. A previous study 
showed a delayed second agonist burst261 in patients with IgMPN and tremor 
suggesting that the cerebellum, although intact, would be a likely candidate 
for a central processor “tricked” into generating tremor in the context of 
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distorted mistimed peripheral signals128. Our data provide evidence that the 
cerebellum is not functioning normally in those patients who develop tremor. 
 
We were able to record SSEPs, albeit delayed, in all CIDP or IgMPN patients 
with tremor. This is in line with the assertion that tremor occurs in the 
presence of distorted rather than absent sensory input128. All patients, 
tremulous and non-tremulous, had normal SAI as compared with normal 
controls. This suggests that despite the peripheral sensory-motor delay due 
to the demyelinating neuropathies, central processes have, remarkably, been 
able to adapt to such delays to reset to the new latency of the N20.  
 
In healthy subjects PAS causes a facilitation of motor evoked potentials in 
the “target muscle” only, lasting for 15-30 minutes . This response shares a 
number of features with long-term potentiation181. Patients with tremor 
showed no response to PAS. The normal SAI in patients with tremor argues 
against afferent dysfunction and associated changes in the sensory motor 
cortex as sole explanation for the abnormal PAS response. This is supported 
by the findings in one tremulous CIDP patient with normal N20 and absent 
PAS response. In recent work, we have demonstrated that cerebellar 
suppression in healthy subjects by transcranial direct current stimulation 
impairs subsequent motor cortical facilitation by PAS262. We therefore 
speculate that the absent PAS response in tremulous neuropathy patients 
may reflect cerebellar dysfunction that is also responsible for their impaired 
EBCC.  
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In patients without tremor, PAS response was also abnormal. Facilitatory 
changes were seen but these occurred in neighbouring ulnar-innervated 
muscles but not in the APB. This latter finding has not, to our knowledge, 
previously been described in any other group of subjects. It is conceivable 
that altered topographical representation triggered by the neuropathy may 
affect sensory-motor integration required to mediate changes associated with 
PAS263 264. An additional speculation is that this unusual response to PAS 
may be explained by a peripheral phenomenon such as ephaptic 
transmission between peripheral nerve fibres.  
 
Here we present evidence that tremor in patients with inflammatory 
neuropathy is associated with cerebellar dysfunction. We acknowledge that 
generalizability is limited by our relatively small sample size. Also, this study 
does not answer the question whether the cerebellar abnormalities in 
tremulous patients are secondary to the presence of tremor or primary. 
Regarding the latter, one possibility is that in those with tremor, the specific 
antibody involved in causing the peripheral neuropathy is capable of crossing 
the blood-brain barrier and binding to the cerebellum. There is indirect 
evidence for this in IgMPN in which tremor is typical. It would be of interest to 
look for evidence of antibodies that bind to cerebellum in tremulous patients 
with CIDP: they may share a common causative antibody for their 
neuropathy and the cerebellar dysfunction that drives the development of 
tremor.  
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Chapter 7: Tremor in Charcot-Marie-Tooth Disease 
 
7.1 Abstract 
	
7.1.1 Objectives  
	
Tremor in Charcot-Marie-Tooth disease (CMT) can be disabling. Cerebellar 
abnormalities are thought to underpin neuropathic tremor. Here, we aim to 
clarify the potential role of the cerebellum in CMT tremor.  
 
7.1.2 Methods  
	
We assessed prevalence of tremor by questionnaire in 84 patients with CMT. 
Of those, 23 patients with CMT with and without arm tremor and healthy 
controls underwent a clinical assessment, classical eyeblink conditioning, 
electro-oculography, visuomotor adaptation test, tremor recording with 
surface EMG and accelerometry, and retrospective correlation with nerve 
conduction studies to investigate the possible mechanisms of tremor 
generation.  
 
7.1.3 Results  
	
The prevalence study revealed tremor in 21% of patients and in 42% of 
those it caused impairment of function. Tremor recordings revealed a mild-to-
moderate amplitude tremor with a weight load-invariant 7.7Hz frequency 
component. Performance on classical eyeblink conditioning, visuomotor 
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adaptation and electro-oculography were no different between tremulous and 
non-tremulous patients and healthy controls.  
 
7.1.4 Conclusions  
	
These results argue against a prominent role for an abnormal cerebellum in 
tremor generation in the patients studied with CMT. Rather, our results 
suggest an enhancement of the central neurogenic component of 
physiological tremor as a possible mechanism for tremor in the patients 
studied.  
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7.2 Introduction 
	
Tremor can occur as part of Charcot-Marie-Tooth disease (CMT) due to a 
variety of mutations. In paediatric CMT, tremor is one of the most disabling 
symptoms243 and also predicts other disabling symptoms244.  The 
mechanisms that give rise to this tremor is not known although various 
hypotheses have been postulated265 266. Cerebellar dysfunction is one 
hypothesis, as has been shown for tremor in inflammatory neuropathies2 128 
248 256. Co-existence of essential tremor has also been considered, where 
cerebellar dysfunction would also be expected. Another possibility is fatigue 
causing entrainment of motor units resulting in an enhanced physiological 
tremor90 267-269. Fatigue is commonly recognised in CMT and represents an 
important outcome measure in clinical trials270. Understanding tremor 
mechanisms is important as little is known about treating tremor in CMT, why 
only some patients seem predisposed and why it predicts other disabling 
symptoms. 
 
Here we investigate clinical and pathophysiological aspects of the tremor 
associated with CMT, with an emphasis on techniques sensitive to cerebellar 
dysfunction such as eyeblink classical conditioning (EBCC)203-206, visuomotor 
adaptation271 and eye movement recording215. We hypothesise that these 
should be abnormal if the cerebellum is functioning abnormally or entrained 
in a pathological network in tremor in CMT.  
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7.3 Methods 
	
7.3.1 Screening for tremor in a large cohort of CMT 
	
Questionnaires were sent to all patients with CMT attending a peripheral 
nerve outpatient clinic at the National Hospital for Neurology and 
Neurosurgery, London, UK (see Table 6.2 and Table 6.3) to assess clinical 
features of tremor. Patients completed a spiral drawing with their dominant 
hand to assess tremor using the Bain and Findley spiral score (0 
representing no tremor; 10 representing severe tremor)238. 
 
7.3.2 Clinical assessment 
	
Twenty-three patients with CMT with and without tremor were recruited. 
Each group was matched for age, gender, diagnosis and severity of 
neuropathy (see Table 6.1). Detailed clinical assessment was performed. 
Patients taking tremorgenic medications were excluded. Summed scores for 
limb strength (MRC score)186, sensation (subset of CMT neuropathy 
score)187 and deep tendon reflexes (NINDS myotactic reflex scale for biceps, 
supinator, triceps, knee and ankle)188 were calculated. Tremor was assessed 
using the Fahn-Tolosa-Marin score189. Saccadic and pursuit eye movements 
were examined as well as a positional manoeuvre for signs of cerebellar 
dysfunction190. Neuropathy severity was assessed with the CMT neuropathy 
score187 and disability measured by the overall neuropathy limitation scale191. 
Patients were divided into two groups for subsequent analysis depending on 
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the clinical presence of tremor (tremulous and non-tremulous groups). 
Patients’ nerve conduction studies were reviewed. 
 
7.3.3 Motor control studies 
	
Differing numbers of patients were recruited for each of the following studies. 
The combined study duration for all experiments was not feasible for all 
subjects.  
 
7.3.3.1 Accelerometry and EMG 
 
16 patients (10 tremulous and 6 non-tremulous) participated. As detailed 
(see section 4.1.5), a triaxial accelerometer (Biometrics Ltd; sensitivity ±50 
mV/G) was attached to the dorsal surface index finger bilaterally. Surface 
EMG was recorded simultaneously, from biceps brachii (BB), forearm flexors 
(FF), forearm extensors (FE) and abductor pollicis brevis (APB) bilaterally. 
Recordings were performed: a) with arms outstretched (postural condition) 
and (b) postural condition with 500g mass attached to the hand (weight 
loading). 
 
7.3.3.2 Eye movement recordings 
 
Five tremulous patients underwent electro-oculography (EOG) to record 
horizontal saccadic and pursuit eye movements. Subjects were seated 84cm 
from a target light source. For saccades, LEDs were randomly presented at 
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10, 20, or 30 degrees in rightward and leftward directions, with inter-stimulus 
interval of 4 seconds. Smooth pursuit eye movements were assessed using 
8 cycles of a target moving horizontally about a centre point with a sinusoidal 
velocity curve. This was repeated for 0.1Hz, 0.2Hz, 0.3Hz and 0.4Hz (target 
displacement +/- 20 degrees, peak velocities from 12.5, 25, 37.5, and 50 
degrees/s respectively). Subjects were instructed to maintain fixation on the 
laser target. Eye movements were calibrated and recorded using bitemporal 
DC electro-oculography.  
 
7.3.3.3 Visuomotor adaptation 
 
14 patients (8 tremulous and 6 non-tremulous) and nine healthy participants 
matched for age, sex and handedness completed this experiment, 
measuring visuomotor adaptation229. Participants used their dominant hand 
to manipulate a cursor (via joystick) to visual targets in a circle on a computer 
screen. A square marked the centre of the circle, and a white cursor 
indicated joystick position. The starting position was in the centre of the circle 
(Figure 7.1C). At the start of each trial, participants were instructed to move 
the joystick to place the cursor inside the (randomly determined) peripheral 
target square (indicated by a colour change) as quickly as possible, returning 
the cursor to the centre square prior to the next trial (figure 7.1D). This was 
repeated 40 times per block.  
 
In the baseline condition, three sequential blocks were presented. In the 
fourth block, the rotation condition, a constant 30-degree anticlockwise 
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angular displacement was introduced into the path of the cursor displayed on 
the screen without participants’ prior explicit knowledge (Figure 7.1E).  
 
7.3.3.4 Eyeblink conditioning 
 
14 patients (7 tremulous and 7 non-tremulous groups) and 12 healthy 
participants matched for age, sex and handedness completed this 
experiment. Methods are described in full in chapter 4 (Figure 7.1G). 
 
7.3.4 Data analysis and statistics 
 
7.3.4.1 Tremor analysis 
 
Fast Fourier transform of the accelerometry and envelope EMG signal was 
performed to define the peak tremor frequency and total power of the spectra 
between 1 and 30 Hz. All parameters were calculated for each 
accelerometer axis. The square root of the sum of the squares of each 
axis272 was derived for each measure of total power. For frequency 
comparisons, the highest total amplitude channel was chosen.  
 
7.3.4.2 Eye movement recordings      
    
For saccades, latency (time to initial horizontal eye velocity offset from target 
presentation), maximum peak velocity and metrics were assessed. Velocity 
measures were calculated as the differential of the EOG trace and are 
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expressed in angular velocity units (degrees/s). Gain (slow phase eye 
velocity/stimulus velocity) for saccades and pursuit, for both rightward and 
leftward eye movements were calculated. Patient data was compared to that 
of eight healthy age and sex-matched controls. 
 
7.3.4.3 Visuomotor adaptation  
      
Temporal and spatial variables used to characterize task performance were 
reaction time (from target presentation to movement onset; RT), movement 
time (from movement onset to stabilisation of the cursor in the target; MT), 
and displacement ratio (ratio between the length, measured in pixels, of a 
straight line “perfect path” between starting point and target, and actual path 
length taken by participant; DR). Improvement was indicated by a ratio in the 
first 10 trials and the last 10 trials below 1 for RT, MT, and DR. 
 
7.3.4.4 Eyeblink conditioning 
 
For EBCC, the percentage of conditioned responses (CR), the onset and 
peak latency of the CR, the amplitudes of the CR and unconditioned 
responses (UR) were used as dependent variables. Latencies to onset and 
peak of conditioned eyeblink responses were visually identified. CR onset 
was defined as an increase in EMG activity greater than 1 SD above 
baseline noise occurring within 200 ms before the onset of supraorbital nerve 
stimulation.  
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7.3.4.5 Statistical analysis 
 
Statistical analysis was performed using PASW Statistics 19. ANOVA was 
used to compare baseline characteristics between groups. For two-way 
comparisons of tremulous versus non-tremulous patients in the 
questionnaire, independent T-tests were used. Spearman’s rank correlation 
coefficient was used for correlation between EMG/accelerometry and clinical 
features. Frequency of abnormal test results between groups was detected 
using Chi-Square Tests, Fisher’s exact (2-sided). Non-parametric tests 
(Mann-Whitney U test, Friedman ANOVA completed by post hoc analysis 
with Wilcoxon test) were used to compare groups where Kolmogorov-
Smirnov test indicated non-normally distributed data. Post-hoc comparisons 
were corrected by the Bonferroni method. Results are expressed by mean 
and SD unless otherwise specified. P-values below 0.05 were considered 
significant. 
 
7.4 Results 
	
7.4.1 Clinical assessment 
	
Clinical characteristics are described in table 7.1. Tremor, where present, 
occurred on posture in both arms, with little detectable clinically on 
movement and no rest component. Minor postural leg tremor was noted in 
two patients with arm tremor. One tremulous patient (1/13) reported benefit 
with alcohol; eight did not report benefit and four do not drink alcohol. There 
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were no differences between the tremulous and non-tremulous group in 
nerve conduction measures of median or ulnar nerve. 
 
Variable Tremulous 
patients 
Non-tremulous 
patients 
p-
value 
Number of patients 13 10 n/a 
Age (years) 54.7 (12.6) 48.5(13.4) 0.41 
Sex 31% female 33% female 1.00 
Diagnosis CMT1A (92%) 
CMT1B (8%) 
CMT1A (80%) 
CMT1B (10%) 
CMT2 mitofusin (10%) 
 
MRC score (arm) 35.9 (5.1) 34.1 (9.7) 0.34 
NINDS reflex score (arm) 1.3 (3.6) 3.8 (5.3) 0.11 
Sensory score (arm) 22.8 (7.5) 23.3 (4.5) 0.83 
CMT neuropathy score 17.5 (7.2) 16.5 (8.6) 0.82 
ONLS score (arm) 1.9 (1.1) 2.0 (1.4) 0.60 
Median nerve conduction 
velocity (wrist to elbow) (m/s) 
21.2 (9.0) 21.7 (12.5) 0.92 
Median nerve CMAP (wrist) 
(mV) 
4.2 (3.4) 2.8 (2.1) 0.29 
Median nerve F-wave latency 
(wrist) (ms) 
56.9 (18.4) 42.9 (16.0) 0.32 
Table 7.1 Clinical features comparing CMT1A patients with and without 
tremor. Results reported as mean (standard deviation); n/a – not applicable. 
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Genetic 
diagnoses of 
responders to 
survey 
Percentage of 
all 
responders 
(n=84) 
CMT1A 49 
CMT1B 4 
CMT1 (other) 10 
CMT 
intermediate 1 
CMT2 34 
CMT4C 1 
 
Table 7.2 Genetic diagnoses of responders to postal survey. 
 
Genetic 
diagnoses of 
non-responders 
to survey 
Percentage of 
all non-
responders 
(n=89) 
CMT1A 31 
CMT1B 7 
CMTX 9 
CMT1 (other) 10 
CMT2 43 
 
Table 7.3 Genetic diagnoses of non-responders to postal survey. 
160	
	
7.4.2 EMG/accelerometry 
	
Table 7.4 summarises the results. For tremulous subjects, there was no 
correlation between age and frequency of postural arm tremor in contrast to 
reports in ET273. There was no difference in postural tremor frequency 
between males, 7.6 (0.61) Hz and females, 8.3 (2.4) Hz with tremor. There 
was no difference in EMG peak frequency between proximal (BB) and distal 
muscles (APB). Six of ten tremulous patients had an EMG peak at the same 
frequency as the main accelerometer peak. Weight loading and alteration of 
posture had no effect on the postural tremor frequency in tremulous patients 
as a group. However, with weight loading, four patients demonstrated a 
secondary accelerometry peak with lower frequency.  
 
Accelerometry  Tremulous 
patients 
Non-tremulous 
patients 
Value p-value Value p-value 
Accel freq (Hz) on posture 7.7 (1.7)  0.90 8.8 (3.4)  0.08 
Accel freq (Hz) with weight  7.8 (2.3) 7.6 (2.8) 
Accel power on posture (mG) 1.0 (3.1) 0.34 0.02 (0.02) 0.22 
Accel power with weight (mG) 2.0 (6.8) 0.03 (0.02) 
 
Table 7.4 Accelerometry measured tremor peak frequency and power 
between tremulous and non-tremulous patients. 
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7.4.3 Eye movement recordings 
	
Clinically, there was no spontaneous or gaze-evoked nystagmus in any 
patient. Head impulse test was normal bilaterally, with normal pursuit and 
saccadic eye movements. There was no difference in horizontal saccadic 
velocity, metric gain or latency between patients and controls. Pursuit gain 
was similar between groups, for all target frequencies (figure 7.1A). There 
were no within-subject effects of direction or saccadic amplitude (figure 
7.1B). For saccadic velocity there was, as expected, an effect of amplitude 
(F(1,11)=74.9, p<0.001) but not direction.  
 
7.4.4 Visuomotor adaptation 
	
All three groups performed the task similarly without differences. All groups 
demonstrated improvement after the first two blocks in all variables, without 
change between Block 2 and 3 suggesting a ceiling effect of learning. In the 
rotation block, all groups demonstrated improved performance in the last 10 
trials compared with the first 10 of the block in variables RT (F(1,21)=13.4; 
p=0.001), MT (F(1,21)=17.6; p<0.0005) and DR (F(1,21)=17.3; p<0.0005). 
There was no Group x Block interaction for RT (F(2,21)=1.07; p=0.36), MT 
(F(2,21)-1.15; p=0.34) or DR (F(2,21)=1.34; p=0.28) (figure 7.1F).  
 
7.4.5 Eyeblink conditioning 
	
There were no differences between the three groups in acquisition or timing 
of CRs. All three groups had an increased proportion of CRs as the blocks 
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progressed F(2.7,63.0) = 10.0, p<0.0005 (between block factor). There was 
no difference in acquisition of CRs between groups (figure 7.1H). Total 
number of CRs over all blocks was similar between groups (healthy controls 
38 (7.1)%, non-tremulous patients 28.8 (8.4)% and tremulous patients 30.7 
(8.8)%). 
 
 
Figure 7.1 Summary results for electrophysiology and eye movement 
studies. (A) Gain (y-axis) of pursuit eye movements. Gain illustrated 
according to angular velocity (degrees/second) and side (R – right; L – left). 
(B) Butterfly plot of saccadic eye movement velocity. Standard error bars 
point upwards for healthy controls, downwards for patients. (C) Test of 
visuomotor adaptation. Screenshot of monitor display at the start of each 
trial. (D) Colour change (to dark grey) indicated cue to move cursor to 
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peripheral target. Arrows demonstrate direction of movement to and from 
peripheral target. (E) Rotation task testing visuomotor adaptation with 30 
degree anti-clockwise perturbation covertly applied to path of cursor. (F) 
Results of visuomotor adaption task showing three groups’ performance on 
RT (reaction time), MT (movement time) and DR (displacement ratio). (G) 
Representation of recording from eyeblink conditioning. Upper trace reveals 
CS (conditioning stimulus) succeeded by an alpha blink and an US 
(unconditioned stimulus) followed by an UR (unconditioned response). The 
lower trace represents acquisition of the CR (conditioned response) after the 
CS and prior to the forthcoming US. (H) Results of eyeblink conditioning. 
 
7.4.6 Screening for tremor in a large cohort of CMT 
	
Eighty-four of 157 questionnaires sent were returned (54%). Fifty-six percent 
were female. Forty-eight percent reported to have upper limb tremor. Mean 
duration of tremor was 11.3 (8.5) years. Of those with tremor, 32% had a 
positive family history of tremor, 7% reported their tremor to improve 
transiently with alcohol, 66% had tremor when drinking or pouring fluids and 
42% had tremor when fastening buttons. Thirty-nine percent reported that 
other people had commented on their tremor. Twenty-two percent with 
tremor were on medication that could potentially cause tremor. None of them 
had been diagnosed with medication-induced tremor. Only 18 of those who 
reported tremor had a formal diagnosis of tremor by a doctor (21% of total 
respondents). Of those, only three had specific causes cited for their tremor, 
namely neuropathic tremor (2) and subarachnoid haemorrhage related 
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tremor (1). Those diagnosed with tremor by a doctor did not have worse 
performance on spiral scores (2.4(1.3)) than those self-reporting tremor 
(2.5(1.3)), t(37) = 0.097, p = 0.92. Tremor caused some impairment of daily 
activities. Those who reported difficulty buttoning clothes due to tremor 
scored significantly worse on the Bain Findley spiral score (3.1(1.4)) than 
those with tremor who did not report such difficulties (2.0(1.0)), t(36)=-2.9, p 
= 0.007. 
 
7.5 Discussion 
	
7.5.1 Overview 
	
In this study, we report the most detailed physiological study of tremor in 
CMT to date. The tremor in CMT has been varyingly reported as 
indistinguishable from 6-8 Hz essential tremor266 110, similar to enhanced 
physiological or cerebellar tremor274 or resulting explicitly from weakness and 
abnormal stretch reflexes mediating central drive to enhanced physiological 
tremor275. Tremor is one of the strongest independent determinants of 
reduced QOL in children with CMT1A243 and multivariate modelling suggests 
that interventions designed to improve tremor might have a beneficial effect 
on QOL.   
 
Essential tremor5 involves the cerebellum but whether or not this is due to 
degenerative change seems questionable11. We demonstrate lack of 
evidence for functional abnormalities in the cerebellum associated with 
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tremor in CMT exemplified by normal visuomotor adaptation, control of eye 
movements and EBCC. Instead, EMG and accelerometry data demonstrate 
a tremor consistent with enhancement of central mechanisms underlying 
enhanced physiological tremor. Our survey of tremor in CMT suggests 
tremor is often under-diagnosed and may be contributing to disability in some 
patients.  
 
7.5.2 Lack of evidence for cerebellar dysfunction underlying tremor in 
CMT 
	
Cerebellar dysfunction has been proposed as a potential mechanism for 
tremor in CMT based on an apparent clinical overlap between the tremor of 
CMT with ET, and the results of experimental studies in patients with tremor 
associated with inflammatory neuropathies which have suggested cerebellar 
involvement248. In this study, we examined a range of physiological and 
behavioural markers of cerebellar dysfunction. We found no differences 
between tremulous CMT patients, non-tremulous CMT patients and healthy 
controls in cerebellar dependent associative conditioning, adaptation to a 
visuomotor perturbation and assessment of eye movements. Our results 
suggest that the tremor seen in patients with CMT is unlikely to be related to 
cerebellar dysfunction, in contrast to patients with ET or cerebellar 
pathology28 215 271 276. This, along with the relative lack of alcohol 
responsiveness found in our series and the high prevalence of tremor 
compared to that expected in the general population14 also suggests that 
tremor in patients with CMT is unlikely to be due to chance co-occurrence of 
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ET. Although a family history of tremor was commonly reported by some 
patients, we believe that it may represent tremor present in other family 
members with CMT, rather than ET. Our results imply that the association 
between ET and CMT seems improbable and would thus not support 
pursuing genetic linkage analysis of ET and CMT as has been suggested in 
the past266. 
 
7.5.3 Tremor in CMT is consistent with enhancement of the central 
component of physiological tremor 
	
Two distinct components are thought to exist in enhanced physiological 
tremor. The first is a peripheral mechanical-reflex component mediated by 
the natural oscillation properties of the limb and the properties of reflex arcs. 
The second is a central neuronal component.  Our results demonstrate the 
tremor in CMT to be a postural tremor of 7.7 Hz. The lack of dependence of 
EMG tremor frequency on weight loading, the proximity of muscles to spinal 
cord, or peripheral nerve conduction velocity argues against a dominant 
mechanical-reflex component117 274 275. Further, the mechanical component 
of physiological tremor is thought to arise in part due to irregularities in motor 
unit firing providing a broad-spectrum signal that drives oscillations in the 
limb at eigenfrequency. In the finger this would be expected to be a higher 
frequency (20-25Hz)277 than observed in our patients. The tremor seen in 
patients studied here most likely reflects enhancement of the central 
component of physiological tremor as previously described278. This is 
invariably associated with a driving modulation of motor-unit activity at 7-
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13Hz regardless of their mean discharge frequency278, not simply a passive 
response to sensory feedback; being present in deafferented patients279. The 
central-neurogenic component of physiological tremor may originate from an 
oscillating network within the central nervous system97 101. This has been 
postulated to include direct central feedback loop from the motor neuron pool 
to Renshaw cells278 or the spinal interneuronal system280. As seen here, this 
central component of enhanced physiological tremor is independent of reflex 
arc length and the frequency is not modulated by increased limb inertia281 or 
stiffness90 278 282 283. We found that tremulous patients had a weight-invariant 
EMG spectral peak at the frequency of the dominant accelerometry peak 
consistent with enhancement of the central component of physiological 
tremor284. More recently, modulation of physiological tremor phase has been 
possible with cerebellar stimulation without effect on amplitude285, in line with 
the contemporaneous idea that although physiological tremor is driven 
centrally, there may be gain modulation more distally, perhaps modulated by 
the neuropathy in the case of tremor in CMT. 
 
Here, neither clinical nor electrophysiological markers of severity 
differentiated between those with or without tremor. Our data suggesting the 
tremor of CMT reflects an enhanced central component of physiological 
tremor provides a basis for speculation regarding mechanism. First, while the 
10-Hz component of physiological tremor may be explained in part by unit 
firing rates, external synchronization may account for increased tremor 
amplitudes observed on strong or fatigued contraction. Fatigued finger 
movements are associated with increased tremor and this is not confined to 
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the fatigued finger, as there is fatigue-related enhancement of a common 
drive at the supraspinal level. Fatigue in neuromuscular disorders is 
pervasive286. Fatigue has been suggested to be an important symptom 
linking tremor and cramp in paediatric CMT1A244. Indeed, our results show 
that for some patients, limb weight loading worsened tremor, although this 
was not significant on a group level. Fatigue could therefore be one factor 
behind the augmentation of physiological tremor in CMT, warranting further 
investigation. An important proposed mechanism for preventing 10Hz central 
oscillations being transmitted to motoneurones resulting in tremor is a “phase 
cancellation” system mediated by spinal interneurons287. There is evidence 
that pathology in peripheral nerves may extend to involve spinal 
interneurons288 289 and spinal cord motoneurone290, and it is possible that 
individual differences in the extent of this pathology is a factor driving the 
manifestation of tremor in a proportion of patients with CMT. 
 
7.5.4 Tremor in CMT may be under-reported 
	
Tremor contributes to disability in CMT and may need assessment in future 
clinical trials. The results of our questionnaire corroborates reports that 
tremor is common in hereditary neuropathies266. Our results indicate that the 
tremor is typically mild to moderate. However, self-report of tremor was 
commoner than doctors’ diagnosis of tremor, so this symptom seemed 
under-reported. 
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7.5.5 Limitations 
	
There are a number of limitations to our study including sample sizes. 
However, the relative rarity of the disease and the requirement for study 
participants to undergo a long duration of experimentation given the multiple 
methods, means that these numbers compare favourably to previous 
studies. Nevertheless, generalisation of the results found here need to be 
tempered until this is replicated by others. Our postal survey had a response 
rate of only 54%. However, there were no obvious differences in the genetic 
subtypes of respondents versus non-respondents in our survey. 
Nevertheless, multiple variables determine response rates to surveys and 
this may include the ability of participants to easily complete a survey by 
hand, thus potentially introducing a bias of lower severity of neuropathy or 
tremor in the responder group. 
 
In summary, tremor occurs in some patients with CMT, is often mild but 
under-diagnosed and may contribute to disability in some patients. We 
demonstrate lack of cerebellar dysfunction and therefore it distinguishes itself 
from tremor in inflammatory neuropathies and essential tremor. Given the 
relatively small sample size, these findings would require validation in a 
larger sample. Nevertheless, our data suggest that tremor in at least some 
patients with CMT represents an enhancement of the central component of 
physiological tremor which may have implications for future studies on the 
role of fatigue and consequence of disability in hereditary neuropathies. 
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Chapter 8: The effect of transcranial direct current 
stimulation of the cerebellum on voluntary rhythmic finger 
movements  
 
8.1 Summary 
	
Previous chapters have demonstrated evidence of how the cerebellum 
appears to be implicated in tremor generation in a sub-set of patients with 
neuropathic tremor, namely those with an inflammatory cause. In other 
tremor disorders, such as ET, non-invasive brain stimulation has been used 
to investigate potential treatment approaches to tremor. Gironel has used 
1Hz rTMS and found tremor amplitude suppression when applied over the 
cerebellum. This may have multiple potential effects, some undesirable. In 
terms of non-invasive approaches to treatment, transcranial direct current 
stimulation (TDCS) has favourable cost implications, ease of use and 
potential portability and translational value. TDCS over the cerebellum is a 
natural potential interest in terms of its possible effects on tremor in ET but 
also in NT, given our results and those of others suggesting an aberrant role 
of the cerebellum. Here, we turn attention to the normal function of the 
cerebellum and how this might be adversely affected by TDCS. We 
investigate a well-established function of the cerebellum, timing of rhythmic 
finger movements and aim to determine qualitatively and quantitatively 
changes in this function induced by cerebellar stimulation. 
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8.2 Abstract 
	
Mounting evidence indicates that the cerebellum plays a pivotal role in the 
timing of rhythmic movements. Previous studies using patients with 
cerebellar lesions have provided evidence for the cerebellum underlying sub-
second movements, but imaging studies and TMS experiments have been 
less consistent. In this study, polarity-specific TDCS was used to modulate 
the activity of the lateral cerebellum. During modulation with TDCS, any 
effect on timing mechanisms was assessed through performance on a 
rhythmic tapping task. A trial comprised of healthy participants tapping in 
time with an auditory cue for 30s (synchronisation phase) and then 
continuing to tap at the same rate without a cue (continuation phase) for a 
further 30 seconds. Trials were completed with tapping frequencies of 0.5, 1 
and 3Hz. Each trial was completed three consecutive times for each of the 
respective frequencies, the latter randomised. Different stimulation modes 
were used on different days, the order randomised across participants. 
TDCS to the right lateral cerebellum was shown to have no effect on 
accuracy or variability of the intertap interval. Whilst it may be possible that 
TDCS does affect cerebellar timing networks, our results failed to reject the 
null hypothesis that the cerebellum does not have a critical role in event 
based timing. 
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8.3 Introduction 
	
Sensory perception and effective motor control are both dependent on 
precise timing mechanisms. Despite the emerging concept of a distributed 
network underpinning timing, the cerebellum appears to play a key role, 
given in part, its ability to respond to inputs with a variety of oscillatory 
outputs220. Disrupting cerebellar circuits can manifest as problems with 
timing156 including the ability to  perform specifically timed rhythmic 
movements. Multiple patient studies with cerebellar insults purporting timing 
deficits support the role of this area as a central clock. Supporting the role of 
the cerebellum in timing are neuroimaging studies that demonstrate 
increased cerebellar activation during imagined timing tasks291. As part of its 
putative role in timing, the cerebellum appears crucial for sensorimotor 
synchronisation (SMS), whereby motor responses are synchronised with 
predictably-timed external stimuli220. In this context, the role of the 
cerebellum is likely confined to discontinuous movements that require event-
based timing for explicit representation of a temporal goal. Such a goal can 
be evaluated for accuracy and any error in timing used to inform the next 
movement in a longer sequence as opposed to continuous tasks where 
emergent timing seems to dominate. The paced finger tapping task (PFT) 
has been used widely in the literature as a measure of timing. Spencer et 
al221 investigated individuals with unilateral cerebellar lesions performing 
repetitive finger tapping tasks and demonstrated ipsilesional increase in the 
coefficient of variability of the inter-tap interval (ITI).  
 
173	
	
The synchronisation-continuation task (SCT) also utilises the PFT and 
requires participants to tap with their index finger in time to a train of auditory 
tones separated by a fixed time interval, or inter-stimulus interval (ISI). In the 
second stage of this test, the continuation phase, the stimulus is 
discontinued but the participant is instructed to continue tapping at the 
previously learned rhythm. The PFT task enables measure of two baseline 
variables, accuracy and inter-tap variability variability. The accuracy of the 
timed response, through the framework of the tapping paradigm, 
demonstrates how ‘well timed’ the taps are, measurable by the mean ITI, or 
alternatively the mean absolute error. Variability is a measure of the spread 
of taps around the temporal target292. Patients with lateral cerebellar lesions 
seem to have greater variability in their performance of the PFT task 
compared with healthy controls222. 
 
The Wing-Kristofferson model suggests that variability be divided into central 
(the internal clock within the brain) and motor variance (execution of the 
movement). In the continuation phase of the PFT task (i.e. tapping without 
the tone) the variability can be associated with the variability of the central 
timekeeper, as the motor variance theoretically remains constant293. Motor 
variance is consistently small except at very short ITI durations, where faster 
tapping may incur fatigue and larger variability (for review, see294). The 
model implies that central and motor variance are processed independently 
of one another, and thus may have separate neural correlates293. Since the 
Wing-Kristofferson model is specific to the continuation phase of the PFT 
task, it is also relevant to ask whether synchronisation and continuation 
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phases of the PFT task have separate neural correlates and whether the 
cerebellum is key to either.  
 
Synchronising finger tapping to an external auditory cue requires formation of 
an internal temporal representation of the stimulus. Representation of this 
stimulus to timed motor outputs requires feed-forward mechanisms rather 
than solely feedback systems given the observation that deafferented 
individuals are able to tap in phase with a metronome despite being unable 
to see or hear their taps294. The cerebellum may play such a feedforward role 
(for review see295), perhaps by modulating efference copy output from other 
areas such as M1296. Despite the importance of feedforward mechanisms on 
tap timing, proprioceptive, visual and auditory feedback are also required to 
update the planned motor actions for subsequent taps, perhaps via the 
cerebellum given its prominence in error correction.  
 
Theoret et al297 applied rTMS over the medial cerebellum demonstrating 
increased variability of tapping in the PFT task. Whilst Del Olmo et al298 also 
found an increase in variability of the PFT task at 2Hz when rTMS was 
applied to the lateral cerebellum, Jancke et al299 found no effect on timing 
when rTMS was given over the the same area. However, Rao et al also 
found that during a temporal task activations of the cerebellum arise later 
than one might expect if it were to be involved in explicit timing300. Although 
cerebellar TDCS has previously been used successfully to modulate 
cerebellar function in a polarity specific manner185 262 271, it has not yet been 
shown in relation to timing. 
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The cerebellum has a number of roles that relate to repetitive movement 
control. Cerebellar abnormalities are known to affect rhythmic hand 
movement control. Indeed in tremor disorders where the cerebellum is rather 
clearly linked to pathophysiology, such as ET, a timing function thought to be 
reliant on the cerebellum is affected as demonstrated by an increased 
variability of rhythmic hand movements when compared with healthy 
controls301. Similarly, it has been shown that inhibitory rTMS, potentially by 
reducing neuronal excitability, can disrupt cerebellar activity and interfere 
with the execution of rhythmic movements in healthy participants. Perhaps 
surprisingly then, in patients with ET, transient improvement in arm tremor 
can be achieved using 1Hz rTMS over the lateral cerebellum on the 
ipsilateral side40. This was postulated by the authors to be due to an 
interference with ongoing oscillatory loops involving the cerebellum. Del 
Olmo et al298 confirmed and expanded the idea that the cerebellum plays a 
main role in the selection of motor strategy of rhythmic finger movements, 
particularly in terms of temporal organization of movement. In particular, they 
showed that there is an evident correlation between the pacing variability 
(ITICV) and the motor strategy adopted by patients with ET. Motor 
impairments observed in these patients can transiently be modified by 1 Hz-
rTMS over the lateral cerebellum, supporting the role of cerebellum in the 
pathogenesis of ET. 
 
8.4 Aims 
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The aims of the present study are to investigate the effect of TDCS over the 
cerebellum on timing accuracy and variability in the PFT task. We 
hypothesise that anodal stimulation will modulate a central timing 
mechanism, measurable by increased tapping accuracy or decreased 
tapping variability compared with control. Given the polarity dependent 
effects of TDCS, cathodal stimulation is thus predicted to cause a significant 
deficit in timing parameters, demonstrable by greater inaccuracy in tapping 
with/or increased variability302 297 298. 
 
8.5 Methods 
 
8.5.1 Subjects  
	
Fourteen healthy right-handed volunteers (6 female; mean age 22.5 ± 3.6 
(SD) yrs; range 20-34) participated in the study. None of the subjects had a 
past history of seizures or hearing disorders and none had an implantable 
pacemaker nor were any taking medications or illicit drugs during the study. 
Participants were naive to the aims of the study. Subjects gave informed 
written consent and the study was approved by the local ethics committee, 
and conformed to the declaration of Helsinki. 
 
8.5.2 TDCS and tapping task  
	
The main intention in the series of experiments was to examine performance 
of a tapping task at different frequencies with the right (dominant in all cases) 
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index finger comparing the effect of anodal, cathodal and sham TDCS over 
the lateral cerebellum. In all experiments, tapping performance was recorded 
before TDCS and during TDCS. 
 
8.5.2.1 Design 
	
Experiments for all participants took place over three days with at least a 
week between days. On each experimental day, participants were randomly 
allocated to receive anodal, cathodal or sham stimulation. On each of these 
days, the participant would complete a pre-stimulation trial where they were 
required to tap in time with a fixed frequency repetitive auditory tone for a 
period of 30 seconds (synchronisation phase), followed by a period of 
tapping for 30 seconds at the same learned frequency but without the 
queued tone (continuation phase). This pre-stimulation trial was repeated 
three times to include in randomised order, three frequencies (0.5Hz, 1Hz, 
3Hz) of tapping. Participants then had a two minute rest period during which 
they had stimulation with TDCS (randomised to anodal, cathodal and sham). 
For sham stimulation, ‘real’ stimulation (randomised to either cathodal or 
anodal) was provided for a 30 second period to improve sham credibility. For 
anodal and cathodal stimulation, TDCS was continued until the end of the 
experiment. After the pre-stimulation trials, TDCS was initiated and the 
subject rested for two minutes to allow time for the stimulation to begin to 
take effect. A similar rest period was included for sham stimulation. 
Participants were then required to undertake nine consecutive trials of 
tapping, similar to pre-stimulation trials but in blocks of three of the same 
178	
	
tapping frequency. After each 3Hz trial, a small break of 90 seconds was 
given to allow the subject to rest their finger before the next trial, to avoid 
excessive fatigue from affecting performance. Order of blocks was 
randomised (see figure 8.1). The experiment was repeated on three days to 
include all three forms of stimulation (anodal, cathodal and sham) in 
randomised order to minimise the effect of practice. 
 
 
  
 
 
 
 
 
 
Figure 8.1 Tapping experiment – study design A) A trial is composed of 30s 
of tapping in time to a tone (synchronisation phase), and then 30s continuing 
tapping without the tone. B) A sample participant timetable, exhibiting the 
A. Trial Composition 
B. Sample Participant Timetable 
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prestimulation, rest and stimulation stages. Note that stimulation days and 
order of frequency trials are randomised across participants. 
 
8.5.2.2 Task 
	
Participants were sat comfortably in a chair with their right arm supported by 
a foam pad resting on a table surface. Subjects used their right index finger 
to tap in the centre of a round plate. A calibrated goniometer (Biometrics) 
was attached at one end to the proximal phalanx of the index finger and at 
the other, over the dorsum of the hand to allow measurement of  the angle 
between the two, tap amplitudes and timing. Participants were thus 
instructed to tap using movements at their metacarpophalangeal joints rather 
than using movements at the wrist or elbow. Taps were performed at a 
comfortable force for the participant. Participants were asked to tap up to the 
height of a visual target. The purpose of the target was to maintain a 
constant tapping height throughout trials. Prior to the beginning of the 
experiment, TDCS electrodes were attached to intended stimulation loci (see 
below). The goniometer was connected to an amplifier and data acquisition 
system which relayed the information to a desktop PC. Subjects were not 
provided with any additional feedback regards their tapping. Information from 
the tapping apparatus and auditory tone was entered in to the computer and 
visible to the experimenter using Spike2 software (CED, Cambridge, UK).  
 
8.5.2.3 TDCS 
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TDCS was delivered to the right cerebellar cortex using a commercially 
available DC stimulator (magstim neuroConn) (see chapter 4). The TDCS 
electrodes were 25cm2 (5cm width square) in surface area, encased in 
sponge pockets, soaked in saline solution and secured to the scalp surface 
with crepe bandage. To stimulate the right cerebellar cortex, one electrode 
was secured 3cm lateral to the inion, and the other electrode was secured 
over the right buccinator muscle. In the anodal condition the electrode from 
the negative terminal electrode was placed over the right buccinator. In the 
cathodal condition the electrode positions were reversed. An intensity of 2mA 
was used for 18 minutes for both anodal and cathodal conditions. The sham 
current consisted of 2mA anodal or cathodal stimulation for 30s, over the 
right cerebellum, enough to briefly mimic the signs of stimulation (itching, 
burning, metallic taste, and rarely, visual phosphenes) without allowing any 
known alteration in cortical activity. During the onset of stimulation the 
current in all conditions was increased in a ramp like fashion over a period of 
15s and ramped down for the termination of stimulation over the same 
duration, a method shown to achieve good blinding223. Anodal, cathodal and 
sham conditions were performed on different days with at least a week’s rest 
interval owing to the long lasting effects of TDCS. The participant but not 
experimenter was blinded to randomisation of stimuli settings. 
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8.5.3 Data Analysis 
	
In the data analysis, the intertap intervals (ITIs) were determined as 
measurements in time between peaks of finger displacement measured by 
goniometry. For each frequency (0.5Hz, 1Hz, 3Hz), mean ITIs and 
coefficients of variation were computed for the synchronisation and 
continuation phase for each of the three trials which were then averaged to 
determine a mean ITI for that condition. CV was used as an indicator of 
temporal variability where CV (%) = (SD/mean)/100. To determine effects of 
stimulation on variability and accuracy, a 3-way repeated measures ANOVA 
was planned for ITIs (accuracy) and CV ITIs (variability) with main factors of 
stimulation (anodal, cathodal, sham), frequency (0.5, 1, 3Hz) and block 
(synchronisation, continuation). Similar 3-way repeated measures ANOVAs 
were planned for pre-stimulation information but with factor stimulation 
replaced with day (day 1, day 2, day 3 and sham). Sham was to be included 
in the pre-stimulation analyses to evaluate its validity as a control for the 
stimulation conditions. Tap amplitude data was extracted from the tapping 
data by taking the area under the tapping curve generated from the force 
plate. This was to be done in the final trials of each condition, as those were 
most likely to show fatiguing effects. The first 3 taps and last 3 taps of each 
trial were removed as subjects often performed poor quality taps during 
these periods. After this truncation, the 4 taps at the beginning of the trial 
were compared to the 4 taps at the end of the trial, as these often lay outside 
of the 1min trial window. A three-way ANOVA was planned for tap amplitude 
measured by goniometry with factors of trial point (beginning, end), 
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stimulation (anodal, cathodal, sham) and frequency (0.5, 1 and 3Hz). Post 
hoc t-test were computed using a Bonferroni correction. None of the data 
violated the normality assumption necessary to conduct parametric statistical 
tests. 
 
8.6 Results 
 
All participants completed all three stimulation sessions. There were no 
complications. No significant main effects were found between TDCS 
stimulation and the accuracy of ITIs in either the synchronisation or 
continuation phases of the PFT task. Neither were there any significant main 
or interaction effects on accuracy between days in the pre-stimulation 
conditions.  
 
The variability of tapping did not significantly differ between TDCS 
stimulation conditions. However, a significant interaction was shown between 
frequency and cue type (synchronisation or continuation), indicating that 
frequency type affected variability differently according to the cue type. 
Analysis of pre-stimulation variability also showed this FREQ*CUE 
interaction. In the stimulation condition, t-tests confirmed that this 
FREQ*CUE interaction was due to differences in CV between 0.5Hz 
synchronisation and continuation phases and 3Hz synchronisation and 
continuation phases. This was also the case for pre-stimulation variability 
with 0.5Hz and 3Hz underlying the FREQ*CUE interaction. Interestingly, in 
both stimulation and pre-stimulation trials, variability of 0.5Hz decreased from 
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synchronisation to continuation phases, whereas for 3Hz variability it 
increased in the continuation phases. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8.2 Mean ITIs of participants tapping to a target ITI of a specified 
frequency during anodal, cathodal or sham cerebellar TDCS stimulation. The 
target ITIs are denoted by the dotted line. No significant changes can be 
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seen in mean ITI of the response in the different stimulation groups across 
the frequencies. 
 
Analysis revealed that the size of participants’ taps were significantly 
different from the beginning of the trial to the end of the trial. Further 
comparisons showed that this was almost entirely due to the 3Hz condition, 
whereby participants began with taps much larger than those from the 1 and 
0.5Hz conditions, and ended with taps of similar height as those from other 
conditions. 
 
8.6.1 Effect of Stimulation on Accuracy 
	
A 3-way repeated measures ANOVA with main factors of STIMULATION 
(anodal, cathodal, sham), FREQ (0.5, 1, 3Hz) and CUE (synchronisation, 
continuation) revealed no significant main effects or interactions of ITIs, apart 
from a borderline FREQ*CUE interaction (F=2.62, df=2, 26, P = 0.09). This 
indicates that change in accuracy in each cue condition varied with tapping 
frequency. Figure 8.2 shows the mean ITI in the stimulation and continuation 
phases of the PFT task across the 3 stimulation conditions. 
 
Accuracy can be determined by how close the group mean ITI matches the 
target ITI, denoted by the dotted line in each frequency condition; 2s for 
0.5Hz, 1s for 1Hz and 0.333s for 3Hz. The results show no trends in 
stimulation effect on accuracy of performance during synchronisation or 
continuation phases, as shown by inconsistent deviations from the target ITI 
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in each frequency. During 1Hz synchronisation, participants in all stimulation 
conditions were noted to tap slightly prior to the metronome tone, previously 
coined negative mean asynchrony, though this was not observed at other 
frequencies or cues. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.5Hz 
1H
z 
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z 
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Figure 8.3 CV ((SD/mean)/100) of finger tapping in the synchronization and 
continuation phase of the PFT task, during anodal, cathodal and sham 
cerebellar TDCS. There are no significant differences in the variability of 
tapping in any frequency under different stimulation modalities. 
 
8.6.2 Effect of Stimulation on Variability 
	
A 3-way repeated measures ANOVA with main factors of STIMULATION 
(anodal, cathodal, sham), FREQ (0.5, 1, 3Hz) and CUE (synchronisation, 
continuation) revealed no significant main effects of coefficient of variability 
(CV) of ITI (see fig. 8.3). A significant FREQ*CUE interaction was found (F= 
10.01, df= 2, 26, p=0.001). This indicates that the effect of frequency on CV 
is different between the cue conditions (see Figure 8.4). Figure 8.4 shows 
that cue type affects CV ITI in different ways depending on frequency; in the 
0.5Hz condition mean CV decreases from synchronisation to continuation 
whereas CV stays the same in 1Hz condition, and increases from 
synchronisation to continuation phase in the 3Hz condition. This was 
confirmed by paired t-tests which showed a significant difference between 
synchronisation and continuation CVs for 0.5Hz (t(41)=3.47 and p=0.001) 
and for 3Hz (t(41)= -2.18, p= 0.035), the negative t value for the 3Hz 
condition denoting the reversal in directionality of the effect, observable from 
fig. 8.4. There was no significant difference in CV ITI between 1Hz 
synchronisation and continuation. 
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8.6.3 Effect of Day on Pre-stimulation Variability and Sham Validity 
	
A 3-way repeated measures ANOVA with main factors of DAY (day 1, day 2, 
day 3 or SHAM stimulation), FREQ (0.5, 1 or 3Hz) and CUE 
(synchronisation, continuation) revealed no significant differences in 
accuracy on different days or during the Sham stimulation. Figure 8.5 shows 
the mean ITI in the stimulation and continuation phases on different days and 
during sham stimulation. The results show no effect of the day of 
performance or of sham stimulation on accuracy of ITIs. This means that 
participants did not improve their timing accuracy with practise over the three 
experimentation days. Additionally, the comparison confirms that the use of 
30s of anodal stimulation in the sham condition to improve participant 
blinding did not have any significant effect on accuracy or CV in comparison 
to the pre-stimulation condition, validating the control. Negative mean 
asynchrony was again observed in the 1Hz condition only, with tapping 
slightly preceeding the tone during the synchronisation phase. 
 
A 3-way repeated measures ANOVA with main factors of DAY (day 1, day 2, 
day 3 or SHAM stimulation), FREQ (0.5, 1 or 3Hz) and CUE 
(synchronisation, continuation) revealed a significant main effect of FREQ 
(F=3.56, df= 2, 26, p=0.04), and a significant interaction of FREQ*CUE on 
CV ITI (F=10.29, df=1,13, p=0.01). Figure 8.6 shows the differences in CV 
ITI on different days and during sham stimulation in the different frequencies, 
showing CV ITI is consistently lower in 1Hz condition than 0.5 and 3Hz 
conditions. Paired t-tests revealed that the main FREQ effect was due to a 
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significant difference between 1Hz CV and 0.5Hz CV (t(111)=3.68, p=0.00), 
and also a significant difference between 1Hz and 3Hz CV (t (111)=-2.15, 
p=0.03). There was no significant difference between 3Hz and 0.5Hz CV 
ITIs. 
 
The FREQ*CUE interaction revealed by the 3-way repeated measures 
ANOVA implies that the effect of frequency on CV is different between the 
cue conditions. Figure 8.4 illustrates this FREQ*CUE interaction, with CV ITI 
decreasing from the synchronisation to the continuation phase for 0.5Hz and 
increasing for 3Hz. A paired t-test confirmed these observations showing a 
significant difference between 3Hz synchronisation and continuation phases 
(t(56)=-2.11, p=0.04) and a borderline non-significant difference between 
0.5Hz synchronisation and continuation (t(56)=1.75, p=0.09) which was of a 
different directionality. There was no difference in 1Hz synchronisation and 
continuation CV ITIs.  Additionally, this comparison proves that the sham 
stimulation is a valid control for the anodal and cathodal conditions, as there 
is no significant change in CV in the sham condition compared to the pre-
stimulation condition. 
 
8.6.4 Tap Amplitude 
	
A 3-way repeated measures ANOVA with main factors of STIMULATION 
(anodal, cathodal and sham), FREQ (0.5, 1 and 3Hz) and TRIAL POINT 
(beginning, end) was used to determine whether the amplitude of 
participants taps varied from the beginning to the end of each 1min trial, with 
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stimulation and/or during different frequencies. A significant main effect of 
TRIAL POINT was revealed (F=5.78, df= 1,13 p=0.03), implying that there 
was a difference in size of taps at the beginning and end of each trial, see 
Figure 8.8. Figure 8.8 demonstrates the difference in mean tap amplitude 
from beginning to end in each of the frequencies, much of which appears to 
be due to a large change in 3Hz tap amplitude. Paired t-tests between tap 
amplitude at the beginning and end of each frequency explored this 
observation, and showed the main effect to be almost completely accounted 
for by difference in tap amplitude from the beginning to the end of 3Hz 
condition (t(41)=2.24, p=0.03) with only an additional borderline (non-
significant) change in tap amplitude in the 1Hz condition (t(41)=1.80, 
p=0.08). There was no significant difference in tap amplitude in 0.5Hz 
condition. The large difference in tap amplitude from the beginning to the end 
of 3Hz condition may be explained by fatiguing of the finger during this 
period of fast tapping. However, the 3Hz end taps are a similar size to the 
end taps of 0.5 and 1Hz, indicating a fatigue effect may not have occurred. 
There were no other main effects or interactions. 
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Figure 8.4 CV interaction of frequency and cue type. This graph shows that 
the effect of frequency on CV is different between the cue types 
(synchronization vs. continuation). Paired t tests revealed a significant 
difference between 0.5Hz synchronization and continuation phases 
(t(41)=3.47 and p=0.00) and 3Hz synchronization and continuation (t(41)= -
2.18, p= 0.04). CV ITI for 0.5Hz decreases from synchronization to 
continuation phases, whereas it increases in the 3Hz condition. 
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Figure 8.5 Mean ITIs of participants tapping to a target ITI of a specified 
frequency during day 1, 2, 3 of experimentation and sham stimulation. The 
target inter-tap-intervals are denoted by the dotted line. No significant 
changes can be seen in mean ITI of the response on the different days, or 
during sham stimulation across the frequencies. 
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Figure 8.6 CV of finger tapping in the synchronization and continuation 
phase of the PFT task, during day 1, day 2 and day 3 pre-stimulation and 
during sham TDCS. A main effect of Frequency was found from a 3 way 
repeated measures ANOVA (F=3.56, df= 2, 26, p=0.04) which is accounted 
for by significant differences in overall CV of 1Hz in comparison to 0.5Hz and 
3Hz CVs (t(111)=3.68, p=0.00) and (t (111)=-2.15, p=0.03) respectively. 
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Figure 8.7 CV (%) of ITI and cue type interaction for prestimulation sessions. 
This graph shows the effect of frequency on CV varies in the different cue 
types (synchronization, continuation). Paired t tests showed a significant 
difference between 3Hz synchronization and continuation (t(56)=-2.11, 
p=0.04), and a borderline significant difference between 0.5Hz 
synchronization and continuation phases (t(56)=1.75, p=0.09). 
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Figure 8.8 Mean tap amplitudes at the beginning and end of each finger 
tapping trial at different frequencies (0.5, 1 and 3Hz).  A significant main 
effect of TRIAL POINT (F=5.78, df= 1,13 p=0.03) indicates a significant 
difference in tap amplitude from beginning to the end of the trial. 3Hz 
undergoes a substantial decrease in tap amplitude from the beginning to the 
end of the trial (t(41)=2.24, p=0.03) whilst there are no other significant 
differences in tap amplitude. 
 
8.7 Discussion 
 
In this study, TDCS over the lateral cerebellum did not appear to have any 
effect on the variability or accuracy of ipsilateral paced finger-tapping 
movements. This data suggests that increasing or decreasing the excitability 
of cerebellar neuronal circuits has no significant effect on timing ability, 
although it may alternatively question the effect of our stimulation paradigm 
on the cerebellum.  
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In both the stimulation and pre-stimulation conditions, analysis of variability 
revealed significant interactions between frequency and cue type. There 
were similarities in this FREQ*CUE interaction in the stimulation and pre-
stimulation conditions: analysis of both showed differences between 3Hz and 
0.5Hz cue types of different directionalities. Regardless of whether the 
participant received stimulation or not, tapping in time to the tone during the 
0.5Hz synchronisation stage was associated with a greater variability than 
tapping without a tone (continuation phase). In contrast, in the faster 3Hz 
condition, variability increased only when subjects had to tap without a tone. 
This suggests that internal timing mechanisms without sensory cues are 
more consistent at slower rates of tapping, of those frequencies studied.  
 
8.7.1 Stimulation of the cerebellum 
	
Given the negative results, i.e. the apparent lack of effect of cerebellar TDCS 
does not have an effect on rhythmic tapping, it is necessary to consider 
whether the experimental paradigm was able to successfully stimulate the 
cerebellum. A TDCS intensity of 2mA was employed, a standard intensity 
used in numerous studies of TDCS to the cerebellum at which modulation in 
cerebellar activity has been observed185 271. This intensity is significantly 
higher than TDCS stimulation applied to non-cerebellar cortical areas, such 
as M1 where 1mA is commonly used successfully303 304, or slightly higher for 
prefrontal areas305. This increased intensity for cerebellar TDCS is 
necessary, given the greater distance of the cerebellum from the scalp 
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surface than M1. Nevertheless it has proven sufficient in other studies aiming 
to influence cerebellar circuits271. 
 
Other studies applying TDCS to the cerebellum have investigated cerebellar 
circuitry underlying other proposed functions such as adaptive learning271, 
eyeblink conditioning259  and cerebellar influence on M1 plasticity262. It is 
conceivable that the lack of a clear stimulation effect could be because 
cerebellar circuitry involving timing may not be susceptible to TDCS 
modulation. Del Olmo et al suggest that circuits in the cerebellum are 
differentially sensitive to external disruption, and that timing circuits for 
synchronisation taps to fast cues (2Hz) may be more sensitive to stimulation 
than other frequencies298, a frequency not tested here. Given the uncertainty, 
it cannot be ruled out that these timing circuits, which appear to have been 
influenced by alternative stimulation paradigms, such as repetitive TMS298, 
may not be sensitive to TDCS. 
 
Nearby circuits in non-cerebellar brain areas may also have impacted on our 
results due to inadvertent stimulation, for example brainstem pathways and 
their connections to the sensorimotor cortex and the thalamus. There is a 
possibility that brainstem pathways such as the medial leminiscus and 
spinothalamic tract are affected during tDCS, impacting on sensory 
transmission262. However, Galea et al found numerous sensory transmission 
dependent variables were not affected by TDCS, such as brainstem MEP 
threshold and size, and blink reflex185, refuting this possibility. Further, our 
negative results do not provide specific evidence for this possibility. 
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The choice of lateral cerebellum as a target for stimulation in this study can 
be justified on the grounds of considerable imaging and lesion data that 
indicates the lateral cerebellum as a locus for temporal processing298 306 307. 
However, a few studies also implicate medial and vermal areas as involved 
in timing170 308 309 297.  Despite this, there are also TMS-induced virtual lesion 
studies and imaging evidence to support damage to lateral cerebellum, 
rather than medial areas, is accompanied by timing abnormalities298 307. 
However, the distinction between damage to the dorsal and ventral portions 
of the dentate which have different projections has been insufficiently 
explored310. The dorsal dentate exerts its effects on M1 and ventral PM 
areas that have sensorimotor roles, whilst the ventral dentate projects to 
areas with cognitive roles such as dorsolateral prefrontal areas. This 
provides two competing ideas to explain deficits in timing following cerebellar 
damage; one favouring sensorimotor disruption311 312, and an opposing 
cognitive viewpoint313. 
 
The use of sham stimulation with participant blinding could potentially be 
inadequate and thus bias results although this might be expected to lead to a 
type 1 rather than type 2 statistical error in contrast to the nature of our 
results. However, our use of real anodal stimulation for the initial 30s of sham 
stimulation provided adequate blinding to the stimulation type as this initial 
phase was when most participants were aware of any side effects of 
stimulation. Further, there was no difference found between the sham 
stimulation and the pre-stimulation phase in terms of performance accuracy 
and variability.  
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8.7.2 Aspects of the PFT task 
	
We demonstrated a difference between tap amplitude at the beginning and 
end of the trial, attributable to a large reduction in tapping size at the 3Hz 
frequency. A possibility could be that participants experienced fatigue 
particularly in the 3Hz condition. However, measures were taken to ensure 
excessive fatigue was avoided. Ninety second breaks between each of the 
3Hz trials was introduced for this reason. Additionally, the change in tapping 
size did not necessarily suggest fatigue (see Figure 8.8). The mean 
amplitude of the 3Hz taps in the early part of the trials were larger than initial 
taps at 0.5 and 1Hz frequencies and mean final taps of 3Hz were of a size 
very similar to 0.5 and 1Hz. If fatiguing had occurred one might expect the 
final mean taps to be smaller in amplitude than other frequency trials. 
Excessive fatigue in a single condition may be expected to generate greater 
variability, as suggested previously294. Variability deteriorated from 
synchronisation to continuation phase (i.e. from beginning to end) in the 3Hz 
category (see Figure 8.7) and was similar to variability in other frequency 
conditions.  
 
One explanation for the negative results in this study may simply suggest 
that our method investigated timing intervals irrelevant to cerebellar timing. 
Much work has focused on the cerebellum as a controller of timing in the 
millisecond to second time scale, consistent with temporal aspects of muscle 
control that are also under cerebellar control302 314. Yet the specialised sub-
second timing role of the cerebellum has been the subject of much debate221 
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309. Lewis and Miall found distinct brain activation patterns for temporal 
discrimination tasks of 0.6s and 3s, and greater cerebellar activation in the 
0.6s group315. Repetitive TMS over the lateral cerebellum disturbed timing in 
the millisecond range, at 2Hz298. Similarly, in an additional cerebellar rTMS 
study Oliveiri et al. found that in a visual time reproduction task deficits in 
timekeeping were seen in millisecond time interval targets316. However, 
cerebellar patients with focal lesions in the lateral cerebellum showed deficits 
in remembering durations of second timescales307. The current study 
investigated a range of timing intervals to cover proposed cerebellar 
millisecond and second timescales; with intervals of 0.33, 1 and 2s. 
Therefore it seems unlikely that an insignificant result was obtained simply 
due to exploration of inappropriate tapping frequencies.  
 
The PFT task is well established in the timing literature317. However data 
exists to suggest preferable cerebellar activation in more demanding tasks 
such as highly complex rhythms318. Our study relied upon a simple tapping 
paradigm that conversely benefits from ease of control of variables. 
 
In concordance with the novelty of the task, cerebellar rTMS disruptions are 
seen only in the synchronisation part of the PFT task298 and not the 
continuation phase. In the novel synchronisation phase the participant must 
prepare and execute motor outputs in time to an external stimulus, during 
which an internal representation of the interval may be formed. It has been 
suggested that the continuation phase may not be cerebellar dependent298 
but rather rely on other brain areas. One study demonstrated that 
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sensorimotor cortex, cerebellum and superior temporal gyrus were active 
during synchronisation, but during the continuation phase the supplementary 
motor area, putamen, inferior frontal gyrus, and ventrolateral thalamus were 
additionally activated172. The prefrontal cortex may play an important role in 
the continuation phase, or when time intervals must be kept in memory314 319, 
supported by evidence from patients with prefrontal lesions demonstrating 
deficits in millisecond time processing.  
 
Given the likely importance of prefrontal brain regions in the continuation 
phase, it poses the question of whether cerebellar stimulation was thus 
unlikely to disrupt this ability to maintain consistent timing. However, this 
seems unlikely as studies disrupting time estimation tasks using rTMS over 
the right dorsolateral prefrontal cortex (DLPFC), have only interfered with 
estimations in the second interval, (2s average) rather than millisecond 
intervals (0.5ms average)320. 
 
8.7.3 Cerebellum and Timing 
	
It is conceivable, given timing ranges, that the cerebellum is not influencing 
timing per se in SMS, but is rather performing its motor coordination roles of 
starting and stopping fast accurate movements315. Motor coordination can be 
considered a state-dependent process whereby motor commands to one 
effector are dependent on predictions on the state of another at that moment 
in time, whereas timing is a process independent of external influence. In a 
series of experiments by Diedrichsen et al312, the timing and coordination 
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roles of the cerebellum were dissociated. The cerebellum was found to be 
active during state-dependent control tasks, representing the predictive 
motor abilities of the cerebellum, but it was not seen to be active during time 
dependent control. As such, the single finger movement in our task would not 
require state-dependent control and according to the proposed dissociation, 
may not require the cerebellum for predictive timing. 
 
8.8 Conclusion 
 
Our experiments suggest that TDCS applied to the lateral cerebellum does 
not interfere with the control of hand movements as measured by rhythmic 
timing and variability. Limitations of the study include the possibility that the 
TDCS dose and position was insufficient for successful cerebellar 
stimulation, or rather induced stimulation in other nearby brain areas. The 
emerging view is that timing implicates wide brain networks. Further, timing 
mechanisms may be split into different categories depending on their 
temporal niche (sub-second, or suprasecond) and also depending on the 
context of the timing (state dependent or time dependent). This study found 
significant interactions between frequency and cue type that suggest timing 
mechanisms greater than 1s work most efficiently independent of timed 
sensory information, as demonstrated in the 0.5Hz category where there was 
a (non-significant) trend for lower variability in the continuation phase. 
Conversely we found that sub-second timing mechanisms function better 
with a timed sensory stimulus, as seen in the synchronisation phase for 3Hz 
where there was less variability than in the continuation phase.  
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The cerebellum may be involved in the synchronisation of subsecond 
movements to timing intervals, as suggested by Del Olmo et al298, though 
this may not involve a ‘pure’ timing mechanism like that suggested as the 
central timekeeper in the Wing and Kristofferson model. Through this 
framework the cerebellum may be involved in the sensorimotor coordination 
required to predict accurately timed movements in relation to other muscle 
states (state dependent control). To further investigate this, it would be useful 
to compare the effects of cerebellar TDCS on finger tapping as compared to 
another movement such as an arm movement that would require predictive 
timing mechanisms about muscle states to be employed.  
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Chapter 9: General discussion, conclusions and further work 
 
Attention is increasingly being turned to the pathophysiological mechanisms 
of differing types of tremor. For example, a proposition for the mechanisms 
underlying Parkinson’s disease tremor has been outlined by Helmich and 
colleagues7. For some commoner tremor types, such as ET and Parkinson’s 
disease tremor, the added insight given by in vivo recording during deep 
brain stimulation implantation has added a unique insight into these 
commoner tremors. Even so, the fundamental causes and the dynamical 
systems involved remain somewhat opaque. For rarer tremors such as 
neuropathic tremor, such insight has not been feasible except on a case 
report basis and from a single neurophysiologial study128. Newer approaches 
to treatment of movement disorders such as tremor is partly dependent on 
an understanding of pathophysiological mechanisms, such as the trials of 
new drugs (e.g. Octanol in ET) or the development of novel uses for deep 
brain stimulation.  
 
This thesis presents the results of a series of experiments exploring aspects 
of sensorimotor physiology associated with patients who have neuropathic 
tremor with the aim of furthering the understanding of the pathophysiological 
basis behind why this symptom arises. The studies were split into those 
investigating patients with inflammatory neuropathies and secondly, those 
with hereditary neuropathies, namely CMT1A. The a priori hypothesis was 
that the cerebellum was functioning abnormally in these patients, likely either 
as a trait or due to a direct targeting of the cerebellum through the 
immunological or hereditary process causing the neuropathy. Tremor 
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occurrence seems requisite in those with inflammatory neuropathies on an 
abnormally functioning cerebellum. Aspects of the neuropathy, in the 
presence of tremor then seem to influence severity lending support to a two 
hit hypothesis for the generation of tremor. Results from patients with 
inflammatory neuropathies supported this hypothesis yet those with 
hereditary neuropathies did not. Those patients with CMT1A and tremor 
seemed rather to demonstrate tremor consistent with an enhanced central or 
physiological tremor. We postulated that this may relate to fatigue. Differing 
tremor types have been shown to involve cerebellothalamocortical circuits 
and on this basis, a number of groups have looked at stimulation of the 
cerebellum as a potential modulator of tremor. With this in mind, the final 
experiment presented in this thesis explores the effects of cerebellar 
stimulation with TDCS on timing of rhythmic movements of the finger in 
healthy controls but with results showing no demonstrable effect.  
 
The work described here generates a number of further questions that will be 
outlined and contextualised in the light of other contemporaneous work. This 
will be presented in the form of planned further work. 
 
9.1 Further work 
 
9.1.1 Cortico-muscular coherence in neuropathic tremor 
 
The proposition that neuropathic tremor in inflammatory neuropathies is 
contingent predominantly on abnormal function of the cerebellum would be 
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analogous to the role it has in some other tremor types such as essential 
tremor. As such, the cerebellothalamocortical network, likely active in tremor 
propogation in ET, may be expected to have activity coherent with the tremor 
phase measured peripherally.  It would be helpful to decipher whether there 
is a cortical (motor cortical) signal coherent to peripherally measured tremor 
in NT as there are some reports suggesting targeting relevant motor areas 
with repetitive TMS may prove helpful for abating symptoms in tremor of 
cortical origin321. Different cortical areas may be temporarily entrained in 
essential tremor54. Determining brain areas coherent with tremor peripherally 
may prove useful in coordinated resetting of tremor322.  
 
9.1.1.1 MEG-EMG correlation 
 
The correlation between cortical activity and final motor output remains a 
central question in motor physiology. This has been probed using methods to 
record electrical brain activity using electroencephalography (EEG) or 
magnetoencephalography (MEG) and correlating it with EMG. For example, 
cortical myoclonus has been investigated using such approaches, where 
jerk-locked back averaging allows subtle cortical activity to be recorded using 
EMG movement-related activity onset as the fiducial point for averaging 
preceeding EEG signal. Similarly, premovement cortical potentials such as 
the Bereitschaftspotential and the contingent negative variation can be 
measured by correlating EEG activity with the onset of EMG activity and 
averaging multiple trials to derive common cortical signals.  
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In addition to time-based approaches to correlation as described, frequency-
based techniques may be employed. There are a number of statistical and 
methodological approaches to determining correlation between two linear 
signals. Such approaches estimate functional connectivity of two regions. 
Coherence analysis, an example of this, enables calculation of a normalised 
magnitude of correlation as a function of frequency. Cortico-muscular 
interaction was shown indirectly in studies correlating single motor unit 
activity in different muscles323 324. MEG was first utilised to demonstrate 
cortico-muscular coherence (above significance levels by revealing 
coherence at beta band frequencies (15-35Hz))94.  Other such measures of 
functional connectivity include dynamic imaging of coherent sources (DICS). 
 
Given our findings of an abnormal EBCC in patients with inflammatory NT, it 
would be useful to know if there is coherence between MEG-EMG in these 
patients. This would be compared with other areas of the brain such as 
motor cortex to determine if networks similar to ET may be active. This could 
provide a picture of tremor that is similar between the two conditions and 
potentially speak to the cerebellothalamocortical circuit as a common final 
end point of tremor and therefore explain the ubiquitous benefit of VIM 
stimulation for most tremor types, including provisional reports for NT.  
 
9.1.2 Structural imaging study 
 
The presence of functional involvement of the cerebellum in neuropathic 
tremor is supported by positron-emission tomography (PET) and functional 
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magnetic resonance imaging (fMRI) 132, but again, it is not clear whether this 
finding reflects primary or secondary changes in the cerebellum. Critically, 
there have been no studies to date assessing the structural integrity of the 
cerebellum in patients with neuropathic tremor compared to those with 
neuropathy but without tremor.  
 
The results here in patients with inflammatory neuropathies, provide a new 
perspective of evidence supporting the role of an abnormally functioning 
cerebellum on tremor occurrence. Similar findings in ET exist, with functional 
imaging, electrophysiological and pathological studies. PET studies have 
demonstrated a bilateral increase in cerebellar and thalamic blood flow 25 and 
MR spectroscopy has suggested dysfunction in the cerebellar cortex 26.  Eye-
blink conditioning is also severely impaired in essential tremor 27 28 
suggesting abnormal plasticity in the cerebellum. The strong evidence for a 
role of the cerebellum in essential tremor has also been corroborated by 
structural imaging studies. Benito-Leon et al. 30 demonstrated structural 
abnormalities in ET patients using VBM and a 3-T MRI scanner. Using lower 
field scanners (1.5-T) contradictory results have been reported 32 33. Using 
Diffusion-weighted imaging to search for evidence of tissue integrity 
abnormalities in these areas in ET patients failed to find any significant 
abnormalities 34, arguing against major structural damage in the ET brain, 
though more subtle neurodegenerative changes could not be ruled out. 
However, Shin et al. 35 investigated changes in anisotropy in patients with ET 
by comparing fractional anisotropy (FA) images generated from diffusion 
tensor imaging data acquired at 1.5T; compared with the control subjects, 
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they found patients with ET exhibited significantly reduced FA in areas of the 
brainstem and bilateral cerebellum.  
 
Neurodegenerative changes in the cerebellum have been found on 
pathological specimens of essential tremor 46 48 confirming this suggestion. 
Essential tremor has also in turn been associated with structural 
abnormalities of the cerebellum in the form of atrophy. In a similar way, it 
would be important to determine whether there are any structural changes in 
the cerebellum in neuropathic tremor, as this will provide significant evidence 
of the underlying aetiological factors and help guide the approach to 
treatment. Similar methods of structural MR imaging used in essential tremor 
might be used in studying cerebellar atrophy in neuropathic tremor. There 
are potential benefits of identifying the role of the cerebellum in treatment of 
neuropathic tremor. For example, activation of the cerebellathalamocortical 
circuit is essential to the presence of ET; such reports have led to lesional 
therapies of the ventral intermediate (VIM) nucleus of the thalamus with 
marked benefit. Effective treatment of neuropathic tremor, though, is less 
clear. However, DBS of the VIM has been reported with sustained benefit in 
a case of hereditary motor sensory neuropathy type 1 139 and a small number 
of cases of anti-MAG neuropathy 141-143 less clear 129 139 141-143.  
 
A sufficiently sized group of patients with inflammatory neuropathies with and 
without tremor as well as healthy controls would need to be recruited. By 
using high field (3-T magnet) imaging of the brain in each of these 
participants, one could assess the extent of structural change or atrophy of 
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the cerebellum, comparing each group. Clinical assessment of the tremor 
would need to be undertaken. 
 
Subjects would undergo 3D dimensional isotropic structural imaging of the 
whole brain at 3T (Siemens TIM Trio). A standard T1-weighted MPRAGE 
sequence, optimised for volumetric imaging would be used with an 
acquisition time of approximately 10 minutes. (Typical parameters: 
1.1x1.1x1.1mm isotropic voxels, 200 sagittal slices, TR/TE 2200/3ms, 
Inversion time 900ms, 256x256 acquisition matrix, flip angle 10 degrees, 1 
signal average). The signal would be received with a 12 channel head matrix 
coil without parallel imaging acceleration with the patient supine and 
positioned to minimise the effect of any tremor on the acquisition.  
 
In addition to the 3D volumetric acquisition it is proposed that each subject 
would also receive standard T1 and T2–weighted diagnostic turbo spin echo 
volumes to allow radiological evaluation of any prominent structural or 
pathological features of the cerebellum (acquisition time ~10 minutes).  
 
The 3D MPRAGE volumes would be analysed using voxel based 
morphometric methods 325, including appropriate steps to smooth the data, 
transform the volumes into a standard anatomical space, segment into grey 
matter, white matter and CSF and perform statistical parametric mapping by 
application of a general linear model. It is anticipated that the SPM5 software 
would be used for VBM analysis (Wellcome Trust Imaging Laboratory, UCL). 
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In addition to the VBM analysis, it is feasible that a region of interest based 
analysis focussing on certain areas of the cerebellum (using methods similar 
to those used by Quattrone and Cerasa 32) might also be performed, 
providing an independent verification of any apparent features in the 
cerebellum using the 3D structural data.  
 
9.1.3 CSF antibody study 
 
Since our work, results of an interesting immunological study of a sub-group 
of patients with CIDP associated with anti-neurofascin 155 antibodies of the 
IgG4 subclass. All patients had a severe, predominantly distal, motor 
demyelinating (but not axonal) neuropathy (as per their initial nerve 
conduction study) with ataxia. Three of these four patients showed a striking 
low-frequency postural and intention tremor that was not present in any other 
patient with CIDP of their series. None of the four patients responded to IVIg, 
perhaps due to a relatively different mechanism of action of the antibody in 
relation to complement binding and binding to Ig Fc domain receptors29. 
When an IVIg-resistant cohort was selected, a higher proportion were 
positive for the antibodies compared with the unselected group of their CIDP 
patients. These antibodies may thus have a therapeutic and prognostic 
implication. 
 
Neurofascin 155 has a key role in myelination functional organisation at the 
node of Ranvier. Selective knockout of neurofascin in mice causes a severe 
demyelinating neuropathy with marked drop in conduction velocities and 
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degeneration of cerebellar Purkinje neurons, precipitating considerable 
tremor and ataxia.25 The authors make this case asserting the likely 
pathogenic nature of these anti-neurofascin 155 antibodies.  
 
No other patient from their cohort showed such a disabling tremor. The 
features of the tremor in their patients suggested a cerebellar origin although 
other signs of cerebellar impairment (nystagmus, oculomotor disturbances) 
were not present. They demonstrate that the serum of anti-NF155+ patients 
react intensely with the neuropil of rat brain, with a pattern of immunostaining 
of hippocampus and cerebellum that was identical in all cases, suggesting 
that neurofascin 155 is one of the target antigens in patients with CIDP who 
have low-frequency, high amplitude tremor. One of their patients did not 
show a prominent tremor but showed a rat brain staining pattern similar to 
the other three. This patient had lower anti-neurofascin155 titres than the 
other three and this could influence the intrathecal levels of anti-
neurofascin155 antibodies and, thus, the presence of tremor. Nevertheless, 
further studies are needed to clarify whether anti-neurofascin155 antibodies 
cause cerebellar pathology and whether these antibodies distinguish 
between CIDP patients with and without overt tremor of cerebellar origin.  
 
In their series, anti-neurofascin155 antibodies were not present in 204 
controls, including 51 patients with GBS. Central demyelination was not 
found on MRI in any of the patients with the antibodies. It would be valuable 
to determine from the sera of our patients with tremor whether or not these 
antibodies are present when controlled against those without tremor. 
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9.1.4 Phase dependent stimulation 
 
Given the lack of effect of TDCS of cerebellum on rhythmic finger tapping, a 
few conclusions could be considered. These have been dealt with in chapter 
8, but essentially include the possibility that the methods used failed to 
provide sufficient stimulation to the cerebellum or that stimulation was 
achieved, but with no effect on the variables measured.  
 
Alternative experiments utilising cerebellar stimulation may require a more 
refined approach. Using transcranial alternating current stimulation (TACS), 
we have used such an approach on patients with differing tremor types to 
determine whether such cerebellar and separately motor cortical stimulation 
might be able to modulate tremor in a phase specific manner when analysed 
retrospectively.  
 
Closed-loop stimulation may allow stimulation in real-time in reaction to a 
measurable biomarker. Phase dependent approaches to closing this loop 
may provide greater understanding of how oscillatory activity within the 
nervous system is generated, propagated and potentially suppressed. In the 
physical sciences, a broad range of biological oscillators, ranging from 
circadian rhythms to the cardiac pacemaker rhythm, have been 
characterised using a mathematical approach known as dynamical systems 
theory. More specifically, the phase response curve, which characterises an 
oscillator’s response to perturbation as a function of its phase, provides an 
intuitive insight into how the oscillation is generated, how it becomes 
entrained by other oscillators, and how it may be desynchronised. 
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In contrast to the single neuron PRC where estimation is straightforward, 
estimates of PRC of an oscillatory neuronal network (i.e a population of 
synchronised neurons with a “cumulative” PRC) has only recently been 
characterised in vitro, where the timing of neuronal firing is known. In 
attempting to estimate the PRC from a neuronal oscillation (such as tremor 
or local field potential from a DBS electrode) both the relationship between 
the underlying single neuronal firing to the population neuronal oscillation 
and the precise timing of the perturbing pulse are unknown. Using single 
neuron simulations we aim to demonstrate how these unknowns invalidate 
the traditional approach to PRC estimation. We have gone on to develop a 
novel iterative method, which overcomes these limitations of the traditional 
PRC estimation. We have begun to apply this method to patients with 
tremulous Parkinson’s disease with preliminary results suggesting the ability 
to recover the tremor PRC derived from TMS applied to primary motor 
cortex.  
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